ACTG Publications

TitleAuthorsDateJournalIssueVolume
As-Needed versus Immediate Etoposide Chemotherapy in Combination with Antiretroviral Therapy for Mild or Moderate AIDS-associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial.Hosseinipour, M C ; Kang, M ; Krown, S E ; Bukuru, A ; Umbleja, T ; Martin, J ; Orem, J ; Godfrey, C ; Hoagland, B ; Mwelase, N ; Langat, D ; Nyirenda, M ; MacRae, J ; Borok-Williams, M ; Samaneka, W ; Moses, A ; Mngqbisa, R ; Busakhala, N ; Martínez-Maza, O ; Ambinder, R ; Dittmer, D P ; Nokta, M ; Campbell, T B ; A5264/AMC-067 REACT-KS t2018 Jan 22Clin Infect Dis
Evaluation of PrediXcan for prioritizing GWAS associations and predicting gene expression.Li, Binglan ; Verma, Shefali S ; Veturi, Yogasudha C ; Verma, Anurag ; Bradford, Yuki ; Haas, David W ; Ritchie, Marylyn D2018Pac Symp Biocomput23
Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study.Celum, Connie ; Hong, Ting ; Cent, Anne ; Donnell, Deborah ; Morrow, Rhoda ; Baeten, Jared M ; Firnhaber, Cynthia ; Grinsztejn, Beatriz ; Hosseinipour, Mina C ; Lalloo, Umesh ; Nyirenda, Mulinda ; Riviere, Cynthia ; Sanchez, Jorge ; Santos, Breno ; Supparatpinyo, Khuanchai ; Hakim, James ; Kumarasamy, N ; Campbell, Thomas B ; ACTG PEARLS/A2017 03 15J Infect Dis6215
Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults.Bisson, Gregory P ; Ramchandani, Ritesh ; Miyahara, Sachiko ; Mngqibisa, Rosie ; Matoga, Mitch ; Ngongondo, McNeil ; Samaneka, Wadzanai ; Koech, Lucy ; Naidoo, Kogieleum ; Rassool, Mohammed ; Kirui, Fredrick ; Banda, Peter ; Mave, Vidya ; Kadam, Dileep ; Leger, Paul ; Henestroza, German ; Manabe, Yukari C ; Bao, Jing ; Kumwenda, Johnstone 2017 Oct 23AIDS1631
CD56NK IL-7Rα expression negatively associates with HCV level, and IL-7-induced NK function is impaired during HCV and HIV infections.Judge, Chelsey J ; Kostadinova, Lenche ; Sherman, Kenneth E ; Butt, Adeel A ; Falck-Ytter, Yngve ; Funderburg, Nicholas T ; Landay, Alan L ; Lederman, Michael M ; Sieg, Scott F ; Sandberg, Johan K ; Anthony, Donald D2017 JulJ Leukoc Biol1102
A Randomized Placebo Controlled Trial of Aspirin Effects on Immune Activation in Chronically Human Immunodeficiency Virus-Infected Adults on Virologically Suppressive Antiretroviral Therapy.O'Brien, Meagan P ; Hunt, Peter W ; Kitch, Douglas W ; Klingman, Karin ; Stein, James H ; Funderburg, Nicholas T ; Berger, Jeffrey S ; Tebas, Pablo ; Clagett, Brian ; Moisi, Daniela ; Utay, Netanya S ; Aweeka, Fran ; Aberg, Judith A2017 WinterOpen Forum Infect Dis14
Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.Gandhi, Rajesh T ; McMahon, Deborah K ; Bosch, Ronald J ; Lalama, Christina M ; Cyktor, Joshua C ; Macatangay, Bernard J ; Rinaldo, Charles R ; Riddler, Sharon A ; Hogg, Evelyn ; Godfrey, Catherine ; Collier, Ann C ; Eron, Joseph J ; Mellors, John W ; ACTG A5321 Team2017 AprPLoS Pathog413
Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection.Sherman, Kenneth E ; Kang, Minhee ; Sterling, Richard ; Umbleja, Triin ; Marks, Kristen ; Kiser, Jennifer J ; Alston-Smith, Beverly ; Greaves, Wayne ; Butt, Adeel A2017 Feb 08World J Hepatol49
Impact of Larger Sputum Volume on XpertMTB/RIF Assay Detection of Mycobacterium tuberculosis in Smear-Negative Individuals with Suspected Tuberculosis.Badal-Faesen, Sharlaa ; Firnhaber, Cynthia ; Kendall, Michelle A ; Wu, Xingye ; Grinsztejn, Beatriz ; Escada, Rodrigo Otavio da Silva ; Fernandez, Michel ; Hogg, Evelyn ; Sanne, Ian ; Johnson, Pamela ; Alland, David ; Mazurek, Gerald H ; Benator, Debra A ; Luetkemeyer, Anne F ; AIDS Clinical Trials Group A5295 ; Tuberculosis Trials Consort2017 Aug 07J Clin Med86
Vitamin A and D Deficiencies Associated With Incident Tuberculosis in HIV-Infected Patients Initiating Antiretroviral Therapy in Multinational Case-Cohort Study.Tenforde, Mark W ; Yadav, Ashish ; Dowdy, David W ; Gupte, Nikhil ; Shivakoti, Rupak ; Yang, Wei-Teng ; Mwelase, Noluthando ; Kanyama, Cecilia ; Pillay, Sandy ; Samaneka, Wadzanai ; Santos, Breno ; Poongulali, Selvamuthu ; Tripathy, Srikanth ; Riviere, Cynthia ; Berendes, Sima ; Lama, Javier R ; Cardoso, Sandra W ; Sugandhavesa, Patcharaph2017 07 01J Acquir Immune Defic Syndr375
Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants.Mukherjee, Pranab K ; Chen, Huichao ; Patton, Lauren L ; Evans, Scott ; Lee, Anthony ; Kumwenda, Johnstone ; Hakim, James ; Masheto, Gaerolwe ; Sawe, Frederick ; Pho, Mai T ; Freedberg, Kenneth A ; Shiboski, Caroline H ; Ghannoum, Mahmoud A ; Salata, Robert A ; Oral HIVAIDS Research Alliance (OHARA)AIDS Clinical Trials Group (ACTG) 5265 Te2017 Jan 02AIDS131
The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults With Human Immunodeficiency Virus Infection.Erlandson, Kristine M ; Kitch, Douglas ; Wester, C William ; Kalayjian, Robert C ; Overton, Edgar Turner ; Castillo-Mancilla, Jose ; Koletar, Susan L ; Benson, Constance A ; Campbell, Thomas B ; Robertson, Kevin ; Lok, Judith J2017 Nov 29Clin Infect Dis1265
Generalized semiparametric varying-coefficient model for longitudinal data with applications to adaptive treatment randomizations.Qi, Li ; Sun, Yanqing ; Gilbert, Peter B2017 06Biometrics273
Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224s.Venuto, Charles S ; Lim, Jihoon ; Messing, Susan ; Hunt, Peter W ; McComsey, Grace A ; Morse, Gene D2017 Nov 24Antivir Ther
Treatment with integrase inhibitor suggests a new interpretation of HIV RNA decay curves that reveals a subset of cells with slow integration.Cardozo, E Fabian ; Andrade, Adriana ; Mellors, John W ; Kuritzkes, Daniel R ; Perelson, Alan S ; Ribeiro, Ruy M2017 JulPLoS Pathog713
Vitamin D Supplementation Does Not Affect Metabolic Changes Seen With ART Initiation.Muhammad, Josh ; Chan, Ellen S ; Brown, Todd T ; Tebas, Pablo ; McComsey, Grace A ; Melbourne, Kathleen ; Hardin, Royce ; Willig, Amanda L ; Yin, Michael T ; Ribaudo, Heather ; Overton, Edgar Turner2017 FallOpen Forum Infect Dis44
Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors.Manasa, Justen ; Varghese, Vici ; Pond, Sergei L Kosakovsky ; Rhee, Soo-Yon ; Tzou, Philip L ; Fessel, W Jeffrey ; Jang, Karen S ; White, Elizabeth ; Rögnvaldsson, Thorsteinn ; Katzenstein, David A ; Shafer, Robert W2017 Sep 14Sci Rep17
Immiscible phase filter extraction and equivalent amplification of genotypes 1-6 of hepatitis C RNA: The building blocks for point-of-care diagnosis.Neto, Mário F ; Butzler, Matthew A ; Reed, Jennifer L ; Rui, Xiang ; Fisher, Mark J ; Kelso, David M ; McFall, Sally M2017 OctJ Virol Methods248
IFN-free therapy is associated with restoration of type I IFN response in HIV-1 patients with acute HCV infection who achieve SVR.Carlton-Smith, C ; Holmes, J A ; Naggie, S ; Lidofsky, A ; Lauer, G M ; Kim, A Y ; Chung, R T ; of the ACTG A5327 study group2017 Nov 29J Viral Hepat
Brief Report: Changes in Levels of Inflammation After Antiretroviral Treatment During Early HIV Infection in AIDS Clinical Trials Group Study A5217.Macatangay, Bernard J ; Yang, Ming ; Sun, Xin ; Morton, Jessica ; De Gruttola, Victor ; Little, Susan ; Hogan, Christine ; Rinaldo, Charles R ; A5217 Team2017 05 01J Acquir Immune Defic Syndr175
Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors.Podany, Anthony T ; Scarsi, Kimberly K ; Fletcher, Courtney V2017 JanClin Pharmacokinet156
Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants.Mollan, Katie R ; Tierney, Camlin ; Hellwege, Jacklyn N ; Eron, Joseph J ; Hudgens, Michael G ; Gulick, Roy M ; Haubrich, Richard ; Sax, Paul E ; Campbell, Thomas B ; Daar, Eric S ; Robertson, Kevin R ; Ventura, Diana ; Ma, Qing ; Edwards, Digna R Velez ; Haas, David W ; AIDS Clinical Trials Group2017 Sep 01J Infect Dis5216
Efavirenz Therapeutic Range in HIV-1 Treatment-Naive Participants.Bednasz, Cindy J ; Venuto, Charles S ; Ma, Qing ; Daar, Eric S ; Sax, Paul E ; Fischl, Margaret A ; Collier, Ann C ; Smith, Kimberly Y ; Tierney, Camlin ; Yang, Yang ; Wilding, Gregory E ; Morse, Gene D2017 DecTher Drug Monit639
Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen.Coban, Hamza ; Robertson, Kevin ; Smurzynski, Marlene ; Krishnan, Supriya ; Wu, Kunling ; Bosch, Ronald J ; Collier, Ann C ; Ellis, Ronald J2017 Jul 17AIDS1131
Disability Among Middle-Aged and Older Persons With Human Immunodeficiency Virus Infection.Johs, Nikolas A ; Wu, Kunling ; Tassiopoulos, Katherine ; Koletar, Susan L ; Kalayjian, Robert C ; Ellis, Ronald J ; Taiwo, Babafemi ; Palella, Frank J ; Erlandson, Kristine M2017 Jul 01Clin Infect Dis165
Racial differences in calculated bioavailable vitamin D with vitamin D/calcium supplementation.Yin, Michael T ; Chan, Ellen S ; Brown, Todd T ; Tebas, Pablo ; McComsey, Grace A ; Melbourne, Kathleen M ; Napoli, Andrew ; Hardin, William R ; Ribaudo, Heather J ; Overton, Edgar T ; A5280 Study Team2017 Nov 13AIDS1731
Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm3.Currier, Judith S ; Britto, Paula ; Hoffman, Risa M ; Brummel, Sean ; Masheto, Gaerolwe ; Joao, Esau ; Santos, Breno ; Aurpibul, Linda ; Losso, Marcelo ; Pierre, Marie F ; Weinberg, Adriana ; Gnanashanmugam, Devasena ; Chakhtoura, Nahida ; Klingman, Karin ; Browning, Renee ; Coletti, Anne ; Mofenson, Lynne ; Shapiro, David ; Pilotto, Jose 2017PLoS One512
T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy.Thomas, Allison S ; Jones, Kimberley L ; Gandhi, Rajesh T ; McMahon, Deborah K ; Cyktor, Joshua C ; Chan, Dora ; Huang, Szu-Han ; Truong, Ronald ; Bosque, Alberto ; Macedo, Amanda B ; Kovacs, Colin ; Benko, Erika ; Eron, Joseph J ; Bosch, Ronald J ; Lalama, Christina M ; Simmens, Samuel ; Walker, Bruce D ; Mellors, John W ; Jones, R Brad2017 SepPLoS Pathog913
Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305).Gulick, Roy M ; Wilkin, Timothy J ; Chen, Ying Q ; Landovitz, Raphael J ; Amico, K Rivet ; Young, Alicia M ; Richardson, Paul ; Marzinke, Mark A ; Hendrix, Craig W ; Eshleman, Susan H ; McGowan, Ian ; Cottle, Leslie M ; Andrade, Adriana ; Marcus, Cheryl ; Klingman, Karin L ; Chege, Wairimu ; Rinehart, Alex R ; Rooney, James F ; Andrew, Phi2017 Jan 15J Infect Dis2215
Associations of Plasma Cytokine and Microbial Translocation Biomarkers With Immune Reconstitution Inflammatory Syndrome.George, Varghese ; Harrison, Linda ; Roach, Margaret ; Li, Xiao-Dong ; Tierney, Camlin ; Fischl, Margaret A ; Aberg, Judith ; Tebas, Pablo ; Asmuth, David M ; Pollard, Richard B ; Godfrey, Catherine ; Pahwa, Savita ; AIDS Clinical Trials Group A5202 Study Team2017 Nov 27J Infect Dis9216
Impact of Medication Adherence on Virologic Failure in A5202: A Randomized, Partially Blinded, Phase 3B Study.Parker, Robert A ; Rabideau, Dustin J ; Sax, Paul E ; Tierney, Camlin ; Daar, Eric S ; Collier, Ann C ; Losina, Elena ; Freedberg, Kenneth A2017 Jun 01Clin Infect Dis1164
Multiphenotype association study of patients randomized to initiate antiretroviral regimens in AIDS Clinical Trials Group protocol A5202.Verma, Anurag ; Bradford, Yuki ; Verma, Shefali S ; Pendergrass, Sarah A ; Daar, Eric S ; Venuto, Charles ; Morse, Gene D ; Ritchie, Marylyn D ; Haas, David W2017 MarPharmacogenet Genomics327
Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption.Park, You Jeong ; Etemad, Behzad ; Ahmed, Hayat ; Naranbhai, Vivek ; Aga, Evgenia ; Bosch, Ronald J ; Mellors, John W ; Kuritzkes, Daniel R ; Para, Michael ; Gandhi, Rajesh T ; Carrington, Mary ; Li, Jonathan Z2017Pathog Immun32
Oral shedding of herpesviruses in HIV-infected patients with varying degrees of immune status.Dittmer, Dirk P ; Tamburro, Kristen ; Chen, Huichao ; Lee, Anthony ; Sanders, Marcia K ; Wade, Tischan A ; Napravnik, Sonia ; Webster-Cyriaque, Jennifer ; Ghannoum, Mahmoud ; Shiboski, Caroline H ; Aberg, Judith A2017 Sep 24AIDS1531
Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial.Gulick, Roy M ; Wilkin, Timothy J ; Chen, Ying Q ; Landovitz, Raphael J ; Amico, K Rivet ; Young, Alicia M ; Richardson, Paul ; Marzinke, Mark A ; Hendrix, Craig W ; Eshleman, Susan H ; McGowan, Ian ; Cottle, Leslie M ; Andrade, Adriana ; Marcus, Cheryl ; Klingman, Karin L ; Chege, Wairimu ; Rinehart, Alex R ; Rooney, James F ; Andrew, Phi2017 Sep 19Ann Intern Med6167
Changes in abdominal fat following antiretroviral therapy initiation in HIV-infected individuals correlate with waist circumference and self-reported changes.Bhagwat, Priya ; Ofotokun, Ighovwerha ; McComsey, Grace A ; Brown, Todd T ; Moser, Carlee ; Sugar, Catherine A ; Currier, Judith S2017Antivir Ther722
Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C.Naggie, Susanna ; Marks, Kristen M ; Hughes, Michael ; Fierer, Daniel S ; Macbrayne, Christine ; Kim, Arthur ; Hollabaugh, Kimberly ; Roa, Jhoanna ; Symonds, Bill ; Brainard, Diana M ; McHutchison, John G ; Peters, Marion G ; Kiser, Jennifer J ; Chung, Raymond ; AIDS Clinical Trials Group (ACTG) A5327 Study Team2017 04 15Clin Infect Dis864
Comparison of Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Participants Enrolled in a Multinational Clinical Trial: HPTN 052.Greer, Amy E ; Ou, San-San ; Wilson, Ethan ; Piwowar-Manning, Estelle ; Forman, Michael S ; McCauley, Marybeth ; Gamble, Theresa ; Ruangyuttikarn, Cholticha ; Hosseinipour, Mina C ; Kumarasamy, Nagalingeswaran ; Nyirenda, Mulinda ; Grinsztejn, Beatriz ; Pilotto, Jose Henrique ; Kosashunhanan, Natthapol ; Gonçalves de Melo, Marineide ; Makh2017 Dec 01J Acquir Immune Defic Syndr476
Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-naïve patients: Findings from two randomized trials.Tam, Edward ; Luetkemeyer, Anne F ; Mantry, Parvez S ; Satapathy, Sanjaya K ; Ghali, Peter ; Kang, Minhee ; Haubrich, Richard ; Shen, Xianlin ; Ni, Liyun ; Camus, Gregory ; Copans, Amanda ; Rossaro, Lorenzo ; Guyer, Bill ; Brown, Robert S ; RESCUE and ACTG A5348 study investigators2017 Nov 01Liver Int
Association Between Frailty and Components of the Frailty Phenotype With Modifiable Risk Factors and Antiretroviral Therapy.Erlandson, Kristine M ; Wu, Kunling ; Koletar, Susan L ; Kalayjian, Robert C ; Ellis, Ronald J ; Taiwo, Babafemi ; Palella, Frank J ; Tassiopoulos, Katherine2017 03 15J Infect Dis6215
Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy.Gay, Cynthia L ; Bosch, Ronald J ; Ritz, Justin ; Hataye, Jason M ; Aga, Evgenia ; Tressler, Randall L ; Mason, Stephen W ; Hwang, Carey K ; Grasela, Dennis M ; Ray, Neelanjana ; Cyktor, Josh C ; Coffin, John M ; Acosta, Edward P ; Koup, Richard A ; Mellors, John W ; Eron, Joseph J ; AIDS Clinical Trials 5326 Study Team2017 Jun 01J Infect Dis11215
Bone mineral density reductions after tenofovir disoproxil fumarate initiation and changes in phosphaturia: a secondary analysis of ACTG A5224s.Gupta, Samir K ; Yeh, Eunice ; Kitch, Douglas W ; Brown, Todd T ; Venuto, Charles S ; Morse, Gene D ; Ha, Belinda ; Melbourne, Kathleen ; McComsey, Grace A2017 Jul 01J Antimicrob Chemother772
Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1-infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Study A5Nixon, Daniel E ; Bosch, Ronald J ; Chan, Ellen S ; Funderburg, Nicholas T ; Hodder, Sally ; Lake, Jordan E ; Lederman, Michael M ; Klingman, Karin L ; Aberg, Judith A ; AIDS Clinical Trials Group Study A5275 Team2017 Jan - FebJ Clin Lipidol111
Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-infected Persons: AIDS Clinical Trials Group Study A5309s.Kiser, Jennifer J ; Lu, Darlene ; Rosenkranz, Susan L ; Morse, Gene D ; DiFrancesco, Robin ; Sherman, Kenneth E ; Butt, Adeel A ; ACTG A5309s study team2017 DecDrugs R D417
Antiretroviral initiation is associated with increased skeletal muscle area and fat content.Erlandson, Kristine M ; Fiorillo, Suzanne ; Masawi, Fadzai ; Scherzinger, Ann ; McComsey, Grace A ; Lake, Jordan E ; Stein, James H ; Currier, Judith S ; Brown, Todd T2017 Aug 24AIDS1331
Treatment of HIV infection with a raltegravir-based regimen increases LDL levels, but improves HDL cholesterol efflux capacity.Funderburg, Nicholas T ; Xu, Dihua ; Playford, Martin P ; Joshi, Aditya A ; Andrade, Adriana ; Kuritzkes, Daniel R ; Lederman, Michael M ; Mehta, Nehal N2017Antivir Ther122
Insulin-Like Growth Factor Is Associated with Changes in Body Composition with Antiretroviral Therapy Initiation.Erlandson, Kristine M ; Fiorillo, Suzanne P ; Cardoso, Sandra Wagner ; Riviere, Cynthia ; Sanchez, Jorge ; Hakim, James ; Kumarasamy, Nagalingeswaran ; Badal-Faesen, Sharlaa ; Lalloo, Umesh ; Kumwenda, Johnstone ; Campbell, Thomas B ; Brown, Todd T2017 SepAIDS Res Hum Retroviruses933
Frailty is strongly associated with increased risk of recurrent falls among older HIV-infected adults.Tassiopoulos, Katherine ; Abdo, Mona ; Wu, Kunling ; Koletar, Susan L ; Palella, Frank J ; Kalayjian, Robert ; Taiwo, Babafemi ; Erlandson, Kristine M2017 10 23AIDS1631
PHENOME-WIDE INTERACTION STUDY (PheWIS) IN AIDS CLINICAL TRIALS GROUP DATA (ACTG).Verma, Shefali S ; Frase, Alex T ; Verma, Anurag ; Pendergrass, Sarah A ; Mahony, Shaun ; Haas, David W ; Ritchie, Marylyn D2016Pac Symp Biocomput21
Diversity and Tropism of HIV-1 Rebound Virus Populations in Plasma Level After Treatment Discontinuation.Bednar, Maria M ; Hauser, Blake M ; Zhou, Shuntai ; Jacobson, Jeffrey M ; Eron, Joseph J ; Frank, Ian ; Swanstrom, Ronald2016 Aug 01J Infect Dis3214
The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption.Li, Jonathan Z ; Etemad, Behzad ; Ahmed, Hayat ; Aga, Evgenia ; Bosch, Ronald J ; Mellors, John W ; Kuritzkes, Daniel R ; Lederman, Michael M ; Para, Michael ; Gandhi, Rajesh T2016 Jan 28AIDS330
Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342).Castillo-Mancilla, Jose R ; Aquilante, Christina L ; Wempe, Michael F ; Smeaton, Laura M ; Firnhaber, Cynthia ; LaRosa, Alberto M ; Kumarasamy, Nagalingeswaran ; Andrade, Adriana ; Baheti, Gautam ; Fletcher, Courtney V ; Campbell, Thomas B ; Haas, David W ; MaWhinney, Samantha ; Anderson, Peter L2016 JunJ Antimicrob Chemother671
Prevalence and risk factors of micronutrient deficiencies pre- and post-antiretroviral therapy (ART) among a diverse multicountry cohort of HIV-infected adults.Shivakoti, Rupak ; Christian, Parul ; Yang, Wei-Teng ; Gupte, Nikhil ; Mwelase, Noluthando ; Kanyama, Cecilia ; Pillay, Sandy ; Samaneka, Wadzanai ; Santos, Breno ; Poongulali, Selvamuthu ; Tripathy, Srikanth ; Riviere, Cynthia ; Berendes, Sima ; Lama, Javier R ; Cardoso, Sandra W ; Sugandhavesa, Patcharaphan ; Tang, Alice M ; Semba, Richa2016 FebClin Nutr135
Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study.La Rosa, Alberto M ; Harrison, Linda J ; Taiwo, Babafemi ; Wallis, Carole L ; Zheng, Lu ; Kim, Peter ; Kumarasamy, Nagalingeswaran ; Hosseinipour, Mina C ; Jarocki, Bernadette ; Mellors, John W ; Collier, Ann C ; ACTG A5273 Study Group2016 JunLancet HIV63
Plasma Efavirenz Concentrations Are Associated With Lipid and Glucose Concentrations.Sinxadi, Phumla Zuleika ; McIlleron, Helen Margaret ; Dave, Joel Alex ; Smith, Peter John ; Levitt, Naomi Sharlene ; Haas, David William ; Maartens, Gary2016 JanMedicine (Baltimore)295
Neurocognition in maraviroc- compared to tenofovir: a double blind randomized placebo controlled trial ACTG A5303.Robertson, Kevin R ; Miyahara, Sachiko ; Lee, Anthony ; Brown, Todd T ; Chan, Ellen S ; Berzins, Baiba ; Rusin, David ; Eron, Joseph J ; Taiwo, Babafemi O ; ACTG 5303 team2016 Jun 20AIDS
Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults.Mave, Vidya ; Erlandson, Kristine M ; Gupte, Nikhil ; Balagopal, Ashwin ; Asmuth, David M ; Campbell, Thomas B ; Smeaton, Laura ; Kumarasamy, Nagalingeswaran ; Hakim, James ; Santos, Breno ; Riviere, Cynthia ; Hosseinipour, Mina C ; Sugandhavesa, Patcharaphan ; Infante, Rosa ; Pillay, Sandy ; Cardoso, Sandra W ; Tripathy, Srikanth ; Mwelas2016 Jul 1J Infect Dis1214
Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4+ T-Cells.Saharia, Kapil K ; Petrovas, Constantinos ; Ferrando-Martinez, Sara ; Leal, Manuel ; Luque, Rafael ; Ive, Prudence ; Luetkemeyer, Anne ; Havlir, Diane ; Koup, Richard A2016PLoS One711
Cytokines and T-Cell Homeostasis in HIV Infection.Freeman, Michael L ; Shive, Carey L ; Nguyen, Thao P ; Younes, Souheil-Antoine ; Panigrahi, Soumya ; Lederman, Michael M2016 Oct 01J Infect Dis214 Suppl 2
Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin.Petersen, Tess ; Lee, Yu-Jin ; Osinusi, Anu ; Amorosa, Valerianna K ; Wang, Crystal ; Kang, Minhee ; Matining, Roy ; Zhang, Xiao ; Dou, Diana ; Umbleja, Triin ; Kottilil, Shyam ; Peters, Marion G2016 JulAIDS Res Hum Retroviruses732
Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption.Bar, Katharine J ; Sneller, Michael C ; Harrison, Linda J ; Justement, J Shawn ; Overton, Edgar T ; Petrone, Mary E ; Salantes, D Brenda ; Seamon, Catherine A ; Scheinfeld, Benjamin ; Kwan, Richard W ; Learn, Gerald H ; Proschan, Michael A ; Kreider, Edward F ; Blazkova, Jana ; Bardsley, Mark ; Refsland, Eric W ; Messer, Michael ; Clarridg2016 11 24N Engl J Med21375
Persistently Elevated C-Reactive Protein Level in the First Year of Antiretroviral Therapy, Despite Virologic Suppression, Is Associated With HIV Disease Progression in Resource-Constrained Settings.Shivakoti, Rupak ; Yang, Wei-Teng ; Berendes, Sima ; Mwelase, Noluthando ; Kanyama, Cecilia ; Pillay, Sandy ; Samaneka, Wadzanai ; Santos, Breno ; Poongulali, Selvamuthu ; Tripathy, Srikanth ; Riviere, Cynthia ; Lama, Javier R ; Cardoso, Sandra W ; Sugandhavesa, Patcharaphan ; Balagopal, Ashwin ; Gupte, Nikhil ; Semba, Richard D ; Campbell2016 Apr 1J Infect Dis7213
Vitamin D, osteoprotegerin/receptor activator of nuclear factor-kappaB ligand (OPG/RANKL) and inflammation with alendronate treatment in HIV-infected patients with reduced bone mineral density.Natsag, J ; Kendall, M A ; Sellmeyer, D E ; McComsey, G A ; Brown, T T2016 MarHIV Med317
Random lopinavir concentrations predict resistance on lopinavir-based antiretroviral therapy.Court, Richard ; Gordon, Michelle ; Cohen, Karen ; Stewart, Annemie ; Gosnell, Bernadett ; Wiesner, Lubbe ; Maartens, Gary2016 AugInt J Antimicrob Agents248
The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection.Jacobson, Jeffrey M ; Zheng, Lu ; Wilson, Cara C ; Tebas, Pablo ; Matining, Roy M ; Egan, Michael A ; Eldridge, John ; Landay, Alan L ; Clifford, David B ; Luetkemeyer, Anne F ; Tiu, Jennifer ; Martinez, Ana L ; Janik, Jennifer ; Spitz, Teresa A ; Hural, John ; McElrath, Juliana ; Frahm, Nicole ; ACTG A5281 Protocol Team2016 Feb 1J Acquir Immune Defic Syndr271
HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients.Rockwood, Neesha ; Meintjes, Graeme ; Chirehwa, Maxwell ; Wiesner, Lubbe ; McIlleron, Helen ; Wilkinson, Robert J ; Denti, Paolo2016 10Antimicrob Agents Chemother1060
Hyperlipidaemia in HIV-infected patients on lopinavir/ritonavir monotherapy in resource-limited settings.Matoga, Mitch M ; Hosseinipour, Mina C ; Aga, Evgenia ; Ribaudo, Heather J ; Kumarasamy, Nagalingeswaran ; Bartlett, John ; Hughes, Michael D ; ACTG A5230 Study Team2016 Oct 14Antivir Ther
Sex-related Differences in Inflammatory and Immune Activation Markers before and after combined Antiretroviral Therapy Initiation.Mathad, Jyoti S ; Gupte, Nikhil ; Balagopal, Ashwin ; Asmuth, David ; Hakim, James ; Santos, Breno ; Riviere, Cynthia ; Hosseinipour, Mina ; Sugandhavesa, Patcharaphan ; Infante, Rosa ; Pillay, Sandy ; Cardoso, Sandra W ; Mwelase, Noluthando ; Pawar, Jyoti ; Berendes, Sima ; Kumarasamy, Nagalingeswaran ; Andrade, Bruno B ; Campbell, Thomas2016 May 27J Acquir Immune Defic Syndr
Differential CD4+ cell count increase and CD4+ :  CD8+ ratio normalization with maraviroc compared with tenofovir.Chan, Ellen S ; Landay, Alan L ; Brown, Todd T ; Ribaudo, Heather J ; Mirmonsef, Paria ; Ofotokun, Igho ; Weitzmann, M Neale ; Martinson, Jeffrey ; Klingman, Karin L ; Eron, Joseph J ; Fichtenbaum, Carl J ; Plants, Jill ; Taiwo, Babafemi O2016 Aug 24AIDS1330
The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1.Jacobson, Jeffrey M ; Bosinger, Steven E ; Kang, Minhee ; Belaunzaran-Zamudio, Pablo ; Matining, Roy M ; Wilson, Cara C ; Flexner, Charles ; Clagett, Brian ; Plants, Jill ; Read, Sarah ; Purdue, Lynette ; Myers, Laurie ; Boone, Linda ; Tebas, Pablo ; Kumar, Princy ; Clifford, David ; Douek, Daniel ; Silvestri, Guido ; Landay, Alan L ; Lede2016 JulAIDS Res Hum Retroviruses732
Binge drinking is associated with differences in weekday and weekend adherence in HIV-infected individuals.De Boni, Raquel B ; Zheng, Lu ; Rosenkranz, Susan L ; Sun, Xin ; Lavenberg, Jeffrey ; Cardoso, Sandra W ; Grinsztejn, Beatriz ; La Rosa, Alberto ; Pierre, Samuel ; Severe, Patrice ; Cohn, Susan E ; Collier, Ann C ; Gross, Robert2016 Feb 1Drug Alcohol Depend159
Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection.Kelesidis, Theodoros ; Jackson, Nicholas ; McComsey, Grace A ; Wang, Xiaoyan ; Elashoff, David ; Dubé, Michael P ; Brown, Todd T ; Yang, Otto O ; Stein, James H ; Currier, Judith S2016 Nov 13AIDS1730
Phenotype, Genotype, and Drug Resistance in Subtype C HIV-1 Infection.Derache, Anne ; Wallis, Carole L ; Vardhanabhuti, Saran ; Bartlett, John ; Kumarasamy, Nagalingeswaran ; Katzenstein, David2016 Jan 15J Infect Dis2213
Characteristics associated with virologic failure in high-risk HIV-positive participants with prior failure: a post hoc analysis of ACTG 5251.Robbins, Gregory K ; Cohn, Susan E ; Harrison, Linda J ; Smeaton, Laura ; Moran, Laura ; Rusin, David ; Dehlinger, Marjorie ; Flynn, Theresa ; Lammert, Sara ; Wu, Albert W ; Safren, Steven A ; Reynolds, Nancy R2016 JulHIV Clin Trials417
The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States.Girouard, Michael P ; Sax, Paul E ; Parker, Robert A ; Taiwo, Babafemi ; Freedberg, Kenneth A ; Gulick, Roy M ; Weinstein, Milton C ; Paltiel, A David ; Walensky, Rochelle P2016 Mar 15Clin Infect Dis662
Changes in plasma levels of oxidized lipoproteins and lipoprotein subfractions with atazanavir-, raltegravir-, darunavir-based initial antiviral therapy and associations with common carotid artery intima-media thickness: ACTG 5260s.Kelesidis, Theodoros ; Tran, Thuy Tien T ; Brown, Todd T ; Moser, Carlee ; Ribaudo, Heather J ; Dubé, Michael P ; Yang, Otto O ; McComsey, Grace A ; Stein, James H ; Currier, Judith S2016 Sep 23Antivir Ther
Effect of Lopinavir and Nevirapine Concentrations on Viral Outcomes in Protease Inhibitor-experienced HIV-infected Children.Moholisa, Retsilisitsoe R ; Schomaker, Michael ; Kuhn, Louise ; Castel, Sandra ; Wiesner, Lubbe ; Coovadia, Ashraf ; Strehlau, Renate ; Patel, Faeezah ; Pinillos, Francoise ; Abrams, Elaine J ; Maartens, Gary ; McIlleron, Helen2016 DecPediatr Infect Dis J1235
CCR5-Δ32 Heterozygosity, HIV-1 Reservoir Size, and Lymphocyte Activation in Individuals Receiving Long-term Suppressive Antiretroviral Therapy.Henrich, Timothy J ; Hanhauser, Emily ; Harrison, Linda J ; Palmer, Christine D ; Romero-Tejeda, Marisol ; Jost, Stephanie ; Bosch, Ronald J ; Kuritzkes, Daniel R2016 Mar 1J Infect Dis5213
Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s.Dirajlal-Fargo, Sahera ; Moser, Carlee ; Brown, Todd T ; Kelesidis, Theodoros ; Dubé, Michael P ; Stein, James H ; Currier, Judith ; McComsey, Grace A2016 SepOpen Forum Infect Dis33
Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons.Sterling, Timothy R ; Scott, Nigel A ; Miro, José M ; Calvet, Guilherme ; La Rosa, Alberto ; Infante, Rosa ; Chen, Michael P ; Benator, Debra A ; Gordin, Fred ; Benson, Constance A ; Chaisson, Richard E ; Villarino, M Elsa ; Tuberculosis Trials Consortium, the AIDS Clinical Trials Group for the PREVENT TB Trial (TBTC Study 26ACTG 5259) The2016 Jun 19AIDS1030
Brief Report: Relationship Among Viral Load Outcomes in HIV Treatment Interruption Trials.Treasure, Graham C ; Aga, Evgenia ; Bosch, Ronald J ; Mellors, John W ; Kuritzkes, Daniel R ; Para, Michael ; Gandhi, Rajesh T ; Li, Jonathan Z2016 Jul 1J Acquir Immune Defic Syndr372
CD14brightCD16- monocytes and sCD14 level negatively associate with CD4-memory T-cell frequency and predict HCV-decline on therapy.Judge, Chelsey J ; Sandberg, Johan K ; Funderburg, Nicholas T ; Sherman, Ken E ; Butt, Adeel A ; Kang, Minhee ; Landay, Alan L ; Lederman, Michael M ; Anthony, Donald D2016 Jun 1J Acquir Immune Defic Syndr
Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s.McComsey, Grace A ; Moser, Carlee ; Currier, Judith ; Ribaudo, Heather J ; Paczuski, Pawel ; Dubé, Michael P ; Kelesidis, Theodoros ; Rothenberg, Jennifer ; Stein, James H ; Brown, Todd T2016 Apr 1Clin Infect Dis762
Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy.Kearney, Mary F ; Wiegand, Ann ; Shao, Wei ; Coffin, John M ; Mellors, John W ; Lederman, Michael ; Gandhi, Rajesh T ; Keele, Brandon F ; Li, Jonathan Z2016 FebJ Virol390
Human papillomavirus infection in the oral cavity of HIV patients is not reduced by initiating antiretroviral therapy.Shiboski, Caroline H ; Lee, Anthony ; Chen, Huichao ; Webster-Cyriaque, Jennifer ; Seaman, Todd ; Landovitz, Raphael J ; John, Malcolm ; Reilly, Nancy ; Naini, Linda ; Palefsky, Joel ; Jacobson, Mark A2016 Jun 19AIDS1030
Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected Patients.Bedimo, Roger ; Kang, Minhee ; Tebas, Pablo ; Overton, Edgar T ; Hollabaugh, Kimberly ; McComsey, Grace ; Bhattacharya, Debika ; Evans, Christopher ; Brown, Todd T ; Taiwo, Babafemi2016 AprAIDS Res Hum Retroviruses432
Soluble Levels of Receptor for Advanced Glycation Endproducts (RAGE) and Progression of Atherosclerosis in Individuals Infected with Human Immunodeficiency Virus: ACTG NWCS 332.Danoff, Ann ; Kendall, Michelle A ; Currier, Judith S ; Kelesidis, Theodoros ; Schmidt, Ann Marie ; Aberg, Judith A2016 AugInflammation439
Antiretroviral Therapy for the Prevention of HIV-1 Transmission.Cohen, Myron S ; Chen, Ying Q ; McCauley, Marybeth ; Gamble, Theresa ; Hosseinipour, Mina C ; Kumarasamy, Nagalingeswaran ; Hakim, James G ; Kumwenda, Johnstone ; Grinsztejn, Beatriz ; Pilotto, Jose H S ; Godbole, Sheela V ; Chariyalertsak, Suwat ; Santos, Breno R ; Mayer, Kenneth H ; Hoffman, Irving F ; Eshleman, Susan H ; Piwowar-Manning2016 09 01N Engl J Med9375
Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings.Luetkemeyer, Anne F ; Firnhaber, Cynthia ; Kendall, Michelle A ; Wu, Xingye ; Mazurek, Gerald H ; Benator, Debra A ; Arduino, Roberto ; Fernandez, Michel ; Guy, Elizabeth ; Johnson, Pamela ; Metchock, Beverly ; Sattler, Fred ; Telzak, Edward ; Wang, Yun F ; Weiner, Marc ; Swindells, Susan ; Sanne, Ian M ; Havlir, Diane V ; Grinsztejn, Beat2016 May 1Clin Infect Dis962
Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans.Lee, Sulggi A ; Mefford, Joel A ; Huang, Yong ; Witte, John S ; Martin, Jeffrey N ; Haas, David W ; McLaren, Paul J ; Mushiroda, Taisei ; Kubo, Michiaki ; Byakwaga, Helen ; Hunt, Peter W ; Kroetz, Deanna L2016 Jul 17AIDS1130
IL-7 Induces SAMHD1 Phosphorylation in CD4+ T Lymphocytes, Improving Early Steps of HIV-1 Life Cycle.Coiras, Mayte ; Bermejo, Mercedes ; Descours, Benjamin ; Mateos, Elena ; García-Pérez, Javier ; López-Huertas, María-Rosa ; Lederman, Michael M ; Benkirane, Monsef ; Alcamí, José2016 Mar 08Cell Rep914
Population pharmacokinetic drug-drug interaction pooled analysis of existing data for rifabutin and HIV PIs.Hennig, Stefanie ; Svensson, Elin M ; Niebecker, Ronald ; Fourie, P Bernard ; Weiner, Marc H ; Bonora, Stefano ; Peloquin, Charles A ; Gallicano, Keith ; Flexner, Charles ; Pym, Alex ; Vis, Peter ; Olliaro, Piero L ; McIlleron, Helen ; Karlsson, Mats O2016 MayJ Antimicrob Chemother571
Using Cognitive Interviews to Enhance Measurement in Empirical Bioethics: Developing a Measure of the Preventive Misconception in Biomedical HIV Prevention Trials.Sugarman, Jeremy ; Seils, Damon M ; Watson-Ormond, J Kemp ; Weinfurt, Kevin P2016AJOB Empir Bioeth17
Continued Elevation of Interleukin-18 and Interferon-γ After Initiation of Antiretroviral Therapy and Clinical Failure in a Diverse Multicountry Human Immunodeficiency Virus Cohort.Balagopal, Ashwin ; Gupte, Nikhil ; Shivakoti, Rupak ; Cox, Andrea L ; Yang, Wei-Teng ; Berendes, Sima ; Mwelase, Noluthando ; Kanyama, Cecilia ; Pillay, Sandy ; Samaneka, Wadzanai ; Santos, Breno ; Poongulali, Selvamuthu ; Tripathy, Srikanth ; Riviere, Cynthia ; Lama, Javier R ; Cardoso, Sandra W ; Sugandhavesa, Patcharaphan ; Semba, Rich2016 SepOpen Forum Infect Dis33
Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.Freeman, Michael L ; Lederman, Michael M ; Gianella, Sara2016 FebCurr HIV/AIDS Rep113
Transmitted HIV Drug Resistance Is High and Longstanding in Metropolitan Washington, DC.Kassaye, Seble G ; Grossman, Zehava ; Balamane, Maya ; Johnston-White, Betsy ; Liu, Chenglong ; Kumar, Princy ; Young, Mary ; Sneller, Michael C ; Sereti, Irini ; Dewar, Robin ; Rehm, Catherine ; Meyer, William ; Shafer, Robert ; Katzenstein, David ; Maldarelli, Frank2016 Jun 15Clin Infect Dis
Changes in Markers of T-Cell Senescence and Exhaustion With Atazanavir-, Raltegravir-, and Darunavir-Based Initial Antiviral Therapy: ACTG 5260s.Kelesidis, Theodoros ; Moser, Carlee ; Stein, James H ; Brown, Todd T ; Tran, Thuy Tien T ; Ribaudo, Heather J ; Dubé, Michael P ; Yang, Otto O ; Currier, Judith S ; McComsey, Grace A2016 Jun 28J Infect Dis
Predicting resistance as indicator for need to switch from first-line antiretroviral therapy among patients with elevated viral loads: development of a risk score algorithm.Rutstein, Sarah E ; Hosseinipour, Mina C ; Weinberger, Morris ; Wheeler, Stephanie B ; Biddle, Andrea K ; Wallis, Carole L ; Balakrishnan, Pachamuthu ; Mellors, John W ; Morgado, Mariza ; Saravanan, Shanmugam ; Tripathy, Srikanth ; Vardhanabhuti, Saran ; Eron, Joseph J ; Miller, William C2016BMC Infect Dis116
Human Immunodeficiency Virus-1 Sequence Changes and Drug Resistance Mutation Among Virologic Failures of Lopinavir/Ritonavir Monotherapy: AIDS Clinical Trials Group Protocol A5230.Vardhanabhuti, Saran ; Katzenstein, David ; Bartlett, John ; Kumarasamy, Nagalingeswaran ; Wallis, Carole L2016 SepOpen Forum Infect Dis33
Double robust and efficient estimation of a prognostic model for events in the presence of dependent censoring.Schnitzer, Mireille E ; Lok, Judith J ; Bosch, Ronald J2016 JanBiostatistics117
A survey of tuberculosis infection control practices at the NIH/NIAID/DAIDS-supported clinical trial sites in low and middle income countries.Godfrey, Catherine ; Tauscher, Gail ; Hunsberger, Sally ; Austin, Melissa ; Scott, Lesley ; Schouten, Jeffrey T ; Luetkemeyer, Anne F ; Benson, Constance ; Coombs, Robert ; Swindells, Susan ; HIV Network Coordinating (HANC) TB Diagnostic Laboratory Working Division of AIDS, National Institute of Allergy and Infectious Diseases2016 06 10BMC Infect Dis16
Long-term body composition changes in antiretroviral-treated HIV-infected individuals.Grant, Philip M ; Kitch, Douglas ; McComsey, Grace A ; Collier, Ann C ; Bartali, Benedetta ; Koletar, Susan L ; Erlandson, Kristine M ; Lake, Jordan E ; Yin, Michael T ; Melbourne, Kathy ; Ha, Belinda ; Brown, Todd T2016 Nov 28AIDS1830
Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women.Weinberg, Adriana ; Park, Jeong-Gun ; Bosch, Ronald ; Cho, Alice ; Livingston, Elizabeth ; Aweeka, Fran ; Cramer, Yoninah ; Watts, D Heather ; Luque, Amneris E ; Cohn, Susan E2016 Feb 1J Acquir Immune Defic Syndr271
Poly(lactic-co-glycolic) Acid-Chitosan Dual Loaded Nanoparticles for Antiretroviral Nanoformulations.Makita-Chingombe, Faithful ; Kutscher, Hilliard L ; DiTursi, Sara L ; Morse, Gene D ; Maponga, Charles C2016J Drug Deliv2016
HIV Transmission Risk Behavior in a Cohort of HIV-Infected Treatment-Naïve Men and Women in the United States.Landovitz, Raphael J ; Tran, Thuy Tien T ; Cohn, Susan E ; Ofotokun, Ighovwhera ; Godfrey, Catherine ; Kuritzkes, Daniel R ; Lennox, Jeffrey L ; Currier, Judith S ; Ribaudo, Heather J2016 Mar 16AIDS Behav
Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1-Infected Adults Receiving Long-term Antiretroviral Therapy.Riddler, Sharon A ; Aga, Evgenia ; Bosch, Ronald J ; Bastow, Barbara ; Bedison, Margaret ; Vagratian, David ; Vaida, Florin ; Eron, Joseph J ; Gandhi, Rajesh T ; Mellors, John W ; ACTG A5276s Protocol Team2016 Feb 15J Infect Dis4213
Long-term Bone Mineral Density Changes in Antiretroviral-Treated HIV-Infected Individuals.Grant, Philip M ; Kitch, Douglas ; McComsey, Grace A ; Collier, Ann C ; Koletar, Susan L ; Erlandson, Kristine M ; Yin, Michael T ; Bartali, Benedetta ; Ha, Belinda ; Melbourne, Kathy ; Brown, Todd T2016 Aug 15J Infect Dis4214
Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.Hosseinipour, Mina C ; Bisson, Gregory P ; Miyahara, Sachiko ; Sun, Xin ; Moses, Agnes ; Riviere, Cynthia ; Kirui, Fredrick K ; Badal-Faesen, Sharlaa ; Lagat, David ; Nyirenda, Mulinda ; Naidoo, Kogieleum ; Hakim, James ; Mugyenyi, Peter ; Henostroza, German ; Leger, Paul D ; Lama, Javier R ; Mohapi, Lerato ; Alave, Jorge ; Mave, Vidya ; V2016 Mar 19Lancet10024387
International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271.Robertson, K ; Jiang, H ; Evans, S R ; Marra, C M ; Berzins, B ; Hakim, J ; Sacktor, N ; Silva, M Tulius ; Campbell, T B ; Nair, A ; Schouten, J ; 5271 study team ; Kumwenda, J ; Supparatpinyo, K ; Tripathy, S ; Kumarasamy, N ; La Rosa, A ; Montano, S ; Mwafongo, A ; Firnhaber, C ; Sanne, I ; Naini, L ; Amod, F ; Walawander, A ; AIDS Clini2016 AugJ Neurovirol422
Parsimonious covariate selection with censored outcomes.DiRienzo, Albert Gregory2016 06Biometrics272
IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection.Younes, Souheil-Antoine ; Freeman, Michael L ; Mudd, Joseph C ; Shive, Carey L ; Reynaldi, Arnold ; Panigrahi, Soumya ; Estes, Jacob D ; Deleage, Claire ; Lucero, Carissa ; Anderson, Jodi ; Schacker, Timothy W ; Davenport, Miles P ; McCune, Joseph M ; Hunt, Peter W ; Lee, Sulggi A ; Serrano-Villar, Sergio ; Debernardo, Robert L ; Jacobson,2016 Jul 01J Clin Invest7126
Predictors of late virologic failure after initial successful suppression of HIV replication on efavirenz-based antiretroviral therapy.Singini, Isaac ; Campbell, Thomas B ; Smeaton, Laura M ; Kumarasamy, Nagalingeswaran ; La Rosa, Alberto ; Taejareonkul, Sineenart ; Safren, Steven A ; Flanigan, Timothy P ; Hakim, James G ; Hughes, Michael D ; ACTG A5175/PEARLS Study Team.2016 Jul 29HIV Clin Trials
Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers.Dooley, Kelly E ; Savic, Radojka M ; Park, Jeong-Gun ; Cramer, Yoninah ; Hafner, Richard ; Hogg, Evelyn ; Janik, Jennifer ; Marzinke, Mark A ; Patterson, Kristine ; Benson, Constance A ; Hovind, Laura ; Dorman, Susan E ; Haas, David W ; ACTG A5311 Study Team2015Antimicrob Agents Chemother659
Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention.Podany, Anthony T ; Bao, Yajing ; Swindells, Susan ; Chaisson, Richard E ; Andersen, Janet W ; Mwelase, Thando ; Supparatpinyo, Khuanchai ; Mohapi, Lerato ; Gupta, Amita ; Benson, Constance A ; Kim, Peter ; Fletcher, Courtney V ; AIDS Clinical Trials Group A5279 Study Team2015 Oct 15Clin Infect Dis861
Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial.Kantor, Rami ; Smeaton, Laura ; Vardhanabhuti, Saran ; Hudelson, Sarah E ; Wallis, Carol L ; Tripathy, Srikanth ; Morgado, Mariza G ; Saravanan, Shanmugham ; Balakrishnan, Pachamuthu ; Reitsma, Marissa ; Hart, Stephen ; Mellors, John W ; Halvas, Elias ; Grinsztejn, Beatriz ; Hosseinipour, Mina C ; Kumwenda, Johnstone ; La Rosa, Alberto ; L2015 May 15Clin Infect Dis1060
Antiretroviral Effects on Host Lipoproteins Are Associated With Changes in Hepatitis C Virus (HCV) RNA Levels in Human Immunodeficiency Virus/HCV Coinfected Individuals.Naggie, Susanna ; Patel, Keyur ; Yang, Lan-Yan ; Chow, Shein-Chung ; Johnson, Victoria ; Guyton, John R ; Muir, Andrew J ; Sulkowski, Mark ; Hicks, Charles2015 AprOpen Forum Infect Dis22
Predictors and outcomes of Mycobacterium tuberculosis bacteremia among patients with HIV and tuberculosis co-infection enrolled in the ACTG A5221 STRIDE study.Crump, John A ; Wu, Xingye ; Kendall, Michelle A ; Ive, Prudence D ; Kumwenda, Johnstone J ; Grinsztejn, Beatriz ; Jentsch, Ute ; Swindells, Susan2015BMC Infect Dis15
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.Wanga, Valentine ; Venuto, Charles ; Morse, Gene D ; Acosta, Edward P ; Daar, Eric S ; Haas, David W ; Li, Chun ; Shepherd, Bryan E2015 SepPharmacogenet Genomics925
Comparison of Three Different FDA-Approved Plasma HIV-1 RNA Assay Platforms Confirms the Virologic Failure Endpoint of 200 Copies per Milliliter Despite Improved Assay Sensitivity.Lalama, Christina M ; Jennings, Cheryl ; Johnson, Victoria A ; Coombs, Robert W ; McKinnon, John E ; Bremer, James W ; Cobb, Bryan R ; Cloherty, Gavin A ; Mellors, John W ; Ribaudo, Heather J ; AIDS Clinical Trials Group2015 AugJ Clin Microbiol853
Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir.Brown, Todd T ; Moser, Carlee ; Currier, Judith S ; Ribaudo, Heather J ; Rothenberg, Jennifer ; Kelesidis, Theodoros ; Yang, Otto ; Dubé, Michael P ; Murphy, Robert L ; Stein, James H ; McComsey, Grace A2015 Oct 15J Infect Dis8212
Combined effect of CYP2B6 and NAT2 genotype on plasma efavirenz exposure during rifampin-based antituberculosis therapy in the STRIDE study.Luetkemeyer, Anne F ; Rosenkranz, Susan L ; Lu, Darlene ; Grinsztejn, Beatriz ; Sanchez, Jorge ; Ssemmanda, Michael ; Sanne, Ian ; McIlleron, Helen ; Havlir, Diane V ; Haas, David W ; Adult AIDS Clinical Trials Group A5221 and A5243 Study Teams2015 Jun 15Clin Infect Dis1260
Changes in metabolic syndrome status after initiation of antiretroviral therapy.Krishnan, Supriya ; Schouten, Jeffrey T ; Atkinson, Benjamin ; Brown, Todd T ; Wohl, David A ; McComsey, Grace A ; Glesby, Marshall J ; Shikuma, Cecilia ; Haubrich, Richard ; Jacobson, Denise L2015 Jan 1J Acquir Immune Defic Syndr168
Differential skeletal impact of tenofovir disoproxil fumarate in young versus old HIV-infected adults.Grant, Philip M ; Kitch, Douglas ; McComsey, Grace A ; Tierney, Camlin ; Ha, Belinda ; Brown, Todd T2015 Mar-AprHIV Clin Trials216
Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case-Cohort Study.Balagopal, Ashwin ; Asmuth, David M ; Yang, Wei-Teng ; Campbell, Thomas B ; Gupte, Nikhil ; Smeaton, Laura ; Kanyama, Cecilia ; Grinsztejn, Beatriz ; Santos, Breno ; Supparatpinyo, Khuanchai ; Badal-Faesen, Sharlaa ; Lama, Javier R ; Lalloo, Umesh G ; Zulu, Fatima ; Pawar, Jyoti S ; Riviere, Cynthia ; Kumarasamy, Nagalingeswaran ; Hakim, J2015 Oct 1J Acquir Immune Defic Syndr270
Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy.McCausland, Marie R ; Juchnowski, Steven M ; Zidar, David A ; Kuritzkes, Daniel R ; Andrade, Adriana ; Sieg, Scott F ; Lederman, Michael M ; Funderburg, Nicholas T2015PLoS One1010
PHARMACOKINETIC EXPOSURE AND VIROLOGIC RESPONSE IN HIV-1 INFECTED PREGNANT WOMEN TREATED WITH LOPINAVIR/RITONAVIR: AIDS CLINICAL TRIALS GROUP PROTOCOL A5153S: A SUBSTUDY TO A5150.Sha, Beverly E ; Tierney, Camlin ; Sun, Xin ; Stek, Alice ; Cohn, Susan E ; Coombs, Robert W ; Bastow, Barbara ; Aweeka, Francesca T ; AIDS Clinical Trials Group (ACTG) 5153s Team2015Jacobs J AIDS HIV11
Patterns of peripheral neuropathy in ART-naïve patients initiating modern ART regimen.Lee, Anthony J ; Bosch, Ronald J ; Evans, Scott R ; Wu, Kunling ; Harrison, Taylor ; Grant, Philip ; Clifford, David B2015 AprJ Neurovirol221
Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s.Longenecker, Chris T ; Kitch, Douglas ; Sax, Paul E ; Daar, Eric S ; Tierney, Camlin ; Gupta, Samir K ; McComsey, Grace A ; AIDS Clinical Trials Group Study A5224s Team2015 Jun 1J Acquir Immune Defic Syndr269
Recent advances in management of the HIV/HCV coinfected patient.Bednasz, Cindy J ; Sawyer, Joshua R ; Martinez, Anthony ; Rose, Patrick G ; Sithole, Samantha S ; Hamilton, Holly R ; Kaufman, Farzia S ; Venuto, Charles S ; Ma, Qing ; Talal, Andrew ; Morse, Gene D2015Future Virol810
High Accuracy of Common HIV-Related Oral Disease Diagnoses by Non-Oral Health Specialists in the AIDS Clinical Trial Group.Shiboski, Caroline H ; Chen, Huichao ; Secours, Rode ; Lee, Anthony ; Webster-Cyriaque, Jennifer ; Ghannoum, Mahmoud ; Evans, Scott ; Bernard, Daphné ; Reznik, David ; Dittmer, Dirk P ; Hosey, Lara ; Severe, Patrice ; Aberg, Judith A ; Oral HIV/AIDS Research Alliance, Subcommittee of the AIDS Clinical Trial Group2015PLoS One710
Regimen selection in the OPTIONS trial of HIV salvage therapy: drug resistance, prior therapy, and race-ethnicity determine the degree of regimen complexity.Tashima, Karen T ; Mollan, Katie R ; Na, Lumine ; Gandhi, Rajesh T ; Klingman, Karin L ; Fichtenbaum, Carl J ; Andrade, Adriana ; Johnson, Victoria A ; Eron, Joseph J ; Smeaton, Laura ; Haubrich, Richard H2015 AugHIV Clin Trials416
A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness.Stein, James H ; Ribaudo, Heather J ; Hodis, Howard N ; Brown, Todd T ; Tran, Thuy Tien T ; Yan, Mingzhu ; Brodell, Elizabeth Lauer ; Kelesidis, Theodore ; McComsey, Grace A ; Dubé, Michael P ; Murphy, Robert L ; Currier, Judith S2015 Sep 10AIDS1429
Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis.Hennig, Stefanie ; Naiker, Suhashni ; Reddy, Tarylee ; Egan, Deirdre ; Kellerman, Tracy ; Wiesner, Lubbe ; Owen, Andrew ; McIlleron, Helen ; Pym, Alexander2015 Oct 19Antimicrob Agents Chemother160
Depot medroxyprogesterone acetate in combination with a twice-daily lopinavir-ritonavir-based regimen in HIV-infected women showed effective contraception and a lack of clinically significant interactions, with good safety and tolerability: results of theLuque, Amneris E ; Cohn, Susan E ; Park, Jeong-Gun ; Cramer, Yoninah ; Weinberg, Adriana ; Livingston, Elizabeth ; Klingman, Karin L ; Aweeka, Francesca ; Watts, D Heather2015 AprAntimicrob Agents Chemother459
Phylogenetic evidence of HIV-1 sequence evolution in subjects with persistent low-level viraemia.Vardhanabhuti, Saran ; Taiwo, Babafemi ; Kuritzkes, Daniel R ; Eron, Joseph J ; Bosch, Ronald J2015Antivir Ther120
A Randomized Comparison of Anthropomorphic Changes With Preferred and Alternative Efavirenz-Based Antiretroviral Regimens in Diverse Multinational Settings.Erlandson, Kristine M ; Taejaroenkul, Sineenart ; Smeaton, Laura ; Gupta, Amita ; Singini, Isaac L ; Lama, Javier R ; Mngqibisa, Rosie ; Firnhaber, Cynthia ; Cardoso, Sandra Wagner ; Kanyama, Cecilia ; Machado da Silva, Andre L ; Hakim, James G ; Kumarasamy, Nagalingeswaran ; Campbell, Thomas B ; Hughes, Michael D2015 SepOpen Forum Infect Dis32
Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia.Vardhanabhuti, Saran ; Ribaudo, Heather J ; Landovitz, Raphael J ; Ofotokun, Ighovwerha ; Lennox, Jeffrey L ; Currier, Judith S ; Olson, Lana M ; Haas, David W2015 SepOpen Forum Infect Dis32
Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.Cillo, Anthony R ; Hilldorfer, Benedict B ; Lalama, Christina M ; McKinnon, John E ; Coombs, Robert W ; Tenorio, Allan R ; Fox, Lawrence ; Gandhi, Rajesh T ; Ribaudo, Heather ; Currier, Judith S ; Gulick, Roy M ; Wilkin, Timothy J ; Mellors, John W2015 Oct 23AIDS1629
HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors: A Randomized, Controlled Trial.Tashima, Karen T ; Smeaton, Laura M ; Fichtenbaum, Carl J ; Andrade, Adriana ; Eron, Joseph J ; Gandhi, Rajesh T ; Johnson, Victoria A ; Klingman, Karin L ; Ritz, Justin ; Hodder, Sally ; Santana, Jorge L ; Wilkin, Timothy ; Haubrich, Richard H ; A5241 Study Team2015 Dec 15Ann Intern Med12163
Concurrent Anemia and Elevated C-Reactive Protein Predicts HIV Clinical Treatment Failure, Including Tuberculosis, After Antiretroviral Therapy Initiation.Shivakoti, Rupak ; Yang, Wei-Teng ; Gupte, Nikhil ; Berendes, Sima ; Rosa, Alberto La ; Cardoso, Sandra W ; Mwelase, Noluthando ; Kanyama, Cecilia ; Pillay, Sandy ; Samaneka, Wadzanai ; Riviere, Cynthia ; Sugandhavesa, Patcharaphan ; Santos, Brento ; Poongulali, Selvamuthu ; Tripathy, Srikanth ; Bollinger, Robert C ; Currier, Judith S ; Ta2015 Jul 1Clin Infect Dis161
Fractures Are Not Associated with CD8(+) T Cell Activation: An Analysis of the ACTG ALLRT Study.Kendall, Michelle A ; Tassiopoulos, Katherine ; McComsey, Grace A ; Yin, Michael T2015 AugAIDS Res Hum Retroviruses831
The pharmacokinetics of lopinavir/ritonavir when given with isoniazid in South African HIV-infected individuals.Decloedt, E H ; van der Walt, J S ; McIlleron, H ; Wiesner, L ; Maartens, G2015 OctInt J Tuberc Lung Dis1019
Early HIV RNA decay during raltegravir-containing regimens exhibits two distinct subphases (1a and 1b).Andrade, Adriana ; Guedj, Jeremie ; Rosenkranz, Susan L ; Lu, Darlene ; Mellors, John ; Kuritzkes, Daniel R ; Perelson, Alan S ; Ribeiro, Ruy M ; ACTG A5249s protocol team2015 Nov 28AIDS1829
Differential Specificity of Interferon-alpha Inducible Gene Expression in Association with Human Immunodeficiency Virus and Hepatitis C Virus Levels and Declines in vivo.Katsounas, Antonios ; Frank, Astrid C ; Lempicki, Richard A ; Polis, Michael A ; Asmuth, David M ; Kottilil, Shyam2015J AIDS Clin Res16
Markers of renal disease and function are associated with systemic inflammation in HIV infection.Gupta, S K ; Kitch, D ; Tierney, C ; Melbourne, K ; Ha, B ; McComsey, G A ; AIDS Clinical Trials Group Study A5224s Team2015 NovHIV Med1016
Transcriptional Changes in CD8(+) T Cells During Antiretroviral Therapy Intensified With Raltegravir.Ouyang, Zhengyu ; Buzon, Maria J ; Zheng, Lu ; Sun, Hong ; Yu, Xu G ; Bosch, Ronald J ; Mellors, John W ; Eron, Joseph J ; Gandhi, Rajesh T ; Lichterfeld, Mathias2015 AprOpen Forum Infect Dis22
Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.Moore, Carrie B ; Verma, Anurag ; Pendergrass, Sarah ; Verma, Shefali S ; Johnson, Daniel H ; Daar, Eric S ; Gulick, Roy M ; Haubrich, Richard ; Robbins, Gregory K ; Ritchie, Marylyn D ; Haas, David W2015 JanOpen Forum Infect Dis12
Epidemiology of Kaposi's sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy.Labo, Nazzarena ; Miley, Wendell ; Benson, Constance A ; Campbell, Thomas B ; Whitby, Denise2015 Jun 19AIDS1029
Differences in antiretroviral safety and efficacy by sex in a multinational randomized clinical trial.Firnhaber, Cynthia ; Smeaton, Laura M ; Grinsztejn, Beatriz ; Lalloo, Umesh ; Faesen, Sharla ; Samaneka, Wadzanai ; Infante, Rosa ; Rana, Aadia ; Kumarasamy, Nagalingeswaran ; Hakim, James ; Campbell, Thomas B2015 May-JunHIV Clin Trials316
Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.Lehmann, David S ; Ribaudo, Heather J ; Daar, Eric S ; Gulick, Roy M ; Haubrich, Richard H ; Robbins, Gregory K ; DE Bakker, Paul I W ; Haas, David W ; McLaren, Paul J2015 FebPharmacogenet Genomics225
Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial.Overton, Edgar Turner ; Chan, Ellen S ; Brown, Todd T ; Tebas, Pablo ; McComsey, Grace A ; Melbourne, Kathleen M ; Napoli, Andrew ; Hardin, William Royce ; Ribaudo, Heather J ; Yin, Michael T2015 Jun 16Ann Intern Med12162
Partner-Focused Adherence Intervention for Second-line Antiretroviral Therapy: A Multinational Randomized Trial (ACTG A5234).Gross, Robert ; Zheng, Lu ; La Rosa, Alberto ; Sun, Xin ; Rosenkranz, Susan L ; Cardoso, Sandra Wagner ; Ssali, Francis ; Camp, Rob ; Godfrey, Catherine ; Cohn, Susan E ; Robbins, Gregory K ; Chisada, Anthony ; Wallis, Carole L ; Reynolds, Nancy R ; Lu, Darlene ; Safren, Steven A ; Hosey, Lara ; Severe, Patrice ; Collier, Ann C2015 Jan 1Lancet HIV12
Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.Villarino, M Elsa ; Scott, Nigel A ; Weis, Stephen E ; Weiner, Marc ; Conde, Marcus B ; Jones, Brenda ; Nachman, Sharon ; Oliveira, Ricardo ; Moro, Ruth N ; Shang, Nong ; Goldberg, Stefan V ; Sterling, Timothy R ; International Maternal Pediatric and Adolescents AIDS Clinical Trials Group ; Tuberculosis Trials Consortium2015 MarJAMA Pediatr3169
Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression.Paris, Robert M ; Petrovas, Constantinos ; Ferrando-Martinez, Sara ; Moysi, Eirini ; Boswell, Kristin L ; Archer, Eva ; Yamamoto, Takuya ; Ambrozak, David ; Casazza, Joseph P ; Haubrich, Richard ; Connors, Mark ; Ake, Julie ; Kim, Jerome H ; Koup, Richard A2015PLoS One1210
Brief Report: Significant Decreases in Both Total and Unbound Lopinavir and Amprenavir Exposures During Coadministration: ACTG Protocol A5143/A5147s Results.Dumond, Julie B ; Rigdon, Joseph ; Mollan, Katie ; Tierney, Camlin ; Kashuba, Angela D M ; Aweeka, Francesca ; Collier, Ann C2015 Dec 15J Acquir Immune Defic Syndr570
Barriers to antiretroviral therapy adherence and plasma HIV RNA suppression among AIDS clinical trials group study participants.Saberi, Parya ; Neilands, Torsten B ; Vittinghoff, Eric ; Johnson, Mallory O ; Chesney, Margaret ; Cohn, Susan E2015 MarAIDS Patient Care STDS329
Comparison of HBV-active HAART regimens in an HIV-HBV multinational cohort: outcomes through 144 weeks.Thio, Chloe L ; Smeaton, Laura ; Hollabaugh, Kimberly ; Saulynas, Melissa ; Hwang, Hyon ; Saravanan, Shanmugam ; Kulkarni, Smita ; Hakim, James ; Nyirenda, Mulinda ; Iqbal, Hussain Syed ; Lalloo, Umesh G ; Campbell, Thomas B ; Lockman, Shahin ; Currier, Judith S2015 Jun 19AIDS1029
Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s.Kelesidis, Theodoros ; Tran, Thuy Tien T ; Stein, James H ; Brown, Todd T ; Moser, Carlee ; Ribaudo, Heather J ; Dubé, Michael P ; Murphy, Robert ; Yang, Otto O ; Currier, Judith S ; McComsey, Grace A2015 Aug 15Clin Infect Dis461
Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230.Kumarasamy, Nagalingeswaran ; Aga, Evgenia ; Ribaudo, Heather J ; Wallis, Carole L ; Katzenstein, David A ; Stevens, Wendy S ; Norton, Michael R ; Klingman, Karin L ; Hosseinipour, Mina C ; Crump, John A ; Supparatpinyo, Khuanchai ; Badal-Faesen, Sharlaa ; Bartlett, John A2015 May 15Clin Infect Dis1060
Presence of Plasmodium falciparum DNA in Plasma Does Not Predict Clinical Malaria in an HIV-1 Infected Population.Orlov, Marika ; Smeaton, Laura M ; Kumwenda, Johnstone ; Hosseinipour, Mina C ; Campbell, Thomas B ; Schooley, Robert T2015PLoS One610
Extended-Release Niacin Versus Fenofibrate in HIV-Infected Participants With Low High-Density Lipoprotein Cholesterol: Effects on Endothelial Function, Lipoproteins, and Inflammation.Dubé, Michael P ; Komarow, Lauren ; Fichtenbaum, Carl J ; Cadden, Joseph J ; Overton, Edgar T ; Hodis, Howard N ; Currier, Judith S ; Stein, James H ; AIDS Clinical Trials Group A5293 Study Team2015 Sep 1Clin Infect Dis561
Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286.Tenorio, Allan R ; Chan, Ellen S ; Bosch, Ronald J ; Macatangay, Bernard J C ; Read, Sarah W ; Yesmin, Suria ; Taiwo, Babafemi ; Margolis, David M ; Jacobson, Jeffrey M ; Landay, Alan L ; Wilson, Cara C ; A5286 Team2015 Mar 1J Infect Dis5211
Cost-effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice.Schackman, Bruce R ; Haas, David W ; Park, Sanghee S ; Li, X Cynthia ; Freedberg, Kenneth A2015 DecPharmacogenomics1816
C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings.Tenforde, Mark W ; Gupte, Nikhil ; Dowdy, David W ; Asmuth, David M ; Balagopal, Ashwin ; Pollard, Richard B ; Sugandhavesa, Patcharaphan ; Lama, Javier R ; Pillay, Sandy ; Cardoso, Sandra W ; Pawar, Jyoti ; Santos, Breno ; Riviere, Cynthia ; Mwelase, Noluthando ; Kanyama, Cecilia ; Kumwenda, Johnstone ; Hakim, James G ; Kumarasamy, Nagali2015PLoS One210
Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257.Ofotokun, Ighovwerha ; Na, Lumine H ; Landovitz, Raphael J ; Ribaudo, Heather J ; McComsey, Grace A ; Godfrey, Catherine ; Aweeka, Francesca ; Cohn, Susan E ; Sagar, Manish ; Kuritzkes, Daniel R ; Brown, Todd T ; Patterson, Kristine B ; Para, Michael F ; Leavitt, Randi Y ; Villasis-Keever, Angelina ; Baugh, Bryan P ; Lennox, Jeffrey L ; Cu2015 Jun 15Clin Infect Dis1260
Leveraging prognostic baseline variables to gain precision in randomized trials.Colantuoni, Elizabeth ; Rosenblum, Michael2015 Aug 15Stat Med1834
Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study.Taiwo, Babafemi O ; Chan, Ellen S ; Fichtenbaum, Carl J ; Ribaudo, Heather ; Tsibris, Athe ; Klingman, Karin L ; Eron, Joseph J ; Berzins, Baiba ; Robertson, Kevin ; Landay, Alan ; Ofotokun, Igho ; Brown, Todd ; AIDS Clinical Trials Group A5303 Study Team2015 Oct 1Clin Infect Dis761
Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine.Wyatt, Christina M ; Kitch, Douglas ; Gupta, Samir K ; Tierney, Camlin ; Daar, Eric S ; Sax, Paul E ; Ha, Belinda ; Melbourne, Kathleen ; McComsey, Grace A ; AIDS Clinical Trials Group Study A5224s Team2014 Sep 1J Acquir Immune Defic Syndr167
Comparison of illumina and 454 deep sequencing in participants failing raltegravir-based antiretroviral therapy.Li, Jonathan Z ; Chapman, Brad ; Charlebois, Patrick ; Hofmann, Oliver ; Weiner, Brian ; Porter, Alyssa J ; Samuel, Reshmi ; Vardhanabhuti, Saran ; Zheng, Lu ; Eron, Joseph ; Taiwo, Babafemi ; Zody, Michael C ; Henn, Matthew R ; Kuritzkes, Daniel R ; Hide, Winston ; ACTG A5262 Study Team ; Wilson, Cara C ; Berzins, Baiba I ; Acosta, Edward2014PLoS One39
Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.Leger, Paul D ; Johnson, Daniel H ; Robbins, Gregory K ; Shafer, Robert W ; Clifford, David B ; Li, Jun ; McLaren, Paul J ; Haas, David W2014 JunJ Neurovirol320
Pre-antiretroviral therapy serum selenium concentrations predict WHO stages 3, 4 or death but not virologic failure post-antiretroviral therapy.Shivakoti, Rupak ; Gupte, Nikhil ; Yang, Wei-Teng ; Mwelase, Noluthando ; Kanyama, Cecilia ; Tang, Alice M ; Pillay, Sandy ; Samaneka, Wadzanai ; Riviere, Cynthia ; Berendes, Sima ; Lama, Javier R ; Cardoso, Sandra W ; Sugandhavesa, Patcharaphan ; Semba, Richard D ; Christian, Parul ; Campbell, Thomas B ; Gupta, Amita ; NWCS 319 and PEARLS2014 NovNutrients116
Drug susceptibility and resistance mutations after first-line failure in resource limited settings.Wallis, Carole L ; Aga, Evgenia ; Ribaudo, Heather ; Saravanan, Shanmugam ; Norton, Michael ; Stevens, Wendy ; Kumarasamy, Nagalingeswaran ; Bartlett, John ; Katzenstein, David ; A5230 team2014 Sep 1Clin Infect Dis559
Minorities remain underrepresented in HIV/AIDS research despite access to clinical trials.Castillo-Mancilla, Jose R ; Cohn, Susan E ; Krishnan, Supriya ; Cespedes, Michelle ; Floris-Moore, Michelle ; Schulte, Gail ; Pavlov, Gregory ; Mildvan, Donna ; Smith, Kimberly Y2014 Jan-FebHIV Clin Trials115
HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy.Besson, Guillaume J ; Lalama, Christina M ; Bosch, Ronald J ; Gandhi, Rajesh T ; Bedison, Margaret A ; Aga, Evgenia ; Riddler, Sharon A ; McMahon, Deborah K ; Hong, Feiyu ; Mellors, John W2014 Nov 1Clin Infect Dis959
Relationship of HIV reservoir characteristics with immune status and viral rebound kinetics in an HIV therapeutic vaccine study.Li, Jonathan Z ; Heisey, Andrea ; Ahmed, Hayat ; Wang, Hongying ; Zheng, Lu ; Carrington, Mary ; Wrin, Terri ; Schooley, Robert T ; Lederman, Michael M ; Kuritzkes, Daniel R ; ACTG A5197 Study Team2014 Nov 28AIDS1828
Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individuals.Kalayjian, Robert C ; Wu, Kunling ; Evans, Scott ; Clifford, David B ; Pallaki, Muraldihar ; Currier, Judith S ; Smryzynski, Marlene2014 Sep 1J Acquir Immune Defic Syndr167
The role of HIV and monocytes/macrophages in adipose tissue biology.Shikuma, Cecilia M ; Gangcuangco, Louie Mar A ; Killebrew, Deirdre A ; Libutti, Daniel E ; Chow, Dominic C ; Nakamoto, Beau K ; Liang, Chin Yuan ; Milne, Cris I P ; Ndhlovu, Lishomwa C ; Barbour, Jason D ; Shiramizu, Bruce T ; Gerschenson, Mariana2014 Feb 01J Acquir Immune Defic Syndr265
Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection.Boswell, Kristin L ; Paris, Robert ; Boritz, Eli ; Ambrozak, David ; Yamamoto, Takuya ; Darko, Sam ; Wloka, Kaska ; Wheatley, Adam ; Narpala, Sandeep ; McDermott, Adrian ; Roederer, Mario ; Haubrich, Richard ; Connors, Mark ; Ake, Julie ; Douek, Daniel C ; Kim, Jerome ; Petrovas, Constantinos ; Koup, Richard A2014 JanPLoS Pathog110
Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group Study.Henrich, Timothy J ; McLaren, Paul J ; Rao, Suhas S P ; Lin, Nina H ; Hanhauser, Emily ; Giguel, Francoise ; Gulick, Roy M ; Ribaudo, Heather ; DE Bakker, Paul I W ; Kuritzkes, Daniel R2014 MarOpen Forum Infect Dis11
Predictors of suboptimal CD4 response among women achieving virologic suppression in a randomized antiretroviral treatment trial, Africa.Asmelash, Aida ; Zheng, Yu ; Kaloustian, Kara Wools ; Shaffer, Douglas ; Sawe, Fred ; Ogwu, Anthony ; Salata, Robert ; Currier, Judith ; Hughes, Michael D ; Lockman, Shahin2014BMC Infect Dis14
Phase I safety, pharmacokinetics, and pharmacogenetics study of the antituberculosis drug PA-824 with concomitant lopinavir-ritonavir, efavirenz, or rifampin.Dooley, Kelly E ; Luetkemeyer, Anne F ; Park, Jeong-Gun ; Allen, Reena ; Cramer, Yoninah ; Murray, Stephen ; Sutherland, Deborah ; Aweeka, Francesca ; Koletar, Susan L ; Marzan, Florence ; Bao, Jing ; Savic, Rada ; Haas, David W ; AIDS Clinical Trials Group A5306 Study Team2014 SepAntimicrob Agents Chemother958
Baseline natural killer and T cell populations correlation with virologic outcome after regimen simplification to atazanavir/ritonavir alone (ACTG 5201).McKinnon, John E ; Mailliard, Robbie B ; Swindells, Susan ; Wilkin, Timothy J ; Borowski, Luann ; Roper, Jillian M ; Bastow, Barbara ; Kearney, Mary ; Wiegand, Ann ; Mellors, John W ; Rinaldo, Charles R ; A5201 study team2014PLoS One59
Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial.Safren, Steven A ; Biello, Katie B ; Smeaton, Laura ; Mimiaga, Matthew J ; Walawander, Ann ; Lama, Javier R ; Rana, Aadia ; Nyirenda, Mulinda ; Kayoyo, Virginia M ; Samaneka, Wadzanai ; Joglekar, Anjali ; Celentano, David ; Martinez, Ana ; Remmert, Jocelyn E ; Nair, Aspara ; Lalloo, Umesh G ; Kumarasamy, Nagalingeswaran ; Hakim, James ; Ca2014PLoS One89
Regulatory T cells and the risk of CMV end-organ disease in patients with AIDS.Weinberg, Adriana ; Bosch, Ronald ; Bennett, Kara ; Tovar-Salazar, Adriana ; Benson, Constance A ; Collier, Ann C ; Zolopa, Andrew ; Gulick, Roy M ; Wohl, David ; Polsky, Bruce ; Erice, Alejo ; Jacobson, Mark A2014 May 1J Acquir Immune Defic Syndr166
Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infection.Sandler, Netanya G ; Zhang, Xinyan ; Bosch, Ronald J ; Funderburg, Nicholas T ; Choi, Andrew I ; Robinson, Janet K ; Fine, Derek M ; Coombs, Robert W ; Jacobson, Jeffrey M ; Landay, Alan L ; Douek, Daniel C ; Tressler, Randall ; Read, Sarah W ; Wilson, Cara C ; Deeks, Steven G ; Lederman, Michael M ; Gandhi, Rajesh T ; AIDS Clinical Trials2014 Nov 15J Infect Dis10210
Associations of inflammatory markers with AIDS and non-AIDS clinical events after initiation of antiretroviral therapy: AIDS clinical trials group A5224s, a substudy of ACTG A5202.McComsey, Grace A ; Kitch, Douglas ; Sax, Paul E ; Tierney, Camlin ; Jahed, Nasreen C ; Melbourne, Kathleen ; Ha, Belinda ; Brown, Todd T ; Bloom, Anthony ; Fedarko, Neal ; Daar, Eric S2014 Feb 1J Acquir Immune Defic Syndr265
Cardiovascular disease risk factors in HIV-infected women after initiation of lopinavir/ritonavir- and nevirapine-based antiretroviral therapy in Sub-Saharan Africa: A5208 (OCTANE).Shaffer, Douglas ; Hughes, Michael D ; Sawe, Fredrick ; Bao, Yajing ; Moses, Agnes ; Hogg, Evelyn ; Lockman, Shahin ; Currier, Judith2014 Jun 1J Acquir Immune Defic Syndr266
Older age is associated with peripheral blood expansion of naïve B cells in HIV-infected subjects on antiretroviral therapy.Van Epps, Puja ; Matining, Roy M ; Tassiopoulos, Katherine ; Anthony, Donald D ; Landay, Alan ; Kalayjian, Robert C ; Canaday, David H2014PLoS One99
The effect of hepatitis C virologic clearance on cardiovascular disease biomarkers in human immunodeficiency virus/hepatitis C virus coinfection.Chew, Kara W ; Hua, Lei ; Bhattacharya, Debika ; Butt, Adeel A ; Bornfleth, Lorelei ; Chung, Raymond T ; Andersen, Janet W ; Currier, Judith S2014 DecOpen Forum Infect Dis31
Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data.Mollan, Katie R ; Smurzynski, Marlene ; Eron, Joseph J ; Daar, Eric S ; Campbell, Thomas B ; Sax, Paul E ; Gulick, Roy M ; Na, Lumine ; O'Keefe, Lauren ; Robertson, Kevin R ; Tierney, Camlin2014 Jul 1Ann Intern Med1161
Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes.Haas, David W ; Kwara, Awewura ; Richardson, Danielle M ; Baker, Paxton ; Papageorgiou, Ioannis ; Acosta, Edward P ; Morse, Gene D ; Court, Michael H2014 AugJ Antimicrob Chemother869
HIV-1 RNA levels and antiretroviral drug resistance in blood and non-blood compartments from HIV-1-infected men and women enrolled in AIDS clinical trials group study A5077.Kantor, Rami ; Bettendorf, Daniel ; Bosch, Ronald J ; Mann, Marita ; Katzenstein, David ; Cu-Uvin, Susan ; D'Aquila, Richard ; Frenkel, Lisa ; Fiscus, Susan ; Coombs, Robert ; ACTG A5077 Study Team2014PLoS One49
Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment.Tenorio, Allan R ; Zheng, Yu ; Bosch, Ronald J ; Krishnan, Supriya ; Rodriguez, Benigno ; Hunt, Peter W ; Plants, Jill ; Seth, Arjun ; Wilson, Cara C ; Deeks, Steven G ; Lederman, Michael M ; Landay, Alan L2014 Oct 15J Infect Dis8210
Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapine.Mwafongo, Albert ; Nkanaunena, Kondwani ; Zheng, Yu ; Hogg, Evelyn ; Samaneka, Wadzanai ; Mulenga, Lloyd ; Siika, Abraham ; Currier, Judith ; Lockman, Shahin ; Hughes, Michael D ; Hosseinipour, Mina ; AIDS Clinical Trial Group (ACTG) A5208 Team2014 May 15AIDS828
Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohort.Kang, Minhee ; Hollabaugh, Kimberly ; Pham, Vinh ; Koletar, Susan L ; Wu, Kunling ; Smurzynski, Marlene ; Aberg, Judith A2014 Jun 1J Acquir Immune Defic Syndr266
Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs.Luetkemeyer, Anne F ; Kendall, Michelle A ; Nyirenda, Mulinda ; Wu, Xingye ; Ive, Prudence ; Benson, Constance A ; Andersen, Janet W ; Swindells, Susan ; Sanne, Ian M ; Havlir, Diane V ; Kumwenda, Johnstone ; Adult AIDS Clinical Trials Group A5221 Study Team2014 Apr 1J Acquir Immune Defic Syndr465
Safety and antiviral activity of the HCV entry inhibitor ITX5061 in treatment-naive HCV-infected adults: a randomized, double-blind, phase 1b study.Sulkowski, Mark S ; Kang, Minhee ; Matining, Roy ; Wyles, David ; Johnson, Victoria A ; Morse, Gene D ; Amorosa, Valerianna ; Bhattacharya, Debika ; Coughlin, Kristine ; Wong-Staal, Flossie ; Glesby, Marshall J ; AIDS Clinical Trials Group A5277 Protocol Team2014 Mar 1J Infect Dis5209
Impact of chemotherapy for HIV-1 related lymphoma on residual viremia and cellular HIV-1 DNA in patients on suppressive antiretroviral therapy.Cillo, Anthony R ; Krishnan, Supriya ; McMahon, Deborah K ; Mitsuyasu, Ronald T ; Para, Michael F ; Mellors, John W2014PLoS One39
Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TB.Luetkemeyer, Anne F ; Kendall, Michelle A ; Wu, Xingye ; Lourenço, Maria Cristina ; Jentsch, Ute ; Swindells, Susan ; Qasba, Sarojini S ; Sanchez, Jorge ; Havlir, Diane V ; Grinsztejn, Beatriz ; Sanne, Ian M ; Firnhaber, Cynthia ; Adult AIDS Clinical Trials Group A5255 Study Team2014 AprJ Clin Microbiol452
Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabine.Smith, Kimberly Y ; Tierney, Camlin ; Mollan, Katie ; Venuto, Charles S ; Budhathoki, Chakra ; Ma, Qing ; Morse, Gene D ; Sax, Paul ; Katzenstein, David ; Godfrey, Catherine ; Fischl, Margaret ; Daar, Eric S ; Collier, Ann C ; AIDS Clinical Trials Group 5202 Study Team2014 FebClin Infect Dis458
Implementation of HIV-related clinical research in the international setting.Godfrey, Catherine ; Schouten, Jeffrey T ; Swindells, Susan2014 Jan 1J Acquir Immune Defic Syndr65 Suppl 1
Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairment.Sacktor, Ned ; Miyahara, Sachiko ; Evans, Scott ; Schifitto, Giovanni ; Cohen, Bruce ; Haughey, Norman ; Drewes, Julia L ; Graham, David ; Zink, M Christine ; Anderson, Caroline ; Nath, Avindra ; Pardo, Carlos A ; McCarthy, Sean ; Hosey, Lara ; Clifford, David ; ACTG A5235 team2014 DecJ Neurovirol620
Frequency of Antiretroviral Resistance Mutations among Infants Exposed to Single-Dose Nevirapine and Short Course Maternal Antiretroviral Regimens: ACTG A5207.Hitti, Jane ; Halvas, Elias K ; Zheng, Lu ; Panousis, Constantinos G ; Kabanda, Joseph ; Taulo, Frank ; Kumarasamy, Nagalingeswaran ; Pape, Jean William ; Lalloo, Umesh ; Sprenger, Heather ; Klingman, Karin L ; Chan, Ellen S ; McMahon, Deborah ; Mellors, John W2014 NovJ AIDS Clin Res115
Combination antiretroviral treatment for women previously treated only in pregnancy: week 24 results of AIDS clinical trials group protocol a5227.Vogler, Mary A ; Smeaton, Laura M ; Wright, Rodney L ; Cardoso, Sandra W ; Sanchez, Jorge ; Infante, Rosa ; Moran, Laura E ; Godfrey, Catherine ; Demeter, Lisa M ; Johnson, Victoria A2014 Apr 15J Acquir Immune Defic Syndr565
Plasma apolipoprotein L1 levels do not correlate with CKD.Bruggeman, Leslie A ; O'Toole, John F ; Ross, Michael D ; Madhavan, Sethu M ; Smurzynski, Marlene ; Wu, Kunling ; Bosch, Ronald J ; Gupta, Samir ; Pollak, Martin R ; Sedor, John R ; Kalayjian, Robert C2014 MarJ Am Soc Nephrol325
Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202.Venuto, Charles S ; Mollan, Katie ; Ma, Qing ; Daar, Eric S ; Sax, Paul E ; Fischl, Margaret ; Collier, Ann C ; Smith, Kimberly Y ; Tierney, Camlin ; Morse, Gene D2014 DecJ Antimicrob Chemother1269
Pilot study of pioglitazone before HCV retreatment in HIV/HCV genotype 1-infected subjects with insulin resistance and previous nonresponse to peginterferon and ribavirin therapy: A5239.Marks, Kristen M ; Kitch, Douglas ; Chung, Raymond T ; Hadigan, Colleen ; Andersen, Janet ; Tien, Phyllis ; Luetkemeyer, Annie ; Alston-Smith, Beverly ; Glesby, Marshall J ; A5239 Team2014 Mar 1J Acquir Immune Defic Syndr365
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.Lennox, Jeffrey L ; Landovitz, Raphael J ; Ribaudo, Heather J ; Ofotokun, Ighovwerha ; Na, Lumine H ; Godfrey, Catherine ; Kuritzkes, Daniel R ; Sagar, Manish ; Brown, Todd T ; Cohn, Susan E ; McComsey, Grace A ; Aweeka, Francesca ; Fichtenbaum, Carl J ; Presti, Rachel M ; Koletar, Susan L ; Haas, David W ; Patterson, Kristine B ; Benson, 2014 Oct 7Ann Intern Med7161
Cystatin C-based renal function changes after antiretroviral initiation: a substudy of a randomized trial.Gupta, Samir K ; Kitch, Douglas ; Tierney, Camlin ; Daar, Eric S ; Sax, Paul E ; Melbourne, Kathleen ; Ha, Belinda ; McComsey, Grace A ; AIDS Clinical Trials Group Study A5224s Team2014 MarOpen Forum Infect Dis11
25-Hydroxyvitamin D insufficiency and deficiency is associated with HIV disease progression and virological failure post-antiretroviral therapy initiation in diverse multinational settings.Havers, Fiona ; Smeaton, Laura ; Gupte, Nikhil ; Detrick, Barbara ; Bollinger, Robert C ; Hakim, James ; Kumarasamy, Nagalingeswaran ; Andrade, Adriana ; Christian, Parul ; Lama, Javier R ; Campbell, Thomas B ; Gupta, Amita ; ACTG PEARLS ; NWCS 319 Study Teams2014 Jul 15J Infect Dis2210
Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women.Kojic, Erna Milunka ; Kang, Minhee ; Cespedes, Michelle S ; Umbleja, Triin ; Godfrey, Catherine ; Allen, Reena T ; Firnhaber, Cynthia ; Grinsztejn, Beatriz ; Palefsky, Joel M ; Webster-Cyriaque, Jennifer Y ; Saah, Alfred ; Aberg, Judith A ; Cu-Uvin, Susan2014 Jul 1Clin Infect Dis159
Renal and metabolic toxicities following initiation of HIV-1 treatment regimen in a diverse, multinational setting: a focused safety analysis of ACTG PEARLS (A5175).Touzard Romo, F ; Smeaton, L M ; Campbell, T B ; Riviere, C ; Mngqibisa, R ; Nyirenda, M ; Supparatpinyo, K ; Kumarasamy, N ; Hakim, J G ; Flanigan, T P2014 Nov-DecHIV Clin Trials615
Low-frequency nevirapine (NVP)-resistant HIV-1 variants are not associated with failure of antiretroviral therapy in women without prior exposure to single-dose NVP.Boltz, Valerie F ; Bao, Yajing ; Lockman, Shahin ; Halvas, Elias K ; Kearney, Mary F ; McIntyre, James A ; Schooley, Robert T ; Hughes, Michael D ; Coffin, John M ; Mellors, John W ; OCTANE/A5208 Team2014 Mar 1J Infect Dis5209
Antiretroviral therapy and efficacy after virologic failure on first-line boosted protease inhibitor regimens.Zheng, Yu ; Hughes, Michael D ; Lockman, Shahin ; Benson, Constance A ; Hosseinipour, Mina C ; Campbell, Thomas B ; Gulick, Roy M ; Daar, Eric S ; Sax, Paul E ; Riddler, Sharon A ; Haubrich, Richard ; Salata, Robert A ; Currier, Judith S2014 Sep 15Clin Infect Dis659
Change in vitamin d levels occurs early after antiretroviral therapy initiation and depends on treatment regimen in resource-limited settings.Havers, Fiona P ; Detrick, Barbara ; Cardoso, Sandra W ; Berendes, Sima ; Lama, Javier R ; Sugandhavesa, Patcharaphan ; Mwelase, Noluthando H ; Campbell, Thomas B ; Gupta, Amita ; ACTG A5175 PEARLS and NWCS319 Study Teams2014PLoS One49
Clinical and immunologic predictors of death after an acute opportunistic infection: results from ACTG A5164.Grant, Philip M ; Komarow, Lauren ; Sanchez, Alejandro ; Sattler, Fred R ; Asmuth, David M ; Pollard, Richard B ; Zolopa, Andrew R2014 Jul-AugHIV Clin Trials415
Role of oral candidiasis in TB and HIV co-infection: AIDS Clinical Trial Group Protocol A5253.Shiboski, C H ; Chen, H ; Ghannoum, M A ; Komarow, L ; Evans, S ; Mukherjee, P K ; Isham, N ; Katzenstein, D ; Asmelash, A ; Omozoarhe, A E ; Gengiah, S ; Allen, R ; Tripathy, S ; Swindells, S ; AIDS Clinical Trials Group Network and Oral HIV/AIDS Research Alliance2014 JunInt J Tuberc Lung Dis618
Factors associated with CD8+ T-cell activation in HIV-1-infected patients on long-term antiretroviral therapy.Zheng, Lu ; Taiwo, Babafemi ; Gandhi, Rajesh T ; Hunt, Peter W ; Collier, Ann C ; Flexner, Charles ; Bosch, Ronald J2014 Oct 1J Acquir Immune Defic Syndr267
Impact of randomized antiretroviral therapy initiation on glucose metabolism.Erlandson, Kristine Mace ; Kitch, Douglas ; Tierney, Camlin ; Sax, Paul E ; Daar, Eric S ; Melbourne, Kathleen M ; Ha, Belinda ; McComsey, Grace A2014 Jun 19AIDS1028
A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy.Jacobson, Jeffrey M ; Wang, Hongying ; Bordi, Rebeka ; Zheng, Lu ; Gross, Barry H ; Landay, Alan L ; Spritzler, John ; Routy, Jean-Pierre ; Benson, Constance ; Aberg, Judith ; Tebas, Pablo ; Haas, David W ; Tiu, Jennifer ; Coughlin, Kristine ; Purdue, Lynette ; Sekaly, Rafick-Pierre ; AIDS Clinical Trials Group (ACTG) A5212 Protocol Team2014 Aug 1J Acquir Immune Defic Syndr466
Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202.Johnson, Daniel H ; Venuto, Charles ; Ritchie, Marylyn D ; Morse, Gene D ; Daar, Eric S ; McLaren, Paul J ; Haas, David W2014 AprPharmacogenet Genomics424
Mitochondrial DNA variation and changes in adiponectin and endothelial function in HIV-infected adults after antiretroviral therapy initiation.Hulgan, Todd ; Stein, James H ; Cotter, Bruno R ; Murdock, Deborah G ; Ritchie, Marylyn D ; Dubé, Michael P ; Gerschenson, Mariana ; Haas, David W ; Torriani, Francesca J ; Aids Clinical Trials Group A5152s And Dacs 252 Study Teams2013 OctAIDS Res Hum Retroviruses1029
Genetic predictors of cervical dysplasia in African American HIV-infected women: ACTG DACS 268.Cespedes, Michelle S ; Kerns, Sarah L ; Holzman, Robert S ; McLaren, Paul J ; Ostrer, Harry ; Aberg, Judith A2013 Nov-DecHIV Clin Trials614
Higher expression of several interferon-stimulated genes in HIV-1-infected females after adjusting for the level of viral replication.Chang, J Judy ; Woods, Matt ; Lindsay, Robert J ; Doyle, Erin H ; Griesbeck, Morgane ; Chan, Ellen S ; Robbins, Gregory K ; Bosch, Ronald J ; Altfeld, Marcus2013 Sep 1J Infect Dis5208
Immune Activation While on Potent Antiretroviral Therapy Can Predict Subsequent CD4+ T-Cell Increases Through 15 Years of Treatment.Zhang, Xinyan ; Hunt, Peter W ; Hammer, Scott M ; Cespedes, Michelle S ; Patterson, Kristine B ; Bosch, Ronald J2013 Mar-AprHIV Clin Trials214
Interleukin-7 promotes HIV persistence during antiretroviral therapy.Vandergeeten, Claire ; Fromentin, Rémi ; DaFonseca, Sandrina ; Lawani, Mariam B ; Sereti, Irini ; Lederman, Michael M ; Ramgopal, Moti ; Routy, Jean-Pierre ; Sekaly, Rafick-Pierre ; Chomont, Nicolas2013 May 23Blood21121
Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE Study.Luetkemeyer, Anne F ; Rosenkranz, Susan L ; Lu, Darlene ; Marzan, Florence ; Ive, Prudence ; Hogg, Evelyn ; Swindells, Susan ; Benson, Constance A ; Grinsztejn, Beatriz ; Sanne, Ian M ; Havlir, Diane V ; Aweeka, Francesca ; Adult AIDS Clinical Trials Group A5221 Study Team2013 AugClin Infect Dis457
Older HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reduction.Kalayjian, Robert C ; Spritzler, John ; Matining, Roy M ; Fiscus, Susan A ; Gross, Barry H ; Francis, Isaac R ; Pollard, Richard B ; Lederman, Michael M ; Landay, Alan2013 Jun 19AIDS1027
Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202.McComsey, Grace A ; Daar, Eric S ; O'Riordan, MaryAnn ; Collier, Ann C ; Kosmiski, Lisa ; Santana, Jorge L ; Fichtenbaum, Carl J ; Fink, Heidi ; Sax, Paul E ; Libutti, Daniel E ; Gerschenson, Mariana2013 Feb 15J Infect Dis4207
Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection.Stein, James H ; Brown, Todd T ; Ribaudo, Heather J ; Chen, Yun ; Yan, Mingzhu ; Lauer-Brodell, Elizabeth ; McComsey, Grace A ; Dubé, Michael P ; Murphy, Robert L ; Hodis, Howard N ; Currier, Judith S2013 Mar 27AIDS627
MACH14: a multi-site collaboration on ART adherence among 14 institutions.Liu, Honghu ; Wilson, Ira B ; Goggin, Kathy ; Reynolds, Nancy ; Simoni, Jane M ; Golin, Carol E ; Rosen, Marc I ; Gross, Robert ; Wagner, Glenn ; Remien, Robert H ; Schneiderman, Neil ; Erlen, Judith A ; Arnsten, Julia H ; Bangsberg, David R2013 JanAIDS Behav117
Modeling clinical endpoints as a function of time of switch to second-line ART with incomplete data on switching times.Johnson, Brent A ; Ribaudo, Heather ; Gulick, Roy M ; Eron, Joseph J2013 SepBiometrics369
The clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefit.Wohl, David A ; Kendall, Michelle A ; Feinberg, Judith ; Alston-Smith, Beverly ; Owens, Susan ; Chafey, Suzette ; Marco, Michael ; Maxwell, Sharon ; Benson, Constance ; Keiser, Philip ; van der Horst, Charles ; Jacobson, Mark A ; A5030 Study Team2013PLoS One118
Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS and respiratory symptoms.Wood, Brian R ; Komarow, Lauren ; Zolopa, Andrew R ; Finkelman, Malcolm A ; Powderly, William G ; Sax, Paul E2013 Mar 27AIDS627
Peripheral neuropathy in ART-experienced patients: prevalence and risk factors.Chen, Huichao ; Clifford, David B ; Deng, Lijuan ; Wu, Kunling ; Lee, Anthony J ; Bosch, Ronald J ; Riddler, Sharon A ; Ellis, Ronald J ; Evans, Scott R2013 DecJ Neurovirol619
ITX 5061 quantitation in human plasma with reverse phase liquid chromatography and mass spectrometry detection.Hochreiter, Jill ; Lapham, Jill ; Wong-Staal, Flossie ; McKelvy, Jeffrey ; Sulkowski, Mark ; Glesby, Marshall J ; Johnson, Victoria A ; Morse, Gene D2013Antivir Ther318
Characterization of HIV-HBV coinfection in a multinational HIV-infected cohort.Thio, Chloe L ; Smeaton, Laura ; Saulynas, Melissa ; Hwang, Hyon ; Saravanan, Shanmugam ; Saravan, Shanmugam ; Kulkarni, Smita ; Hakim, James ; Nyirenda, Mulinda ; Iqbal, Hussain S ; Lalloo, Umesh G ; Mehta, Anand S ; Hollabaugh, Kimberly ; Campbell, Thomas B ; Lockman, Shahin ; Currier, Judith S2013 Jan 14AIDS227
Clinical and genetic determinants of plasma nevirapine exposure following an intrapartum dose to prevent mother-to-child HIV transmission.Vardhanabhuti, Saran ; Acosta, Edward P ; Ribaudo, Heather J ; Severe, Patrice ; Lalloo, Umesh ; Kumarasamy, Nagalingeshwaran ; Taulo, Frank ; Kabanda, Joseph ; Oneko, Olola ; Ive, Prudence ; Sambarey, Pradeep ; Chan, Ellen S ; Hitti, Jane ; Hong, Francis ; McMahon, Deborah ; Haas, David W ; A5207 ACTG Study Team2013 Aug 15J Infect Dis4208
Controlling healthcare-associated infections in the international research setting.Godfrey, Catherine ; Villa, Christie ; Dawson, Liza ; Swindells, Susan ; Schouten, Jeffrey T2013 Apr 1J Acquir Immune Defic Syndr462
Anthropometric differences between HIV-infected individuals prior to antiretroviral treatment and the general population from 1998-2007: the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT) cohort and NHANES.Atkinson, Benjamin E ; Krishnan, Supriya ; Cox, Gary ; Hulgan, Todd ; Collier, Ann C2013PLoS One68
Outcomes among HIV-1 infected individuals first starting antiretroviral therapy with concurrent active TB or other AIDS-defining disease.Périssé, André R S ; Smeaton, Laura ; Chen, Yun ; La Rosa, Alberto ; Walawander, Ann ; Nair, Apsara ; Grinsztejn, Beatriz ; Santos, Breno ; Kanyama, Cecilia ; Hakim, James ; Nyirenda, Mulinda ; Kumarasamy, Nagalingeswaran ; Lalloo, Umesh G ; Flanigan, Timothy ; Campbell, Thomas B ; Hughes, Michael D ; P E A R L S study team of the ACTG2013PLoS One128
Associations of T cell activation and inflammatory biomarkers with virological response to darunavir/ritonavir plus raltegravir therapy.Taiwo, Babafemi ; Matining, Roy M ; Zheng, Lu ; Lederman, Michael M ; Rinaldo, Charles R ; Kim, Peter S ; Berzins, Baiba I ; Kuritzkes, Daniel R ; Jennings, Amy ; Eron, Joseph J ; Wilson, Cara C2013 AugJ Antimicrob Chemother868
Site nurse-initiated adherence and symptom support telephone calls for HIV-positive individuals starting antiretroviral therapy, ACTG 5031: substudy of ACTG 384.Robbins, Gregory K ; Testa, Marcia A ; Su, Max ; Safren, Steven A ; Morse, Gene ; Lammert, Sara ; Shafer, Robert W ; Reynolds, Nancy R ; Chesney, Margaret A2013 Sep-OctHIV Clin Trials514
Model-based estimates of the effects of efavirenz on bedaquiline pharmacokinetics and suggested dose adjustments for patients coinfected with HIV and tuberculosis.Svensson, Elin M ; Aweeka, Francesca ; Park, Jeong-Gun ; Marzan, Florence ; Dooley, Kelly E ; Karlsson, Mats O2013 JunAntimicrob Agents Chemother657
The impact of age on the prognostic capacity of CD8+ T-cell activation during suppressive antiretroviral therapy.Lok, Judith J ; Hunt, Peter W ; Collier, Ann C ; Benson, Constance A ; Witt, Mallory D ; Luque, Amneris E ; Deeks, Steven G ; Bosch, Ronald J2013 Aug 24AIDS1327
Predictors of residual viraemia in patients on long-term suppressive antiretroviral therapy.Zheng, Lu ; Bosch, Ronald J ; Chan, Ellen S ; Read, Sarah ; Kearney, Mary ; Margolis, David M ; Mellors, John W ; Eron, Joseph J ; Gandhi, Rajesh T ; DS Clinical Trials Group (ACTG) A5244 Team2013Antivir Ther118
Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load?Abu-Raddad, Laith J ; Barnabas, Ruanne V ; Janes, Holly ; Weiss, Helen A ; Kublin, James G ; Longini, Ira M ; Wasserheit, Judith N ; HIV Viral Load Working Group2013 Mar 27AIDS627
The design of single-arm clinical trials of combination antiretroviral regimens for treatment-naive HIV-infected patients.Zheng, Lu ; Rosenkranz, Susan L ; Taiwo, Babafemi ; Para, Michael F ; Eron, Joseph J ; Hughes, Michael D2013 AprAIDS Res Hum Retroviruses429
CD8+ T-cell activation in HIV-1-infected patients experiencing transient low-level viremia during antiretroviral therapy.Taiwo, Babafemi ; Hunt, Peter W ; Gandhi, Rajesh T ; Ellingson, Andrew ; McKenna, Matthew ; Jacobson, Jeffrey M ; Gripshover, Barbara ; Bosch, Ronald J2013 May 1J Acquir Immune Defic Syndr163
High-grade anal intraepithelial neoplasia among HIV-1-infected men screening for a multicenter clinical trial of a human papillomavirus vaccine.Wilkin, Timothy ; Lee, Jeannette Y ; Lensing, Shelly Y ; Stier, Elizabeth A ; Goldstone, Stephen E ; Berry, Michael J ; Jay, Naomi ; Aboulafia, David M ; Einstein, Mark H ; Saah, Alfred ; Mitsuyasu, Ronald T ; Palefsky, Joel M2013 Mar-AprHIV Clin Trials214
Racial differences in response to antiretroviral therapy for HIV infection: an AIDS clinical trials group (ACTG) study analysis.Ribaudo, Heather J ; Smith, Kimberly Y ; Robbins, Gregory K ; Flexner, Charles ; Haubrich, Richard ; Chen, Yun ; Fischl, Margaret A ; Schackman, Bruce R ; Riddler, Sharon A ; Gulick, Roy M2013 DecClin Infect Dis1157
Experience and challenges presented by a multicenter crossover study of combination analgesic therapy for the treatment of painful HIV-associated polyneuropathies.Harrison, Taylor ; Miyahara, Sachiko ; Lee, Anthony ; Evans, Scott ; Bastow, Barbara ; Simpson, David ; Gilron, Ian ; Dworkin, Robert ; Daar, Eric S ; Wieclaw, Linda ; Clifford, David B ; ACTG A5252 Team2013 JulPain Med714
Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation.Grant, Philip M ; Kitch, Douglas ; McComsey, Grace A ; Dubé, Michael P ; Haubrich, Richard ; Huang, Jeannie ; Riddler, Sharon ; Tebas, Pablo ; Zolopa, Andrew R ; Collier, Ann C ; Brown, Todd T2013 NovClin Infect Dis1057
Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202.Grant, Philip M ; Tierney, Camlin ; Budhathoki, Chakra ; Daar, Eric S ; Sax, Paul E ; Collier, Ann C ; Fischl, Margaret A ; Zolopa, Andrew R ; Balamane, Maya ; Katzenstein, David2013 Nov-DecHIV Clin Trials614
Hepatitis C virus/HIV coinfection and responses to initial antiretroviral treatment.Hua, Lei ; Andersen, Janet W ; Daar, Eric S ; Glesby, Marshall J ; Hollabaugh, Kimberly ; Tierney, Camlin2013 Nov 13AIDS1727
Factors associated with remaining on initial randomized efavirenz-containing regimens.Smurzynski, Marlene ; Wu, Kunling ; Schouten, Jeffrey T ; Lok, Judith J ; Bosch, Ronald J ; Taiwo, Babafemi ; Johnson, Victoria Anne ; Collier, Ann C2013 Jul 31AIDS1227
Greater suppression of nevirapine resistance with 21- vs 7-day antiretroviral regimens after intrapartum single-dose nevirapine for prevention of mother-to-child transmission of HIV.McMahon, Deborah K ; Zheng, Lu ; Hitti, Jane ; Chan, Ellen S ; Halvas, Elias K ; Hong, Feiyu ; Kabanda, Joseph ; Taulo, Frank ; Kumarasamy, Nagalingeswaran ; Bonhomme, Jerry ; Wallis, Carole L ; Klingman, Karin L ; Hughes, Michael D ; Mellors, John W2013 AprClin Infect Dis756
Bone mineral density effects of randomized regimen and nucleoside reverse transcriptase inhibitor selection from ACTG A5142.Huang, Jeannie S ; Hughes, Michael D ; Riddler, Sharon A ; Haubrich, Richard H ; Aids Clinical Trials Group A5142 Study Team2013 Sep-OctHIV Clin Trials514
Body composition, soluble markers of inflammation, and bone mineral density in antiretroviral therapy-naive HIV-1-infected individuals.Brown, Todd T ; Chen, Yun ; Currier, Judith S ; Ribaudo, Heather J ; Rothenberg, Jennifer ; Dubé, Michael P ; Murphy, Robert ; Stein, James H ; McComsey, Grace A2013 Jul 1J Acquir Immune Defic Syndr363
Perturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 Study.Kelesidis, Theodoros ; Kendall, Michelle A ; Yang, Otto O ; Hodis, Howard ; Currier, Judith S2013 JunAIDS Res Hum Retroviruses629
Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapy.Fiscus, Susan A ; Cu-Uvin, Susan ; Eshete, Abel Tilahun ; Hughes, Michael D ; Bao, Yajing ; Hosseinipour, Mina ; Grinsztejn, Beatriz ; Badal-Faesen, Sharlaa ; Dragavon, Joan ; Coombs, Robert W ; Braun, Ken ; Moran, Laura ; Hakim, James ; Flanigan, Timothy ; Kumarasamy, N ; Campbell, Thomas B ; A5185s Team2013 JulClin Infect Dis257
Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls.McLaren, Paul J ; Coulonges, Cédric ; Ripke, Stephan ; van den Berg, Leonard ; Buchbinder, Susan ; Carrington, Mary ; Cossarizza, Andrea ; Dalmau, Judith ; Deeks, Steven G ; Delaneau, Olivier ; De Luca, Andrea ; Goedert, James J ; Haas, David ; Herbeck, Joshua T ; Kathiresan, Sekar ; Kirk, Gregory D ; Lambotte, Olivier ; Luo, Ma ; Mallal, 2013PLoS Pathog79
Discordant associations between SLCO1B1 521T→C and plasma levels of ritonavir-boosted protease inhibitors in AIDS clinical trials group study A5146.Zhang, Xinyan ; Tierney, Camlin ; Albrecht, Mary ; Demeter, Lisa M ; Morse, Gene ; DiFrancesco, Robin ; Dykes, Carrie ; Jiang, Hongyu ; Haas, David W2013 AprTher Drug Monit235
Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248.Andrade, Adriana ; Rosenkranz, Susan L ; Cillo, Anthony R ; Lu, Darlene ; Daar, Eric S ; Jacobson, Jeffrey M ; Lederman, Michael ; Acosta, Edward P ; Campbell, Thomas ; Feinberg, Judith ; Flexner, Charles ; Mellors, John W ; Kuritzkes, Daniel R ; AIDS Clinical Trials Group A5248 Team2013 SepJ Infect Dis6208
Impact of UGT1A1 Gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS Clinical Trials Group Study A5202.Ribaudo, Heather J ; Daar, Eric S ; Tierney, Camlin ; Morse, Gene D ; Mollan, Katie ; Sax, Paul E ; Fischl, Margaret A ; Collier, Ann C ; Haas, David W ; DS Clinical Trials Group2013 Feb 1J Infect Dis3207
Improving diagnostic capability for HPV disease internationally within the NIH-NIAID Division of AIDS Clinical Trial Networks.Godfrey, Catherine C ; Michelow, Pamela M ; Godard, Mandana ; Sahasrabuddhe, Vikrant V ; Darden, Janice ; Firnhaber, Cynthia S ; Wetherall, Neal T ; Bremer, James ; Coombs, Robert W ; Wilkin, Timothy ; A5282 Study Team2013 DecAm J Clin Pathol6140
Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trial.Amorosa, Valerianna K ; Luetkemeyer, Anne ; Kang, Minhee ; Johnson, Victoria A ; Umbleja, Triin ; Haas, David W ; Yesmin, Suria ; Bardin, Matthew C ; Chung, Ray T ; Alston-Smith, Beverly ; Tebas, Pablo ; Peters, Marion G2013 Nov-DecHIV Clin Trials614
Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial.Rodriguez, Benigno ; Asmuth, David M ; Matining, Roy M ; Spritzler, John ; Jacobson, Jeffrey M ; Mailliard, Robbie B ; Li, Xiao-Dong ; Martinez, Ana I ; Tenorio, Allan R ; Lori, Franco ; Lisziewicz, Julianna ; Yesmin, Suria ; Rinaldo, Charles R ; Pollard, Richard B2013 Dec 1J Acquir Immune Defic Syndr464
In HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use.Branch, Andrea D ; Kang, Minhee ; Hollabaugh, Kimberly ; Wyatt, Christina M ; Chung, Raymond T ; Glesby, Marshall J2013 AugAm J Clin Nutr298
Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failure.Li, Jonathan Z ; Paredes, Roger ; Ribaudo, Heather J ; Kozal, Michael J ; Svarovskaia, Evguenia S ; Johnson, Jeffrey A ; Geretti, Anna Maria ; Metzner, Karin J ; Jakobsen, Martin R ; Hullsiek, Katherine Huppler ; Ostergaard, Lars ; Miller, Michael D ; Kuritzkes, Daniel R2013 Mar 15J Infect Dis6207
HIV escape mutations occur preferentially at HLA-binding sites of CD8 T-cell epitopes.Bronke, Corine ; Almeida, Coral-Ann M ; McKinnon, Elizabeth ; Roberts, Steven G ; Keane, Niamh M ; Chopra, Abha ; Carlson, Jonathan M ; Heckerman, David ; Mallal, Simon ; John, Mina2013 Mar 27AIDS627
Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabine.Funderburg, Nicholas T ; Andrade, Adriana ; Chan, Ellen S ; Rosenkranz, Susan L ; Lu, Darlene ; Clagett, Brian ; Pilch-Cooper, Heather A ; Rodriguez, Benigno ; Feinberg, Judith ; Daar, Eric ; Mellors, John ; Kuritzkes, Daniel ; Jacobson, Jeffrey M ; Lederman, Michael M2013PLoS One128
Dysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adults.Kelesidis, Theodoros ; Yang, Otto O ; Kendall, Michelle A ; Hodis, Howard N ; Currier, Judith S2013Lipids Health Dis12
Screening for pulmonary tuberculosis in HIV-infected individuals: AIDS Clinical Trials Group Protocol A5253.Swindells, S ; Komarow, L ; Tripathy, S ; Cain, K P ; MacGregor, R R ; Achkar, J M ; Gupta, A ; Veloso, V G ; Asmelash, A ; Omoz-Oarhe, A E ; Gengiah, S ; Lalloo, U ; Allen, R ; Shiboski, C ; Andersen, J ; Qasba, S S ; Katzenstein, D K ; AIDS Clinical Trials Group 5253 Study Team2013 AprInt J Tuberc Lung Dis417
Residual plasma viraemia and infectious HIV-1 recovery from resting memory CD4 cells in patients on antiretroviral therapy: results from ACTG A5173.Gandhi, Rajesh T ; Bosch, Ronald J ; Aga, Evgenia ; Bedison, Margaret A ; Bastow, Barbara ; Schmitz, John L ; Siliciano, Janet D ; Siliciano, Robert F ; Eron, Joseph J ; Mellors, John W ; ACTG A5173 team2013Antivir Ther418
A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control.Bartha, István ; Carlson, Jonathan M ; Brumme, Chanson J ; McLaren, Paul J ; Brumme, Zabrina L ; John, Mina ; Haas, David W ; Martinez-Picado, Javier ; Dalmau, Judith ; López-Galíndez, Cecilio ; Casado, Concepción ; Rauch, Andri ; Günthard, Huldrych F ; Bernasconi, Enos ; Vernazza, Pietro ; Klimkait, Thomas ; Yerly, Sabine ; O'Brien, Steph2013Elife2
Effect of statin therapy in reducing the risk of serious non-AIDS-defining events and nonaccidental death.Overton, E T ; Kitch, D ; Benson, C A ; Hunt, P W ; Stein, J H ; Smurzynski, M ; Ribaudo, H J ; Tebas, P2013 MayClin Infect Dis1056
Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density.Erlandson, Kristine M ; Kitch, Douglas ; Tierney, Camlin ; Sax, Paul E ; Daar, Eric S ; Tebas, Pablo ; Melbourne, Kathleen ; Ha, Belinda ; Jahed, Nasreen C ; McComsey, Grace A2013 Aug 24AIDS1327
Zidovudine (AZT) monotherapy selects for the A360V mutation in the connection domain of HIV-1 reverse transcriptase.Brehm, Jessica H ; Scott, Yanille ; Koontz, Dianna L ; Perry, Steven ; Hammer, Scott ; Katzenstein, David ; Mellors, John W ; Sluis-Cremer, Nicolas ; AIDS Clinical Trials Group Study 175 Protocol Team2012PLoS One27
Differential use of CCR5 by HIV-1 clinical isolates resistant to small-molecule CCR5 antagonists.Henrich, Timothy J ; Lewine, Nicolas R P ; Lee, Sun-Hee ; Rao, Suhas S P ; Berro, Reem ; Gulick, Roy M ; Moore, John P ; Tsibris, Athe M N ; Kuritzkes, Daniel R2012 AprAntimicrob Agents Chemother456
Clinical perspectives on human genetic screening to prevent nevirapine toxicity.Haas, David W ; Mootsikapun, Piroon ; Ruxrungtham, Kiat ; Podzamczer, Daniel ; Nevirapine Toxicogenomics Study Team2012 Sep 1Per Med79
HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study.Porter, Kimberly A ; Cole, Stephen R ; Eron, Joseph J ; Zheng, Yu ; Hughes, Michael D ; Lockman, Shahin ; Poole, Charles ; Skinner-Adams, Tina S ; Hosseinipour, Mina ; Shaffer, Doug ; D'Amico, Ronald ; Sawe, Frederick K ; Siika, Abraham ; Stringer, Elizabeth ; Currier, Judith S ; Chipato, Tsungai ; Salata, Robert ; McCarthy, James S ; Mesh2012 FebAntimicrob Agents Chemother256
Quality of life among individuals with HIV starting antiretroviral therapy in diverse resource-limited areas of the world.Safren, Steven A ; Hendriksen, Ellen S ; Smeaton, Laura ; Celentano, David D ; Hosseinipour, Mina C ; Barnett, Ronald ; Guanira, Juan ; Flanigan, Timothy ; Kumarasamy, N ; Klingman, Karin ; Campbell, Thomas2012 FebAIDS Behav216
Baseline levels of soluble CD14 and CD16+56- natural killer cells are negatively associated with response to interferon/ribavirin therapy during HCV-HIV-1 coinfection.Anthony, Donald D ; Conry, Sara J ; Medvik, Kathy ; Sandhya Rani, M R ; Falck-Ytter, Yngve ; Blanton, Ronald E ; Lederman, Michael M ; Rodriguez, Benigno ; Landay, Alan L ; Sandberg, Johan K2012 Sep 15J Infect Dis6206
Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1.Carlson, Jonathan M ; Brumme, Chanson J ; Martin, Eric ; Listgarten, Jennifer ; Brockman, Mark A ; Le, Anh Q ; Chui, Celia K S ; Cotton, Laura A ; Knapp, David J H F ; Riddler, Sharon A ; Haubrich, Richard ; Nelson, George ; Pfeifer, Nico ; Deziel, Charles E ; Heckerman, David ; Apps, Richard ; Carrington, Mary ; Mallal, Simon ; Harrigan, 2012 DecJ Virol2486
Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America.Genberg, Becky L ; Wilson, Ira B ; Bangsberg, David R ; Arnsten, Julia ; Goggin, Kathy ; Remien, Robert H ; Simoni, Jane ; Gross, Robert ; Reynolds, Nancy ; Rosen, Marc ; Liu, Honghu ; MACH14 Investigators2012 Jul 17AIDS1126
Interferon-alpha administration enhances CD8+ T cell activation in HIV infection.Manion, Maura ; Rodriguez, Benigno ; Medvik, Kathleen ; Hardy, Gareth ; Harding, Clifford V ; Schooley, Robert T ; Pollard, Richard ; Asmuth, David ; Murphy, Robert ; Barker, Edward ; Brady, Kirsten E ; Landay, Alan ; Funderburg, Nick ; Sieg, Scott F ; Lederman, Michael M2012PLoS One17
Equal HIV-1 decay kinetics in HSV-2-infected and HSV-2-uninfected clinical trial participants treated with antiretroviral therapy.Schouten, Jeffrey Thomas ; Schiffer, Joshua T2012 May 1J Acquir Immune Defic Syndr160
IL-7 induces expression and activation of integrin α4β7 promoting naive T-cell homing to the intestinal mucosa.Cimbro, Raffaello ; Vassena, Lia ; Arthos, James ; Cicala, Claudia ; Kehrl, John H ; Park, Chung ; Sereti, Irini ; Lederman, Michael M ; Fauci, Anthony S ; Lusso, Paolo2012 Sep 27Blood13120
Extended therapy with pegylated interferon and weight-based ribavirin for HCV-HIV coinfected patients.Chung, Raymond T ; Umbleja, Triin ; Chen, Jennifer Y ; Andersen, Janet W ; Butt, Adeel A ; Sherman, Kenneth E ; Actg A5178 Study Team2012 Mar-AprHIV Clin Trials213
Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African Americans.McLaren, Paul J ; Ripke, Stephan ; Pelak, Kimberly ; Weintrob, Amy C ; Patsopoulos, Nikolaos A ; Jia, Xiaoming ; Erlich, Rachel L ; Lennon, Niall J ; Kadie, Carl M ; Heckerman, David ; Gupta, Namrata ; Haas, David W ; Deeks, Steven G ; Pereyra, Florencia ; Walker, Bruce D ; DE Bakker, Paul I W ; International HIV Controllers Study2012 Oct 1Hum Mol Genet1921
Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial.Lorenzana, Sarah B ; Hughes, Michael D ; Grinsztejn, Beatriz ; Collier, Ann C ; Luz, Paula Mendes ; Freedberg, Kenneth A ; Wood, Robin ; Levison, Julie H ; Mugyenyi, Peter N ; Salata, Robert ; Wallis, Carole L ; Weinstein, Milton C ; Schooley, Robert T ; Walensky, Rochelle P2012 Jun 1AIDS926
Racial/Ethnic disparities in ART adherence in the United States: findings from the MACH14 study.Simoni, Jane M ; Huh, David ; Wilson, Ira B ; Shen, Jie ; Goggin, Kathy ; Reynolds, Nancy R ; Remien, Robert H ; Rosen, Marc I ; Bangsberg, David R ; Liu, Honghu2012 Aug 15J Acquir Immune Defic Syndr560
Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection.Kelesidis, Theodoros ; Kendall, Michelle A ; Yang, Otto O ; Hodis, Howard N ; Currier, Judith S2012 Nov 15J Infect Dis10206
HIV peripheral neuropathy progression: protection with glucose-lowering drugs?Evans, Scott R ; Lee, Anthony J ; Ellis, Ronald J ; Chen, Huichao ; Wu, Kunling ; Bosch, Ronald J ; Clifford, David B2012 OctJ Neurovirol518
Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170).McLinden, Robert J ; Paris, Robert M ; Polonis, Victoria R ; Close, Nicole C ; Su, Zhaohui ; Shikuma, Cecilia M ; Margolis, David M ; Kim, Jerome H2012 Jan 2AIDS126
The frequency of malaria is similar among women receiving either lopinavir/ritonavir or nevirapine-based antiretroviral treatment.Skinner-Adams, Tina S ; Butterworth, Alice S ; Porter, Kimberly A ; D'Amico, Ronald ; Sawe, Fred ; Shaffer, Doug ; Siika, Abraham ; Hosseinipour, Mina C ; Stringer, Elizabeth ; Currier, Judith S ; Chipato, Tsungai ; Salata, Robert ; Lockman, Shahin ; Eron, Joseph J ; Meshnick, Steven R ; McCarthy, James S2012PLoS One47
Meta-analysis of the safety, tolerability, and efficacy of lopinavir/ritonavir-containing antiretroviral therapy in HIV-1-infected women.Hermes, A ; Squires, K ; Fredrick, L ; Martinez, M ; Pasley, M ; Trinh, R ; Norton, M2012 Nov-DecHIV Clin Trials613
Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir.McComsey, Grace A ; Kitch, Douglas ; Daar, Eric S ; Tierney, Camlin ; Jahed, Nasreen C ; Melbourne, Kathleen ; Ha, Belinda ; Brown, Todd T ; Bloom, Anthony ; Fedarko, Neal ; Sax, Paul E2012 Jul 17AIDS1126
Evaluating the Effect of Early Versus Late ARV Regimen Change if Failure on an Initial Regimen: Results From the AIDS Clinical Trials Group Study A5095.Li, Li ; Eron, Joseph J ; Ribaudo, Heather ; Gulick, Roy M ; Johnson, Brent A2012J Am Stat Assoc498107
Fractures after antiretroviral initiation.Yin, Michael T ; Kendall, Michelle A ; Wu, Xingye ; Tassiopoulos, Katherine ; Hochberg, Marc ; Huang, Jeannie S ; Glesby, Marshall J ; Bolivar, Hector ; McComsey, Grace A2012 Nov 13AIDS1726
Disruption of the ECM33 gene in Candida albicans prevents biofilm formation, engineered human oral mucosa tissue damage and gingival cell necrosis/apoptosis.Rouabhia, Mahmoud ; Semlali, Abdelhabib ; Chandra, Jyotsna ; Mukherjee, Pranab ; Chmielewski, Witold ; Ghannoum, Mahmoud A2012Mediators Inflamm2012
High-avidity, high-IFNγ-producing CD8 T-cell responses following immune selection during HIV-1 infection.Keane, Niamh M ; Roberts, Steven G ; Almeida, Coral-Ann M ; Krishnan, Tanya ; Chopra, Abha ; Demaine, Emma ; Laird, Rebecca ; Tschochner, Monika ; Carlson, Jonathan M ; Mallal, Simon ; Heckerman, David ; James, Ian ; John, Mina2012 FebImmunol Cell Biol290
HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease status.Mollan, Katie ; Daar, Eric S ; Sax, Paul E ; Balamane, Maya ; Collier, Ann C ; Fischl, Margaret A ; Lalama, Christina M ; Bosch, Ronald J ; Tierney, Camlin ; Katzenstein, David ; AIDS Clinical Trials Group Study A5202 Team2012 Dec 15J Infect Dis12206
Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings.Bartlett, John A ; Ribaudo, Heather J ; Wallis, Carole L ; Aga, Evgenia ; Katzenstein, David A ; Stevens, Wendy S ; Norton, Michael R ; Klingman, Karin L ; Hosseinipour, Mina C ; Crump, John A ; Supparatpinyo, Khuanchai ; Badal-Faesen, Sharlaa ; Kallungal, Beatrice A ; Kumarasamy, Nagalingeswaran2012 Jul 17AIDS1126
Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women.Dong, Betty J ; Zheng, Yu ; Hughes, Michael D ; Frymoyer, Adam ; Verotta, Davide ; Lizak, Patricia ; Sawe, Frederick ; Currier, Judith S ; Lockman, Shahin ; Aweeka, Francesca T ; AIDS Clinical Trials Group Study 5208 Team2012 Apr 24AIDS726
Evaluation of HIV-1 ambiguous nucleotide frequency during antiretroviral treatment interruption.Li, Jonathan Z ; Christensen, Julie A ; Wang, Hongying ; Spritzler, John ; Kuritzkes, Daniel R ; AIDS Clinical Trials Group A5197 Study Team2012 Sep 1J Acquir Immune Defic Syndr161
Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study.Robertson, K ; Jiang, H ; Kumwenda, J ; Supparatpinyo, K ; Evans, S ; Campbell, T B ; Price, R ; Tripathy, S ; Kumarasamy, N ; La Rosa, A ; Santos, B ; 5199 study team ; Silva, M T ; Montano, S ; Kanyama, C ; Faesen, S ; Murphy, R ; Hall, C ; Marra, C M ; Marcus, C ; Berzins, B ; Allen, R ; Housseinipour, M ; Amod, F ; Sanne, I ; Hakim, J 2012 SepClin Infect Dis655
No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapy.Gandhi, Rajesh T ; Coombs, Robert W ; Chan, Ellen S ; Bosch, Ronald J ; Zheng, Lu ; Margolis, David M ; Read, Sarah ; Kallungal, Beatrice ; Chang, Ming ; Goecker, Erin A ; Wiegand, Ann ; Kearney, Mary ; Jacobson, Jeffrey M ; D'Aquila, Richard ; Lederman, Michael M ; Mellors, John W ; Eron, Joseph J ; AIDS Clinical Trials Group (ACTG) A52442012 Mar 1J Acquir Immune Defic Syndr359
The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals.Hogan, Christine M ; Degruttola, Victor ; Sun, Xin ; Fiscus, Susan A ; Del Rio, Carlos ; Hare, C Bradley ; Markowitz, Martin ; Connick, Elizabeth ; Macatangay, Bernard ; Tashima, Karen T ; Kallungal, Beatrice ; Camp, Rob ; Morton, Tia ; Daar, Eric S ; Little, Susan ; A5217 Study Team2012 Jan 1J Infect Dis1205
Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial.Lockman, Shahin ; Hughes, Michael ; Sawe, Fred ; Zheng, Yu ; McIntyre, James ; Chipato, Tsungai ; Asmelash, Aida ; Rassool, Mohammed ; Kimaiyo, Sylvester ; Shaffer, Douglas ; Hosseinipour, Mina ; Mohapi, Lerato ; Ssali, Francis ; Chibowa, Margret ; Amod, Farida ; Halvas, Elias ; Hogg, Evelyn ; Alston-Smith, Beverly ; Smith, Laura ; Schoole2012PLoS Med69
Examining the challenges and solutions to the implementation of trials in resource-limited settings: Limited Resource Trials.Blanchard-Horan, Christina ; Stocker, Vicki ; Moran, Laura ; Ferguson, Elaine Okubo ; Klingman, Karin L ; McMahon, Deborah ; Hitti, Jane2012 Jan 1Appl Clin Trials121
Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure.Li, Jonathan Z ; Paredes, Roger ; Ribaudo, Heather J ; Svarovskaia, Evguenia S ; Kozal, Michael J ; Hullsiek, Katherine H ; Miller, Michael D ; Bangsberg, David R ; Kuritzkes, Daniel R2012 Jan 14AIDS226
Infant outcomes after maternal antiretroviral exposure in resource-limited settings.Nielsen-Saines, Karin ; Komarow, Lauren ; Cu-Uvin, Susan ; Jourdain, Gonzague ; Klingman, Karin L ; Shapiro, David E ; Mofenson, Lynne ; Moran, Laura ; Campbell, Thomas B ; Hitti, Jane ; Fiscus, Susan ; Currier, Judith ; ACTG 5190/PACTG 1054 Study Team2012 JunPediatrics6129
Relationship between microbial translocation and endothelial function in HIV infected patients.Blodget, Emily ; Shen, Changyu ; Aldrovandi, Grace ; Rollie, Adrienne ; Gupta, Samir K ; Stein, James H ; Dubé, Michael P2012PLoS One87
Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings.Campbell, Thomas B ; Smeaton, Laura M ; Kumarasamy, N ; Flanigan, Timothy ; Klingman, Karin L ; Firnhaber, Cynthia ; Grinsztejn, Beatriz ; Hosseinipour, Mina C ; Kumwenda, Johnstone ; Lalloo, Umesh ; Riviere, Cynthia ; Sanchez, Jorge ; Melo, Marineide ; Supparatpinyo, Khuanchai ; Tripathy, Srikanth ; Martinez, Ana I ; Nair, Apsara ; Walawa2012PLoS Med89
T cell activation markers and African mitochondrial DNA haplogroups among non-Hispanic black participants in AIDS clinical trials group study 384.Hulgan, Todd ; Robbins, Gregory K ; Kalams, Spyros A ; Samuels, David C ; Grady, Benjamin ; Shafer, Robert ; Murdock, Deborah G ; Selph, Doug ; Haas, David W ; Pollard, Richard B ; AIDS Clinical Trials Group2012PLoS One87
Drug-resistant virus has reduced ability to induce immune activation.Wang, Rui ; Bosch, Ronald J ; Benson, Constance A ; Lederman, Michael M2012 Dec 1J Acquir Immune Defic Syndr461
Characteristics and outcomes of initial virologic suppressors during analytic treatment interruption in a therapeutic HIV-1 gag vaccine trial.Li, Jonathan Z ; Brumme, Chanson J ; Lederman, Michael M ; Brumme, Zabrina L ; Wang, Hongying ; Spritzler, John ; Carrington, Mary ; Medvik, Kathleen ; Walker, Bruce D ; Schooley, Robert T ; Kuritzkes, Daniel R ; AIDS Clinical Trials Group A5197 Study Team2012PLoS One37
Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study.Butt, Adeel A ; Umbleja, Triin ; Andersen, Janet W ; Sherman, Kenneth E ; Chung, Raymond T ; Actg A5178 Study Team2012 SepClin Infect Dis555
Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naive HIV-infected individuals.Krishnan, Supriya ; Schouten, Jeffrey T ; Atkinson, Benjamin ; Brown, Todd ; Wohl, David ; McComsey, Grace A ; Glesby, Marshall J ; Shikuma, Cecilia ; Haubrich, Richard ; Tebas, Pablo ; Campbell, Thomas B ; Jacobson, Denise L2012 Nov 1J Acquir Immune Defic Syndr361
Resampling-based methods in single and multiple testing for equality of covariance/correlation matrices.Yang, Yang ; Degruttola, Victor2012Int J Biostat18
Safety, tolerability, and pharmacokinetic interactions of the antituberculous agent TMC207 (bedaquiline) with efavirenz in healthy volunteers: AIDS Clinical Trials Group Study A5267.Dooley, Kelly E ; Park, Jeong-Gun ; Swindells, Susan ; Allen, Reena ; Haas, David W ; Cramer, Yoninah ; Aweeka, Francesca ; Wiggins, Ilene ; Gupta, Amita ; Lizak, Patricia ; Qasba, Sonia ; van Heeswijk, Rolf ; Flexner, Charles ; ACTG 5267 Study Team2012 Apr 15J Acquir Immune Defic Syndr559
Cost-effectiveness of adding an agent that improves immune responses to initial antiretroviral therapy (ART) in HIV-infected patients: guidance for drug development.Morris, Bethany L ; Scott, Callie A ; Wilkin, Timothy J ; Sax, Paul E ; Gulick, Roy M ; Freedberg, Kenneth A ; Schackman, Bruce R2012 Jan-FebHIV Clin Trials113
Health-related quality of life in subjects with HCV/HIV coinfection: results from ACTG 5178 study.Kemmer, N ; Hua, L ; Andersen, J W ; Chung, R T ; Butt, A A ; Sherman, K E ; ACTG 5178 Study Team2012 NovJ Viral Hepat1119
Association of HIV viral load and CD4 cell count with human papillomavirus detection and clearance in HIV-infected women initiating highly active antiretroviral therapy.Kang, M ; Cu-Uvin, S2012 JulHIV Med613
Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures.Tsibris, Athe M N ; Hu, Zixin ; Paredes, Roger ; Leopold, Kay E ; Putcharoen, Opass ; Schure, Allison L ; Mazur, Natalie ; Coakley, Eoin ; Su, Zhaohui ; Gulick, Roy M ; Kuritzkes, Daniel R2012 JunJ Virol1286
Tenofovir use and renal insufficiency among pregnant and general adult population of HIV-infected, ART-naïve individuals in Lilongwe, Malawi.Johnson, Derek C ; Chasela, Charles ; Maliwichi, Madalitso ; Mwafongo, Albert ; Akinkuotu, Adesola ; Moses, Agness ; Jamieson, Denise J ; Kourtis, Athena P ; King, Caroline C ; van der Horst, Charlie ; Hosseinipour, Mina C2012PLoS One77
Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants.Holzinger, Emily R ; Grady, Benjamin ; Ritchie, Marylyn D ; Ribaudo, Heather J ; Acosta, Edward P ; Morse, Gene D ; Gulick, Roy M ; Robbins, Gregory K ; Clifford, David B ; Daar, Eric S ; McLaren, Paul ; Haas, David W2012 DecPharmacogenet Genomics1222
Host gene expression changes correlating with anti-HIV-1 effects in human subjects after treatment with peginterferon Alfa-2a.Hubbard, Jonathan J ; Greenwell-Wild, Teresa ; Barrett, Lisa ; Yang, Jun ; Lempicki, Richard A ; Wahl, Sharon M ; Asmuth, David M ; Murphy, Robert L ; Pollard, Richard B ; Kottilil, Shyam2012 May 1J Infect Dis9205
CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studies.Tassiopoulos, Katherine ; Landay, Alan ; Collier, Ann C ; Connick, Elizabeth ; Deeks, Steven G ; Hunt, Peter ; Lewis, Dorothy E ; Wilson, Cara ; Bosch, Ronald2012 JunJ Infect Dis11205
HIV-1 clinical isolates resistant to CCR5 antagonists exhibit delayed entry kinetics that are corrected in the presence of drug.Putcharoen, Opass ; Lee, Sun Hee ; Henrich, Timothy J ; Hu, Zixin ; Vanichanan, Jakapat ; Coakley, Eoin ; Greaves, Wayne ; Gulick, Roy M ; Kuritzkes, Daniel R ; Tsibris, Athe M N2012 JanJ Virol286
Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome during ACTG A5164.Grant, Philip M ; Komarow, Lauren ; Lederman, Michael M ; Pahwa, Savita ; Zolopa, Andrew R ; Andersen, Janet ; Asmuth, David M ; Devaraj, Sridevi ; Pollard, Richard B ; Richterman, Aaron ; Kanthikeel, Sudheesh ; Sereti, Irini2012 Dec 1J Infect Dis11206
A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256.Wilkin, Timothy J ; Lalama, Christina M ; McKinnon, John ; Gandhi, Rajesh T ; Lin, Nina ; Landay, Alan ; Ribaudo, Heather ; Fox, Lawrence ; Currier, Judith S ; Mellors, John W ; Gulick, Roy ; Tenorio, Allan R2012 Aug 15J Infect Dis4206
Sex-associated differences in pre-antiretroviral therapy plasma HIV-1 RNA in diverse areas of the world vary by CD4(+) T-cell count.Grinsztejn, Beatriz ; Smeaton, Laura ; Barnett, Ronald ; Klingman, Karin ; Hakim, James ; Flanigan, Timothy ; Kumarasamy, N ; Campbell, Thomas ; Currier, Judith ; PEARLS study team of the ACTG2011Antivir Ther716
A randomized clinical trial evaluating therapeutic drug monitoring (TDM) for protease inhibitor-based regimens in antiretroviral-experienced HIV-infected individuals: week 48 results of the A5146 study.Albrecht, Mary ; Mukherjee, A Lisa ; Tierney, Camlin ; Morse, Gene D ; Dykes, Carrie ; Klingman, Karin L ; Demeter, Lisa M2011 Jul-AugHIV Clin Trials412
Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South Africa.Wallis, Carole L ; Mellors, John W ; Venter, Willem D F ; Sanne, Ian ; Stevens, Wendy2011AIDS Res Treat2011
Three months of rifapentine and isoniazid for latent tuberculosis infection.Sterling, Timothy R ; Villarino, M Elsa ; Borisov, Andrey S ; Shang, Nong ; Gordin, Fred ; Bliven-Sizemore, Erin ; Hackman, Judith ; Hamilton, Carol Dukes ; Menzies, Dick ; Kerrigan, Amy ; Weis, Stephen E ; Weiner, Marc ; Wing, Diane ; Conde, Marcus B ; Bozeman, Lorna ; Horsburgh, C Robert ; Chaisson, Richard E ; TB Trials Consortium PREVE2011 Dec 08N Engl J Med23365
Incidence of non-AIDS-defining cancer in antiretroviral treatment-naïve subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysis.Krishnan, Supriya ; Schouten, Jeffrey T ; Jacobson, Denise L ; Benson, Constance A ; Collier, Ann C ; Koletar, Susan L ; Santana, Jorge ; Sattler, Fred R ; Mitsuyasu, Ronald ; ACTG-ALLRT Protocol Team2011Oncology1-280
Emerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremia.Gallien, Sebastien ; Delaugerre, Constance ; Charreau, Isabelle ; Braun, Joséphine ; Boulet, Thomas ; Barrail-Tran, Aurélie ; de Castro, Nathalie ; Molina, Jean-Michel ; Kuritzkes, Daniel R2011 Mar 13AIDS525
Interaction of reverse transcriptase (RT) mutations conferring resistance to lamivudine and etravirine: effects on fitness and RT activity of human immunodeficiency virus type 1.Hu, Zixin ; Kuritzkes, Daniel R2011 NovJ Virol2185
Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262).Taiwo, Babafemi ; Zheng, Lu ; Gallien, Sebastien ; Matining, Roy M ; Kuritzkes, Daniel R ; Wilson, Cara C ; Berzins, Baiba I ; Acosta, Edward P ; Bastow, Barbara ; Kim, Peter S ; Eron, Joseph J ; ACTG A5262 Team2011 Nov 13AIDS1725
The effect of AIDS Clinical Trials Group Protocol 5164 on the time from Pneumocystis jirovecii pneumonia diagnosis to antiretroviral initiation in routine clinical practice: a case study of diffusion, dissemination, and implementation.Geng, Elvin H ; Kahn, James S ; Chang, Olivia C ; Hare, C Bradley ; Christopoulos, Katerina A ; Jones, Diane ; Petersen, Maya L ; Deeks, Steven G ; Havlir, Diane V ; Gandhi, Monica2011 NovClin Infect Dis1053
Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals.Shikuma, Cecilia M ; Ribaudo, Heather J ; Zheng, Yu ; Gulick, Roy M ; Meyer, William A ; Tashima, Karen T ; Bastow, Barbara ; Kuritzkes, Daniel R ; Glesby, Marshall J ; AIDS Clinical Trials Group A5095 Study Team2011 MayAIDS Res Hum Retroviruses527
Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection.Yamamoto, Takuya ; Price, David A ; Casazza, Joseph P ; Ferrari, Guido ; Nason, Martha ; Chattopadhyay, Pratip K ; Roederer, Mario ; Gostick, Emma ; Katsikis, Peter D ; Douek, Daniel C ; Haubrich, Richard ; Petrovas, Constantinos ; Koup, Richard A2011 May 5Blood18117
Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase.Brehm, Jessica H ; Lalama, Christina M ; Hughes, Michael D ; Haubrich, Richard ; Riddler, Sharon A ; Sluis-Cremer, Nicolas ; Mellors, John W ; AIDS Clinical Trials Group Study A5142 Protocol Team2011 AprJ Acquir Immune Defic Syndr456
First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial.Ciaranello, Andrea L ; Lockman, Shahin ; Freedberg, Kenneth A ; Hughes, Michael ; Chu, Jennifer ; Currier, Judith ; Wood, Robin ; Holmes, Charles B ; Pillay, Sandy ; Conradie, Francesca ; McIntyre, James ; Losina, Elena ; Walensky, Rochelle P ; CEPAC-International and OCTANE Investigators2011 Feb 20AIDS425
European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142.Hulgan, Todd ; Haubrich, Richard ; Riddler, Sharon A ; Tebas, Pablo ; Ritchie, Marylyn D ; McComsey, Grace A ; Haas, David W ; Canter, Jeffrey A2011 Jan 2AIDS125
Peripheral neuropathy in HIV: prevalence and risk factors.Evans, Scott R ; Ellis, Ronald J ; Chen, Huichao ; Yeh, Tzu-min ; Lee, Anthony J ; Schifitto, Giovanni ; Wu, Kunling ; Bosch, Ronald J ; McArthur, Justin C ; Simpson, David M ; Clifford, David B2011 Apr 24AIDS725
Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial.Eshleman, Susan H ; Hudelson, Sarah E ; Redd, Andrew D ; Wang, Lei ; Debes, Rachel ; Chen, Ying Q ; Martens, Craig A ; Ricklefs, Stacy M ; Selig, Ethan J ; Porcella, Stephen F ; Munshaw, Supriya ; Ray, Stuart C ; Piwowar-Manning, Estelle ; McCauley, Marybeth ; Hosseinipour, Mina C ; Kumwenda, Johnstone ; Hakim, James G ; Chariyalertsak, Su2011 Dec 15J Infect Dis12204
Factors associated with viral rebound in HIV-1-infected individuals enrolled in a therapeutic HIV-1 gag vaccine trial.Li, Jonathan Z ; Brumme, Zabrina L ; Brumme, Chanson J ; Wang, Hongying ; Spritzler, John ; Robertson, Michael N ; Lederman, Michael M ; Carrington, Mary ; Walker, Bruce D ; Schooley, Robert T ; Kuritzkes, Daniel R ; AIDS Clinical Trials Group A5197 Study Team2011 Apr 1J Infect Dis7203
HIV-1 viruses detected during episodic blips following interleukin-7 administration are similar to the viruses present before and after interleukin-7 therapy.Imamichi, Hiromi ; Degray, Gerald ; Asmuth, David M ; Fischl, Margaret A ; Landay, Alan L ; Lederman, Michael M ; Sereti, Irini2011 Jan 14AIDS225
No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT.Ribaudo, Heather J ; Benson, Constance A ; Zheng, Yu ; Koletar, Susan L ; Collier, Ann C ; Lok, Judith J ; Smurzynski, Marlene ; Bosch, Ronald J ; Bastow, Barbara ; Schouten, Jeffrey T ; ACTG A5001/ALLRT Protocol Team2011 Apr 1Clin Infect Dis752
Mitochondrial genomics and CD4 T-cell count recovery after antiretroviral therapy initiation in AIDS clinical trials group study 384.Grady, Benjamin J ; Samuels, David C ; Robbins, Gregory K ; Selph, Doug ; Canter, Jeffrey A ; Pollard, Richard B ; Haas, David W ; Shafer, Robert ; Kalams, Spyros A ; Murdock, Deborah G ; Ritchie, Marylyn D ; Hulgan, Todd ; ACTG 384 and DACS 250 Study Teams2011 Dec 1J Acquir Immune Defic Syndr458
Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials.Taylor, Lynn E ; Holubar, Marisa ; Wu, Kunling ; Bosch, Ronald J ; Wyles, David L ; Davis, John A ; Mayer, Kenneth H ; Sherman, Kenneth E ; Tashima, Karen T2011 Mar 15Clin Infect Dis652
The incidence, predictors and management of anaemia and its association with virological response in HCV / HIV coinfected persons treated with long-term pegylated interferon alfa 2a and ribavirin.Butt, A A ; Umbleja, T ; Andersen, J W ; Chung, R T ; Sherman, K E ; Actg A5178 Study Team2011 JunAliment Pharmacol Ther1133
A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings.Robertson, Kevin ; Kumwenda, Johnstone ; Supparatpinyo, Khuanchai ; Jiang, Jeanne H ; Evans, Scott ; Campbell, Thomas B ; Price, Richard W ; Murphy, Robert ; Hall, Colin ; Marra, Christina M ; Marcus, Cheryl ; Berzins, Baiba ; Masih, Reena ; Santos, Breno ; Silva, Marcus T ; Kumarasamy, N ; Walawander, Ann ; Nair, Apsara ; Tripathy, Srikan2011 OctJ Neurovirol517
A closer look at depression and its relationship to HIV antiretroviral adherence.Wagner, Glenn J ; Goggin, Kathy ; Remien, Robert H ; Rosen, Marc I ; Simoni, Jane ; Bangsberg, David R ; Liu, Honghu ; MACH14 Investigators2011 DecAnn Behav Med342
Augmented HIV-specific interferon-gamma responses, but impaired lymphoproliferation during interruption of antiretroviral treatment initiated in primary HIV infection.Connick, Elizabeth ; Bosch, Ronald J ; Aga, Evgenia ; Schlichtemeier, Rick ; Demeter, Lisa M ; Volberding, Paul ; ACTG 709 Team2011 Sep 1J Acquir Immune Defic Syndr158
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results.Sax, Paul E ; Tierney, Camlin ; Collier, Ann C ; Daar, Eric S ; Mollan, Katie ; Budhathoki, Chakra ; Godfrey, Catherine ; Jahed, Nasreen C ; Myers, Laurie ; Katzenstein, David ; Farajallah, Awny ; Rooney, James F ; Ha, Belinda ; Woodward, William C ; Feinberg, Judith ; Tashima, Karen ; Murphy, Robert L ; Fischl, Margaret A ; AIDS Clinical 2011 Oct 15J Infect Dis8204
Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infectionHaubrich, Richard H ; Riddler, Sharon A ; Ribaudo, Heather ; Direnzo, Gregory ; Klingman, Karin L ; Garren, Kevin W ; Butcher, David L ; Rooney, James F ; Havlir, Diane V ; Mellors, John W ; AIDS Clinical Trials Group (ACTG) A5160 and A5142 Study Teams2011 Nov 28AIDS1825
Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data.Simpson, Kit N ; Dietz, Birgitta ; Baran, Robert W ; Garren, Kevin W ; Riddler, Sharon A ; Bhor, Menaka ; Haubrich, Richard H2011Cost Eff Resour Alloc9
Clinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals.Schifitto, Giovanni ; Deng, Lijuan ; Yeh, Tzu-min ; Evans, Scott R ; Ernst, Thomas ; Zhong, Jianhui ; Clifford, David2011 FebJ Neurovirol117
Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort.Smurzynski, Marlene ; Wu, Kunling ; Letendre, Scott ; Robertson, Kevin ; Bosch, Ronald J ; Clifford, David B ; Evans, Scott ; Collier, Ann C ; Taylor, Michael ; Ellis, Ronald2011 Jan 28AIDS325
Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine.Boltz, Valerie F ; Zheng, Yu ; Lockman, Shahin ; Hong, Feiyu ; Halvas, Elias K ; McIntyre, James ; Currier, Judith S ; Chibowa, Margret C ; Kanyama, Cecelia ; Nair, Apsara ; Owino-Ong'or, Willis ; Hughes, Michael ; Coffin, John M ; Mellors, John W2011 May 31Proc Natl Acad Sci U S A22108
Reanalysis of coreceptor tropism in HIV-1-infected adults using a phenotypic assay with enhanced sensitivity.Wilkin, Timothy J ; Goetz, Mathew Bidwell ; Leduc, Robert ; Skowron, Gail ; Su, Zhaohui ; Chan, Ellen S ; Heera, Jayyant ; Chapman, Doug ; Spritzler, John ; Reeves, Jacqueline D ; Gulick, Roy M ; Coakley, Eoin2011 Apr 1Clin Infect Dis752
Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis.Li, Jonathan Z ; Paredes, Roger ; Ribaudo, Heather J ; Svarovskaia, Evguenia S ; Metzner, Karin J ; Kozal, Michael J ; Hullsiek, Kathy Huppler ; Balduin, Melanie ; Jakobsen, Martin R ; Geretti, Anna Maria ; Thiebaut, Rodolphe ; Ostergaard, Lars ; Masquelier, Bernard ; Johnson, Jeffrey A ; Miller, Michael D ; Kuritzkes, Daniel R2011 Apr 6JAMA13305
Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia.Sax, Paul E ; Komarow, Lauren ; Finkelman, Malcolm A ; Grant, Philip M ; Andersen, Janet ; Scully, Eileen ; Powderly, William G ; Zolopa, Andrew R ; AIDS Clinical Trials Group Study A5164 Team2011 Jul 15Clin Infect Dis253
Episomal viral cDNAs identify a reservoir that fuels viral rebound after treatment interruption and that contributes to treatment failure.Sharkey, Mark ; Babic, Dunja Z ; Greenough, Thomas ; Gulick, Roy ; Kuritzkes, Daniel R ; Stevenson, Mario2011 FebPLoS Pathog27
Body mass index and CD4+ T-lymphocyte recovery in HIV-infected men with viral suppression on antiretroviral therapy.Palermo, Brandon ; Bosch, Ronald J ; Bennett, Kara ; Jacobson, Jeffrey M2011 Jul-AugHIV Clin Trials412
Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial.Sacktor, N ; Miyahara, S ; Deng, L ; Evans, S ; Schifitto, G ; Cohen, B A ; Paul, R ; Robertson, K ; Jarocki, B ; Scarsi, K ; Coombs, R W ; Zink, M C ; Nath, A ; Smith, E ; Ellis, R J ; Singer, E ; Weihe, J ; McCarthy, S ; Hosey, L ; Clifford, D B ; ACTG A5235 team2011 Sep 20Neurology1277
Prevention of HIV-1 infection with early antiretroviral therapy.Cohen, Myron S ; Chen, Ying Q ; McCauley, Marybeth ; Gamble, Theresa ; Hosseinipour, Mina C ; Kumarasamy, Nagalingeswaran ; Hakim, James G ; Kumwenda, Johnstone ; Grinsztejn, Beatriz ; Pilotto, Jose H S ; Godbole, Sheela V ; Mehendale, Sanjay ; Chariyalertsak, Suwat ; Santos, Breno R ; Mayer, Kenneth H ; Hoffman, Irving F ; Eshleman, Susan2011 Aug 11N Engl J Med6365
Incidence rate of and factors associated with loss to follow-up in a longitudinal cohort of antiretroviral-treated HIV-infected persons: an AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) analysis.Krishnan, S ; Wu, K ; Smurzynski, M ; Bosch, R J ; Benson, C A ; Collier, A C ; Klebert, M K ; Feinberg, J ; Koletar, S L ; ALLRT/A5001 Team2011 Jul-AugHIV Clin Trials412
Baseline immune phenotypes and CD4+ T lymphocyte responses to antiretroviral therapy in younger versus older HIV-infected individuals.Hoffman, Risa M ; Jamieson, Beth D ; Bosch, Ronald J ; Currier, Judith ; Kitchen, Christina M R ; Schmid, Ingrid ; Zhu, Yuda ; Bennett, Kara ; Mitsuyasu, Ronald2011 OctJ Clin Immunol531
Comparative effectiveness of initial antiretroviral therapy regimens: ACTG 5095 and 5142 clinical trials relative to ART-CC cohort study.Mugavero, Michael J ; May, Margaret ; Ribaudo, Heather J ; Gulick, Roy M ; Riddler, Sharon A ; Haubrich, Richard ; Napravnik, Sonia ; Abgrall, Sophie ; Phillips, Andrew ; Harris, Ross ; Gill, M John ; de Wolf, Frank ; Hogg, Robert ; Günthard, Huldrych F ; Chêne, Geneviève ; D'Arminio Monforte, Antonella ; Guest, Jodie L ; Smith, Colette ; 2011 Nov 1J Acquir Immune Defic Syndr358
The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort.Linas, B P ; Wang, B ; Smurzynski, M ; Losina, E ; Bosch, R J ; Schackman, B R ; Rong, J ; Sax, P E ; Walensky, R P ; Schouten, J ; Freedberg, K A2011 JulJ Viral Hepat718
Use of biological knowledge to inform the analysis of gene-gene interactions involved in modulating virologic failure with efavirenz-containing treatment regimens in ART-naïve ACTG clinical trials participants.Grady, Benjamin J ; Torstenson, Eric S ; McLaren, Paul J ; DE Bakker, Paul I W ; Haas, David W ; Robbins, Gregory K ; Gulick, Roy M ; Haubrich, Richard ; Ribaudo, Heather ; Ritchie, Marylyn D2011Pac Symp Biocomput
Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362.Cohn, Susan E ; Jiang, Hongyu ; McCutchan, J Allen ; Koletar, Susan L ; Murphy, Robert L ; Robertson, Kevin R ; de St Maurice, Annabelle M ; Currier, Judith S ; Williams, Paige L2011 JunAIDS Care623
Sex differences in lopinavir and ritonavir pharmacokinetics among HIV-infected women and men.Umeh, Obi C ; Currier, Judith S ; Park, Jeong-Gun ; Cramer, Yoninah ; Hermes, Ashwaq E ; Fletcher, Courtney V2011 DecJ Clin Pharmacol1251
Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTGMcComsey, Grace A ; Kitch, Douglas ; Daar, Eric S ; Tierney, Camlin ; Jahed, Nasreen C ; Tebas, Pablo ; Myers, Laurie ; Melbourne, Kathleen ; Ha, Belinda ; Sax, Paul E2011 Jun 15J Infect Dis12203
Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals.Anthony, D D ; Umbleja, T ; Aberg, J A ; Kang, M ; Medvik, K ; Lederman, M M ; Peters, M G ; Koziel, M J ; Overton, E T2011 Apr 27Vaccine1929
High-sensitivity C-reactive protein levels do not decrease with the use of statins in all persons with HIV infection.Fichtenbaum, Carl J ; Evans, Scott E ; Aberg, Judith A2011 Oct 23AIDS1625
Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.Daar, Eric S ; Tierney, Camlin ; Fischl, Margaret A ; Sax, Paul E ; Mollan, Katie ; Budhathoki, Chakra ; Godfrey, Catherine ; Jahed, Nasreen C ; Myers, Laurie ; Katzenstein, David ; Farajallah, Awny ; Rooney, James F ; Pappa, Keith A ; Woodward, William C ; Patterson, Kristine ; Bolivar, Hector ; Benson, Constance A ; Collier, Ann C ; AIDS2011 Apr 5Ann Intern Med7154
Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapy.Taiwo, Babafemi ; Gallien, Sebastien ; Aga, Evgenia ; Ribaudo, Heather ; Haubrich, Richard ; Kuritzkes, Daniel R ; Eron, Joseph J2011 Aug 15J Infect Dis4204
Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224s.McComsey, Grace A ; Kitch, Douglas ; Sax, Paul E ; Tebas, Pablo ; Tierney, Camlin ; Jahed, Nasreen C ; Myers, Laurie ; Melbourne, Kathleen ; Ha, Belinda ; Daar, Eric S2011 Jul 15Clin Infect Dis253
Lower CD4 cell count and higher virus load, but not antiretroviral drug resistance, are associated with AIDS-defining events and mortality: an ACTG Longitudinal Linked Randomized Trials (ALLRT) analysis.Swindells, Susan ; Jiang, Hongyu ; Mukherjee, A Lisa ; Winters, Mark ; Bosch, Ronald J ; Katzenstein, David2011 Mar-AprHIV Clin Trials212
Translation of HLA-HIV associations to the cellular level: HIV adapts to inflate CD8 T cell responses against Nef and HLA-adapted variant epitopes.Almeida, Coral-Ann M ; Bronke, Corine ; Roberts, Steven G ; McKinnon, Elizabeth ; Keane, Niamh M ; Chopra, Abha ; Kadie, Carl ; Carlson, Jonathan ; Haas, David W ; Riddler, Sharon A ; Haubrich, Richard ; Heckerman, David ; Mallal, Simon ; John, Mina2011 Sep 1J Immunol5187
Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america.Abraham, Alison G ; Lau, Bryan ; Deeks, Steven ; Moore, Richard D ; Zhang, Jinbing ; Eron, Joseph ; Harrigan, Richard ; Gill, M John ; Kitahata, Mari ; Klein, Marina ; Napravnik, Sonia ; Rachlis, Anita ; Rodriguez, Benigno ; Rourke, Sean ; Benson, Constance ; Bosch, Ron ; Collier, Ann ; Gebo, Kelly ; Goedert, James ; Hogg, Robert ; Horberg2011 Sep 15Am J Epidemiol6174
A randomized trial of interleukin-2 during withdrawal of antiretroviral treatment.Bosch, Ronald J ; Pollard, Richard B ; Landay, Alan ; Aga, Evgenia ; Fox, Lawrence ; Mitsuyasu, Ronald ; AIDS Clinical Trials Group A5132 Team2011 JunJ Interferon Cytokine Res631
Postpartum viral load rebound in HIV-1-infected women treated with highly active antiretroviral therapy: AIDS Clinical Trials Group Protocol A5150.Sha, Beverly E ; Tierney, Camlin ; Cohn, Susan E ; Sun, Xin ; Coombs, Robert W ; Frenkel, Lisa M ; Kalams, Spyros A ; Aweeka, Francesca T ; Bastow, Barbara ; Bardeguez, Arlene ; Kmack, Anne ; Stek, Alice ; Aids Clinical Trials Group ACTG A5150 Team2011 Jan-FebHIV Clin Trials112
Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.Havlir, Diane V ; Kendall, Michelle A ; Ive, Prudence ; Kumwenda, Johnstone ; Swindells, Susan ; Qasba, Sarojini S ; Luetkemeyer, Anne F ; Hogg, Evelyn ; Rooney, James F ; Wu, Xingye ; Hosseinipour, Mina C ; Lalloo, Umesh ; Veloso, Valdilea G ; Some, Fatuma F ; Kumarasamy, N ; Padayatchi, Nesri ; Santos, Breno R ; Reid, Stewart ; Hakim, Ja2011 Oct 20N Engl J Med16365
Comparison of immunologic assays for detecting immune responses in HIV immunotherapeutic studies: AIDS Clinical Trials Group Trial A5181.Macatangay, Bernard J C ; Zheng, Lu ; Rinaldo, Charles R ; Landay, Alan L ; Pollard, Richard B ; Pahwa, Savita ; Lederman, Michael M ; Bucy, R Pat2010 SepClin Vaccine Immunol917
Hemodialysis does not significantly affect the pharmacokinetics of nevirapine in HIV-1-infected persons requiring hemodialysis: results from ACTG A5177.Cramer, Yoninah S ; Rosenkranz, Susan L ; Hall, Stephen D ; Szczech, Lynda A ; Amorosa, Valerianna ; Gupta, Samir K2010 AugJ Acquir Immune Defic Syndr454
Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection.Grant, Philip M ; Komarow, Lauren ; Andersen, Janet ; Sereti, Irini ; Pahwa, Savita ; Lederman, Michael M ; Eron, Joseph ; Sanne, Ian ; Powderly, William ; Hogg, Evelyn ; Suckow, Carol ; Zolopa, Andrew2010PLoS One75
Evolution of CCR5 antagonist resistance in an HIV-1 subtype C clinical isolate.Henrich, Timothy J ; Tsibris, Athe M N ; Lewine, Nicolas R P ; Konstantinidis, Ioannis ; Leopold, Kay E ; Sagar, Manish ; Kuritzkes, Daniel R2010 DecJ Acquir Immune Defic Syndr455
Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure.Paredes, Roger ; Lalama, Christina M ; Ribaudo, Heather J ; Schackman, Bruce R ; Shikuma, Cecilia ; Giguel, Francoise ; Meyer, William A ; Johnson, Victoria A ; Fiscus, Susan A ; D'Aquila, Richard T ; Gulick, Roy M ; Kuritzkes, Daniel R ; AIDS Clinical Trials Group (ACTG) A5095 Study Team2010 MarJ Infect Dis5201
Measurement of antiretroviral drugs in the lungs of HIV-infected patients.Twigg, Homer L ; Schnizlein-Bick, Carol T ; Weiden, Michael ; Valentine, Fred ; Wheat, Joseph ; Day, Richard B ; Rominger, Helen ; Zheng, Lu ; Collman, Ronald G ; Coombs, Robert W ; Bucy, R Pat ; Rezk, Naser L ; Kashuba, Angela Dm2010 Mar 1HIV Ther24
African mitochondrial DNA subhaplogroups and peripheral neuropathy during antiretroviral therapy.Canter, Jeffrey A ; Robbins, Gregory K ; Selph, Doug ; Clifford, David B ; Kallianpur, Asha R ; Shafer, Robert ; Levy, Shawn ; Murdock, Deborah G ; Ritchie, Marylyn D ; Haas, David W ; Hulgan, Todd ; AIDS Clinical Trials Group Study 384 Team ; New Work Concept Sheet 273 Team2010 Jun 1J Infect Dis11201
Exploiting knowledge of immune selection in HIV-1 to detect HIV-specific CD8 T-cell responses.Almeida, Coral-Ann M ; Roberts, Steven G ; Laird, Rebecca ; McKinnon, Elizabeth ; Ahmad, Imran ; Keane, Niamh M ; Chopra, Abha ; Kadie, Carl ; Heckerman, David ; Mallal, Simon ; John, Mina2010 Aug 23Vaccine3728
The relationship of CCR5 antagonists to CD4+ T-cell gain: a meta-regression of recent clinical trials in treatment-experienced HIV-infected patients.Wilkin, Timothy J ; Ribaudo, Heather R ; Tenorio, Allan R ; Gulick, Roy M2010 Nov-DecHIV Clin Trials611
Contraceptive efficacy of oral and transdermal hormones when co-administered with protease inhibitors in HIV-1-infected women: pharmacokinetic results of ACTG trial A5188.Vogler, Mary A ; Patterson, Kristine ; Kamemoto, Lori ; Park, Jeong-Gun ; Watts, Heather ; Aweeka, Francesca ; Klingman, Karin L ; Cohn, Susan E2010 DecJ Acquir Immune Defic Syndr455
AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein.Schooley, Robert T ; Spritzler, John ; Wang, Hongying ; Lederman, Michael M ; Havlir, Diane ; Kuritzkes, Daniel R ; Pollard, Richard ; Battaglia, Cathy ; Robertson, Michael ; Mehrotra, Devan ; Casimiro, Danilo ; Cox, Kara ; Schock, Barbara ; AIDS Clinical Trials Group 5197 Study Team2010 Sep 1J Infect Dis5202
Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens.Sherman, Kenneth E ; Rouster, Susan D ; Stanford, Sandra ; Blackard, Jason T ; Shire, Norah ; Koziel, Margaret ; Peters, Marion ; Chung, Raymond T ; AIDS Clinical Trials Group 5071 Study Team2010 MarJ Infect Dis5201
A faunistic survey of cercariae isolated from lymnaeid snails in central areas of Mazandaran, Iran.Sharif, M ; Daryani, A ; Karimi, S A2010 Feb 15Pak J Biol Sci413
Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy.Brown, Todd T ; Tassiopoulos, Katherine ; Bosch, Ronald J ; Shikuma, Cecilia ; McComsey, Grace A2010 OctDiabetes Care1033
Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220.Overton, E T ; Kang, M ; Peters, M G ; Umbleja, T ; Alston-Smith, B L ; Bastow, B ; Demarco-Shaw, D ; Koziel, M J ; Mong-Kryspin, L ; Sprenger, H L ; Yu, J Y ; Aberg, J A2010 Aug 2Vaccine3428
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.International HIV Controllers Study ; Pereyra, Florencia ; Jia, Xiaoming ; McLaren, Paul J ; DE Bakker, Paul I W ; Walker, Bruce D ; Ripke, Stephan ; Brumme, Chanson J ; Pulit, Sara L ; Carrington, Mary ; Kadie, Carl M ; Carlson, Jonathan M ; Heckerman, David ; Graham, Robert R ; Plenge, Robert M ; Deeks, Steven G ; Gianniny, Lauren ; Craw2010 Dec 10Science6010330
Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs.John, Mina ; Heckerman, David ; James, Ian ; Park, Lawrence P ; Carlson, Jonathan M ; Chopra, Abha ; Gaudieri, Silvana ; Nolan, David ; Haas, David W ; Riddler, Sharon A ; Haubrich, Richard ; Mallal, Simon2010 Apr 15J Immunol8184
A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206.Tungsiripat, Marisa ; Kitch, Douglas ; Glesby, Marshall J ; Gupta, Samir K ; Mellors, John W ; Moran, Laura ; Jones, Lynne ; Alston-Smith, Beverly ; Rooney, James F ; Aberg, Judith A2010 Jul 17AIDS1124
Treatment with recombinant growth hormone is associated with modest improvement in CD4 lymphocyte reconstitution in HIV-infected persons on antiretroviral therapy: results of ACTG A5174.Smith, Kimberly ; Zheng, Lu ; Bosch, Ronald ; Margolis, David M ; Tenorio, Allan ; Napolitano, Laura ; Saag, Michael ; Connick, Elizabeth ; Gross, Barry ; Francis, Isaac ; Valdez, Hernan ; Muurahainen, Norma ; Stocker, Vicky ; Pollard, Richard2010 AprAIDS Res Hum Retroviruses426
Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir.Crawford, Keith W ; Spritzler, John ; Kalayjian, Robert C ; Parsons, Teresa ; Landay, Alan ; Pollard, Richard ; Stocker, Vicki ; Lederman, Michael M ; Flexner, Charles ; AIDS Clinical Trials Protocol 5015 Team2010 JunAIDS Res Hum Retroviruses626
Vicriviroc and peripheral neuropathy: results from AIDS Clinical Trials Group 5211.Yeh, Tzu-min ; Evans, Scott R ; Gulick, Roy M ; Clifford, David B2010 Jan-FebHIV Clin Trials111
The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection.Markowitz, Martin ; Vaida, Florin ; Hare, C Bradley ; Boden, Daniel ; Mohri, Hiroshi ; Hecht, Frederick M ; Kalayjian, Robert C ; Conrad, Ann ; Mildvan, Donna ; Aberg, Judith ; Hogan, Christine ; Kilby, J Michael ; Balfour, Henry H ; Schafer, Kim ; Richman, Douglas ; Little, Susan2010 May 1J Infect Dis9201
Measurement of naive CD4 cells reliably predicts potential for immune reconstitution in HIV.Schacker, Timothy W ; Bosch, Ronald J ; Bennett, Kara ; Pollard, Richard ; Robbins, Gregory K ; Collier, Ann C ; Gulick, Roy M ; Spritzler, John ; Mildvan, Donna ; AIDS Clinical Trials Group2010 May 1J Acquir Immune Defic Syndr154
Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patients.Wilkin, Timothy J ; Su, Zhaohui ; Krambrink, Amy ; Long, Jianmin ; Greaves, Wayne ; Gross, Robert ; Hughes, Michael D ; Flexner, Charles ; Skolnik, Paul R ; Coakley, Eoin ; Godfrey, Catherine ; Hirsch, Martin ; Kuritzkes, Daniel R ; Gulick, Roy M2010 AugJ Acquir Immune Defic Syndr554
Pharmacokinetic/pharmacodynamic modeling of the antiretroviral activity of the CCR5 antagonist Vicriviroc in treatment experienced HIV-infected subjects (ACTG protocol 5211).Crawford, Keith W ; Li, Chonghua ; Keung, Anther ; Su, Zhaohui ; Hughes, Michael D ; Greaves, Wayne ; Kuritzkes, Daniel ; Gulick, Roy ; Flexner, Charles ; ACTG A5211 Study Team2010 AprJ Acquir Immune Defic Syndr553
Substitution of nevirapine because of efavirenz toxicity in AIDS clinical trials group A5095.Schouten, Jeffrey T ; Krambrink, Amy ; Ribaudo, Heather J ; Kmack, Anne ; Webb, Nancy ; Shikuma, Cecilia ; Kuritzkes, Daniel R ; Gulick, Roy M2010 Mar 1Clin Infect Dis550
Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial.Flexner, Charles ; Tierney, Camlin ; Gross, Robert ; Andrade, Adriana ; Lalama, Christina ; Eshleman, Susan H ; Aberg, Judith ; Sanne, Ian ; Parsons, Teresa ; Kashuba, Angela ; Rosenkranz, Susan L ; Kmack, Anne ; Ferguson, Elaine ; Dehlinger, Marjorie ; Mildvan, Donna ; ACTG A5073 Study Team2010 Apr 1Clin Infect Dis750
Early antiretroviral therapy for patients with acute aids-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164.Sax, Paul E ; Sloan, Caroline E ; Schackman, Bruce R ; Grant, Philip M ; Rong, Jian ; Zolopa, Andrew R ; Powderly, William ; Losina, Elena ; Freedberg, Kenneth A ; Cepac US And Actg A5164 Investigators2010 Sep-OctHIV Clin Trials511
No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapy.Gandhi, Rajesh T ; Bosch, Ronald J ; Aga, Evgenia ; Albrecht, Mary ; Demeter, Lisa M ; Dykes, Carrie ; Bastow, Barbara ; Para, Michael ; Lai, Jun ; Siliciano, Robert F ; Siliciano, Janet D ; Eron, Joseph J ; AIDS Clinical Trials Group A5173 Team2010 Jan 15J Infect Dis2201
Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087.Fichtenbaum, Carl J ; Yeh, Tzu-min ; Evans, Scott R ; Aberg, Judith A2010 Jul-AugJ Clin Lipidol44
Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy.Kalayjian, Robert C ; Machekano, Rhoderick N ; Rizk, Nesrine ; Robbins, Gregory K ; Gandhi, Rajesh T ; Rodriguez, Benigno A ; Pollard, Richard B ; Lederman, Michael M ; Landay, Alan2010 Jun 15J Infect Dis12201
Detection and quantitation of HPV in genital and oral tissues and fluids by real time PCR.Seaman, William T ; Andrews, Elizabeth ; Couch, Marion ; Kojic, Erna M ; Cu-Uvin, Susan ; Palefsky, Joel ; Deal, Allison M ; Webster-Cyriaque, Jennifer2010Virol J7
A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen.Hammer, Scott M ; Ribaudo, Heather ; Bassett, Roland ; Mellors, John W ; Demeter, Lisa M ; Coombs, Robert W ; Currier, Judith ; Morse, Gene D ; Gerber, John G ; Martinez, Ana I ; Spreen, William ; Fischl, Margaret A ; Squires, Kathleen E ; AIDS Clinical Trials Group (ACTG) 372A Study Team2010 Nov-DecHIV Clin Trials611
Phase I/II trial of the anti-HIV activity of mifepristone in HIV-infected subjects ACTG 5200.Para, Michael F ; Schouten, Jeff ; Rosenkranz, Susan L ; Yu, Song ; Weiner, David ; Tebas, Pablo ; White, C Jo ; Reeds, Dominic ; Lertora, Juan ; Patterson, Kristine B ; Daar, Eric S ; Cavert, Winston ; Brizz, Barbara ; ACTG A5200 Team of the ACTG2010 Apr 1J Acquir Immune Defic Syndr453
Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG Protocol A5051, a rollover trial of ACTG Protocol A328).Bosch, Ronald J ; Pollard, Richard B ; Landay, Alan ; Aga, Evgenia ; Fox, Lawrence ; Mitsuyasu, Ronald2010AIDS Res Ther7
Relationship between CD4+ T-cell counts/HIV-1 RNA plasma viral load and AIDS-defining events among persons followed in the ACTG longitudinal linked randomized trials study.Smurzynski, Marlene ; Wu, Kunling ; Benson, Constance A ; Bosch, Ronald J ; Collier, Ann C ; Koletar, Susan L2010 SepJ Acquir Immune Defic Syndr155
Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas.Firnhaber, Cynthia ; Smeaton, Laura ; Saukila, Nasinuku ; Flanigan, Timothy ; Gangakhedkar, Raman ; Kumwenda, Johnstone ; La Rosa, Alberto ; Kumarasamy, Nagalingeswaran ; De Gruttola, Victor ; Hakim, James Gita ; Campbell, Thomas B2010 DecInt J Infect Dis1214
The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial.Gandhi, Rajesh T ; Zheng, Lu ; Bosch, Ronald J ; Chan, Ellen S ; Margolis, David M ; Read, Sarah ; Kallungal, Beatrice ; Palmer, Sarah ; Medvik, Kathy ; Lederman, Michael M ; Alatrakchi, Nadia ; Jacobson, Jeffrey M ; Wiegand, Ann ; Kearney, Mary ; Coffin, John M ; Mellors, John W ; Eron, Joseph J ; AIDS Clinical Trials Group A5244 team2010PLoS Med87
Instantaneous inhibitory potential is similar to inhibitory quotient at predicting HIV-1 response to antiretroviral therapy.Henrich, Timothy J ; Ribaudo, Heather J ; Kuritzkes, Daniel R2010 Jul 1Clin Infect Dis151
Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men.Wilkin, Timothy ; Lee, Jeannette Y ; Lensing, Shelly Y ; Stier, Elizabeth A ; Goldstone, Stephen E ; Berry, J Michael ; Jay, Naomi ; Aboulafia, David ; Cohn, David L ; Einstein, Mark H ; Saah, Alfred ; Mitsuyasu, Ronald T ; Palefsky, Joel M2010 Oct 15J Infect Dis8202
Intracellular Casp8p41 content is inversely associated with CD4 T cell count.Cummins, Nathan W ; Jiang, Wei ; McGinty, John ; Bren, Gary D ; Bosch, Ronald J ; Landay, Alan ; Deeks, Steven G ; Martin, Jeffrey N ; Douek, Daniel ; Lederman, Michael M ; Brenchley, Jason ; Badley, Andrew D2010 Aug 15J Infect Dis3202
Effect of raltegravir resistance mutations in HIV-1 integrase on viral fitness.Hu, Zixin ; Kuritzkes, Daniel R2010 OctJ Acquir Immune Defic Syndr255
Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection.Lok, Judith J ; Bosch, Ronald J ; Benson, Constance A ; Collier, Ann C ; Robbins, Gregory K ; Shafer, Robert W ; Hughes, Michael D ; ALLRT team2010 Jul 31AIDS1224
Quality assessment for therapeutic drug monitoring in AIDS Clinical Trials Group (ACTG 5146): a multicenter clinical trial.DiFrancesco, Robin ; Rosenkranz, Susan ; Mukherjee, A Lisa ; Demeter, Lisa M ; Jiang, Hongyu ; DiCenzo, Robert ; Dykes, Carrie ; Rinehart, Alex ; Albrecht, Mary ; Morse, Gene D2010 AugTher Drug Monit432
Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-1 immune control.Ferreira, Manuel A R ; Mangino, Massimo ; Brumme, Chanson J ; Zhao, Zhen Zhen ; Medland, Sarah E ; Wright, Margaret J ; Nyholt, Dale R ; Gordon, Scott ; Campbell, Megan ; McEvoy, Brian P ; Henders, Anjali ; Evans, David M ; Lanchbury, Jerry S ; Pereyra, Florencia ; International HIV Controllers Study ; Walker, Bruce D ; Haas, David W ; Sor2010 JanAm J Hum Genet186
Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group study.Ribaudo, Heather J ; Liu, Huan ; Schwab, Matthias ; Schaeffeler, Elke ; Eichelbaum, Michel ; Motsinger-Reif, Alison A ; Ritchie, Marylyn D ; Zanger, Ulrich M ; Acosta, Edward P ; Morse, Gene D ; Gulick, Roy M ; Robbins, Gregory K ; Clifford, David ; Haas, David W2010 Sep 1J Infect Dis5202
Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection.Rosenberg, Eric S ; Graham, Barney S ; Chan, Ellen S ; Bosch, Ronald J ; Stocker, Vicki ; Maenza, Janine ; Markowitz, Martin ; Little, Susan ; Sax, Paul E ; Collier, Ann C ; Nabel, Gary ; Saindon, Suzanne ; Flynn, Theresa ; Kuritzkes, Daniel ; Barouch, Dan H ; AIDS Clinical Trials Group A5187 Team2010PLoS One55
Antiretroviral therapies in women after single-dose nevirapine exposure.Lockman, Shahin ; Hughes, Michael D ; McIntyre, James ; Zheng, Yu ; Chipato, Tsungai ; Conradie, Francesca ; Sawe, Fred ; Asmelash, Aida ; Hosseinipour, Mina C ; Mohapi, Lerato ; Stringer, Elizabeth ; Mngqibisa, Rosie ; Siika, Abraham ; Atwine, Diana ; Hakim, James ; Shaffer, Douglas ; Kanyama, Cecilia ; Wools-Kaloustian, Kara ; Salata, Ro2010 Oct 14N Engl J Med16363
Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial.Asmuth, David M ; Murphy, Robert L ; Rosenkranz, Susan L ; Lertora, Juan J L ; Kottilil, Shyam ; Cramer, Yoninah ; Chan, Ellen S ; Schooley, Robert T ; Rinaldo, Charles R ; Thielman, Nathan ; Li, Xiao-Dong ; Wahl, Sharon M ; Shore, Jessica ; Janik, Jennifer ; Lempicki, Richard A ; Simpson, Yaa ; Pollard, Richard B ; AIDS Clinical Trials Gr2010 Jun 1J Infect Dis11201
Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C).Sherman, Kenneth E ; Andersen, Janet W ; Butt, Adeel A ; Umbleja, Triin ; Alston, Beverly ; Koziel, Margaret J ; Peters, Marion G ; Sulkowski, Mark ; Goodman, Zachary D ; Chung, Raymond T ; AIDS Clinical Trials Group A5178 Study Team2010 Dec 15J Acquir Immune Defic Syndr555
Performance characteristics of the Cavidi ExaVir viral load assay and the ultra-sensitive P24 assay relative to the Roche Monitor HIV-1 RNA assay.Stewart, Paul ; Cachafeiro, Ada ; Napravnik, Sonia ; Eron, Joseph J ; Frank, Ian ; van der Horst, Charles ; Bosch, Ronald J ; Bettendorf, Daniel ; Bohlin, Peter ; Fiscus, Susan A2010 NovJ Clin Virol349
A meta-analysis of six placebo-controlled trials of thiazolidinedione therapy for HIV lipoatrophy.Raboud, Janet M ; Diong, Christina ; Carr, Andrew ; Grinspoon, Steven ; Mulligan, Kathleen ; Sutinen, Jussi ; Rozenbaum, William ; Cavalcanti, Rodrigo B ; Wand, Handan ; Costagliola, Dominique ; Walmsley, Sharon ; Glitazone and Lipoatrophy Meta-Analysis Working Group2010 Jan-FebHIV Clin Trials111
Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort.Robertson, K R ; Su, Z ; Margolis, D M ; Krambrink, A ; Havlir, D V ; Evans, S ; Skiest, D J ; A5170 Study Team2010 Apr 20Neurology1674
Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229.McComsey, Grace A ; Walker, Ulrich A ; Budhathoki, Chakra B ; Su, Zhaohui ; Currier, Judith S ; Kosmiski, Lisa ; Naini, Linda G ; Charles, Stéphannie ; Medvik, Kathy ; Aberg, Judith A ; AIDS Clinical Trials Group A5229 Team2010 Oct 23AIDS1624
Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patients.Halvas, Elias K ; Wiegand, Ann ; Boltz, Valerie F ; Kearney, Mary ; Nissley, Dwight ; Wantman, Michael ; Hammer, Scott M ; Palmer, Sarah ; Vaida, Florin ; Coffin, John M ; Mellors, John W2010 MarJ Infect Dis5201
Prevalence of primary resistance at baseline in acutely and recently infected subjects enrolled in AIDS clinical trials group protocol 371.Dykes, Carrie ; Mukherjee, A Lisa ; Bosch, Ronald J ; Connick, Elizabeth ; Volberding, Paul A ; Demeter, Lisa M2010 SepJ Acquir Immune Defic Syndr155
Memantine for AIDS dementia complex: open-label report of ACTG 301.Zhao, Yu ; Navia, Bradford A ; Marra, Christina M ; Singer, Elyse J ; Chang, Linda ; Berger, Joseph ; Ellis, Ronald J ; Kolson, Dennis L ; Simpson, David ; Miller, Eric N ; Lipton, Stuart A ; Evans, Scott R ; Schifitto, Giovanni ; Adult Aids Clinical Trial Group (ACTG) 301 Team2010 Jan-FebHIV Clin Trials111
A comparison of tests for restricted orderings in the three-class case.Alonzo, Todd A ; Nakas, Christos T ; Yiannoutsos, Constantin T ; Bucher, Sherri2009 Mar 30Stat Med728
A randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patients.Demeter, Lisa M ; Jiang, Hongyu ; Mukherjee, A Lisa ; Morse, Gene D ; DiFrancesco, Robin ; DiCenzo, Robert ; Dykes, Carrie ; Sista, Prakash ; Bacheler, Lee ; Klingman, Karin ; Rinehart, Alex ; Albrecht, Mary2009 Jan 28AIDS323
Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virions.Hosoya, Noriaki ; Su, Zhaohui ; Wilkin, Timothy ; Gulick, Roy M ; Flexner, Charles ; Hughes, Michael D ; Skolnik, Paul R ; Giguel, Francoise ; Greaves, Wayne L ; Coakley, Eoin ; Kuritzkes, Daniel R2009 AugJ Clin Microbiol847
Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of AIDS clinical trials group A5211.Su, Zhaohui ; Gulick, Roy M ; Krambrink, Amy ; Coakley, Eoin ; Hughes, Michael D ; Han, Dong ; Flexner, Charles ; Wilkin, Timothy J ; Skolnik, Paul R ; Greaves, Wayne L ; Kuritzkes, Daniel R ; Reeves, Jacqueline D ; AIDS Clinical Trials Group A5211 Team2009 Dec 1J Infect Dis11200
The effect of aging on T-regulatory cell frequency in HIV infection.Tenorio, Allan R ; Spritzler, John ; Martinson, Jeffrey ; Gichinga, Caroline N ; Pollard, Richard B ; Lederman, Michael M ; Kalayjian, Robert C ; Landay, Alan L2009 MarClin Immunol3130
A novel codon insert in protease of clade B HIV type 1.Jordan, Parris S ; Poon, Art ; Eron, Joseph ; Squires, Kathleen ; Ignacio, Caroline ; Richman, Douglas D ; Smith, Davey M2009 MayAIDS Res Hum Retroviruses525
Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir.Haas, David W ; Koletar, Susan L ; Laughlin, Laura ; Kendall, Michelle A ; Suckow, Carol ; Gerber, John G ; Zolopa, Andrew R ; Bertz, Richard ; Child, Michael J ; Hosey, Lara ; Alston-Smith, Beverly ; Acosta, Edward P ; A5213 StudyTeam2009 Mar 1J Acquir Immune Defic Syndr350
Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115.Tenorio, Allan R ; Jiang, Hongyu ; Zheng, Yu ; Bastow, Barbara ; Kuritzkes, Daniel R ; Bartlett, John A ; Deeks, Steven G ; Landay, Alan L ; Riddler, Sharon A2009 FebAIDS Res Hum Retroviruses225
The effects of HIV type-1 viral suppression and non-viral factors on quantitative proteinuria in the highly active antiretroviral therapy era.Gupta, Samir K ; Smurzynski, Marlene ; Franceschini, Nora ; Bosch, Ronald J ; Szczech, Lynda A ; Kalayjian, Robert C ; AIDS Clinical Trials Group Longitudinal Linked Randomized Trials Study Team2009Antivir Ther414
Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients.Clifford, D B ; Smurzynski, M ; Park, L S ; Yeh, T-M ; Zhao, Y ; Blair, L ; Arens, M ; Evans, S R2009 Jul 28Neurology473
Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitution.Williams, Pl ; Wu, Jw ; Cohn, Se ; Koletar, Sl ; McCutchan, Ja ; Murphy, Rl ; Currier, Js ; AIDS Clinical Trials Group 362 Study Team2009 MayHIV Med510
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.Deeks, Steven G ; Gange, Stephen J ; Kitahata, Mari M ; Saag, Michael S ; Justice, Amy C ; Hogg, Robert S ; Eron, Joseph J ; Brooks, John T ; Rourke, Sean B ; Gill, M John ; Bosch, Ronald J ; Benson, Constance A ; Collier, Ann C ; Martin, Jeffrey N ; Klein, Marina B ; Jacobson, Lisa P ; Rodriguez, Benigno ; Sterling, Timothy R ; Kirk, Greg2009 Nov 15Clin Infect Dis1049
Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy.Fife, Kenneth H ; Wu, Julia W ; Squires, Kathleen E ; Watts, D Heather ; Andersen, Janet W ; Brown, Darron R2009 Jul 1J Acquir Immune Defic Syndr351
Long-term impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals (ACTG 5097s).Clifford, David B ; Evans, Scott ; Yang, Yijun ; Acosta, Edward P ; Ribaudo, Heather ; Gulick, Roy M ; A5097s Study Team2009 Nov-DecHIV Clin Trials610
Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110.Tebas, P ; Zhang, J ; Hafner, R ; Tashima, K ; Shevitz, A ; Yarasheski, K ; Berzins, B ; Owens, S ; Forand, J ; Evans, S ; Murphy, R2009 MayJ Antimicrob Chemother563
Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.Wohl, D A ; Kendall, M A ; Andersen, J ; Crumpacker, C ; Spector, S A ; Feinberg, J ; Alston-Smith, B ; Owens, S ; Chafey, S ; Marco, M ; Maxwell, S ; Lurain, N ; Jabs, D ; Benson, C ; Keiser, P ; Jacobson, M A ; A5030 Study Team2009 May-JunHIV Clin Trials310
Improving noninvasive methods of assessing liver fibrosis in patients with hepatitis C virus/human immunodeficiency virus co-infection.Shire, Norah J ; Rao, Marepalli B ; Succop, Paul ; Buncher, C Ralph ; Andersen, Janet A ; Butt, Adeel A ; Chung, Raymond T ; Sherman, Kenneth E ; AIDS Clinical Trials Group 5178 Study Group2009 AprClin Gastroenterol Hepatol47
Statin therapy and changes in hip circumference among HIV-infected participants in the ALLRT Cohort.Brown, Todd T ; Smurzynski, Marlene ; Wu, Kunling ; Bosch, Ronald J ; McComsey, Grace A2009Antivir Ther614
Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment.Volberding, Paul ; Demeter, Lisa ; Bosch, Ronald J ; Aga, Evgenia ; Pettinelli, Carla ; Hirsch, Martin ; Vogler, Mary ; Martinez, Ana ; Little, Susan ; Connick, Elizabeth ; ACTG 371 Team2009 Sep 24AIDS1523
Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects.Skowron, Gail ; Spritzler, John G ; Weidler, Jodi ; Robbins, Gregory K ; Johnson, Victoria A ; Chan, Ellen S ; Asmuth, David M ; Gandhi, Rajesh T ; Lie, Yolanda ; Bates, Michael ; Pollard, Richard B ; NIH/NIAID ACTG 384 Protocol Team and Monogram Biosciences2009 Mar 1J Acquir Immune Defic Syndr350
Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors.Hulgan, Todd ; Donahue, John P ; Smeaton, Laura ; Pu, Minya ; Wang, Hongying ; Lederman, Michael M ; Smith, Kimberly ; Valdez, Hernan ; Pilcher, Christopher ; Haas, David W ; AIDS Clinical Trials Group Study A5138 Team2009 NovEur J Clin Pharmacol1165
Predictive value of pharmacokinetics-adjusted phenotypic susceptibility on response to ritonavir-enhanced protease inhibitors (PIs) in human immunodeficiency virus-infected subjects failing prior PI therapy.Eron, Joseph J ; Park, Jeong-Gun ; Haubrich, Richard ; Aweeka, Francesca ; Bastow, Barbara ; Pakes, Gary E ; Yu, Song ; Wu, Hulin ; Richman, Douglas D ; ACTG5126 Study Team2009 JunAntimicrob Agents Chemother653
Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo.Tsibris, Athe M N ; Korber, Bette ; Arnaout, Ramy ; Russ, Carsten ; Lo, Chien-Chi ; Leitner, Thomas ; Gaschen, Brian ; Theiler, James ; Paredes, Roger ; Su, Zhaohui ; Hughes, Michael D ; Gulick, Roy M ; Greaves, Wayne ; Coakley, Eoin ; Flexner, Charles ; Nusbaum, Chad ; Kuritzkes, Daniel R2009PLoS One54
Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes.Wilkin, Timothy J ; McKinnon, John E ; DiRienzo, A Gregory ; Mollan, Katie ; Fletcher, Courtney V ; Margolis, David M ; Bastow, Barbara ; Thal, Gary ; Woodward, William ; Godfrey, Catherine ; Wiegand, Ann ; Maldarelli, Frank ; Palmer, Sarah ; Coffin, John M ; Mellors, John W ; Swindells, Susan2009 Mar 15J Infect Dis6199
Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.Sax, Paul E ; Tierney, Camlin ; Collier, Ann C ; Fischl, Margaret A ; Mollan, Katie ; Peeples, Lynne ; Godfrey, Catherine ; Jahed, Nasreen C ; Myers, Laurie ; Katzenstein, David ; Farajallah, Awny ; Rooney, James F ; Ha, Belinda ; Woodward, William C ; Koletar, Susan L ; Johnson, Victoria A ; Geiseler, P Jan ; Daar, Eric S ; AIDS Clinical 2009 Dec 3N Engl J Med23361
GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy.Stapleton, Jack T ; Chaloner, Kathryn ; Zhang, Jingyang ; Klinzman, Donna ; Souza, Inara E ; Xiang, Jinhua ; Landay, Alan ; Fahey, John ; Pollard, Richard ; Mitsuyasu, Ronald2009 Mar 13AIDS523
Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial.Zolopa, Andrew ; Andersen, Janet ; Powderly, William ; Sanchez, Alejandro ; Sanne, Ian ; Suckow, Carol ; Hogg, Evelyn ; Komarow, Lauren2009PLoS One54
Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211.Tsibris, Athe M N ; Paredes, Roger ; Chadburn, Amy ; Su, Zhaohui ; Henrich, Timothy J ; Krambrink, Amy ; Hughes, Michael D ; Aberg, Judith A ; Currier, Judith S ; Tashima, Karen ; Godfrey, Catherine ; Greaves, Wayne ; Flexner, Charles ; Skolnik, Paul R ; Wilkin, Timothy J ; Gulick, Roy M ; Kuritzkes, Daniel R2009 Mar 1Clin Infect Dis548
Treatment responses in antiretroviral treatment-naive premenopausal and postmenopausal HIV-1-infected women: an analysis from AIDS Clinical Trials Group Studies.Patterson, Kristine B ; Cohn, Susan E ; Uyanik, Jennifer ; Hughes, Michael ; Smurzynski, Marlene ; Eron, Joseph J2009 Aug 1Clin Infect Dis349
Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients.Chow, Dominic ; Chen, Huichao ; Glesby, Marshall J ; Busti, Anthony ; Souza, Scott ; Andersen, Janet ; Kohrs, Sharon ; Wu, Julia ; Koletar, Susan L2009 Oct 23AIDS1623
IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.Sereti, Irini ; Dunham, Richard M ; Spritzler, John ; Aga, Evgenia ; Proschan, Michael A ; Medvik, Kathy ; Battaglia, Catherine A ; Landay, Alan L ; Pahwa, Savita ; Fischl, Margaret A ; Asmuth, David M ; Tenorio, Allan R ; Altman, John D ; Fox, Lawrence ; Moir, Susan ; Malaspina, Angela ; Morre, Michel ; Buffet, Renaud ; Silvestri, Guido ;2009 Jun 18Blood25113
Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1.Meier, Angela ; Chang, J Judy ; Chan, Ellen S ; Pollard, Richard B ; Sidhu, Harlyn K ; Kulkarni, Smita ; Wen, Tom Fang ; Lindsay, Robert J ; Orellana, Liliana ; Mildvan, Donna ; Bazner, Suzane ; Streeck, Hendrik ; Alter, Galit ; Lifson, Jeffrey D ; Carrington, Mary ; Bosch, Ronald J ; Robbins, Gregory K ; Altfeld, Marcus2009 AugNat Med815
Selegiline and oxidative stress in HIV-associated cognitive impairment.Schifitto, G ; Yiannoutsos, C T ; Ernst, T ; Navia, B A ; Nath, A ; Sacktor, N ; Anderson, C ; Marra, C M ; Clifford, D B ; ACTG 5114 Team2009 Dec 8Neurology2373
Acetyl-l-carnitine and nucleoside reverse transcriptase inhibitor-associated neuropathy in HIV infection.Valcour, V ; Yeh, T-M ; Bartt, R ; Clifford, D ; Gerschenson, M ; Evans, S R ; Cohen, B A ; Ebenezer, G J ; Hauer, P ; Millar, L ; Gould, M ; Tran, P ; Shikuma, C ; Souza, S ; McArthur, J C ; AIDS Clinical Trials Group (ACTG) 5157 protocol team2009 FebHIV Med210
Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance.Marra, Christina M ; Zhao, Yu ; Clifford, David B ; Letendre, Scott ; Evans, Scott ; Henry, Katherine ; Ellis, Ronald J ; Rodriguez, Benigno ; Coombs, Robert W ; Schifitto, Giovanni ; McArthur, Justin C ; Robertson, Kevin ; AIDS Clinical Trials Group 736 Study Team2009 Jul 17AIDS1123
Effect of early versus deferred antiretroviral therapy for HIV on survival.Kitahata, Mari M ; Gange, Stephen J ; Abraham, Alison G ; Merriman, Barry ; Saag, Michael S ; Justice, Amy C ; Hogg, Robert S ; Deeks, Steven G ; Eron, Joseph J ; Brooks, John T ; Rourke, Sean B ; Gill, M John ; Bosch, Ronald J ; Martin, Jeffrey N ; Klein, Marina B ; Jacobson, Lisa P ; Rodriguez, Benigno ; Sterling, Timothy R ; Kirk, Grego2009 Apr 30N Engl J Med18360
IL1A alleles associate with a virological response to antiretroviral therapy in HIV patients beginning therapy with advanced disease.Price, Patricia ; James, Ian2009 Jun 1AIDS923
Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.Jiang, Wei ; Lederman, Michael M ; Hunt, Peter ; Sieg, Scott F ; Haley, Kathryn ; Rodriguez, Benigno ; Landay, Alan ; Martin, Jeffrey ; Sinclair, Elizabeth ; Asher, Ava I ; Deeks, Steven G ; Douek, Daniel C ; Brenchley, Jason M2009 Apr 15J Infect Dis8199
Effect of HIV-1 infection on human DNA yield from saliva.Basham, Rebecca J ; Richardson, Danielle M ; Sutcliffe, Cara B ; Haas, David W2009 Jul-AugHIV Clin Trials410
Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial.Gross, Robert ; Tierney, Camlin ; Andrade, Adriana ; Lalama, Christina ; Rosenkranz, Susan ; Eshleman, Susan H ; Flanigan, Timothy ; Santana, Jorge ; Salomon, Nadim ; Reisler, Ronald ; Wiggins, Ilene ; Hogg, Evelyn ; Flexner, Charles ; Mildvan, Donna ; AIDS Clinical Trials Group A5073 Study Team2009 Jul 13Arch Intern Med13169
A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy.Gandhi, Rajesh T ; O'Neill, David ; Bosch, Ronald J ; Chan, Ellen S ; Bucy, R Pat ; Shopis, Janet ; Baglyos, Lynn ; Adams, Elizabeth ; Fox, Lawrence ; Purdue, Lynette ; Marshak, Ann ; Flynn, Theresa ; Masih, Reena ; Schock, Barbara ; Mildvan, Donna ; Schlesinger, Sarah J ; Marovich, Mary A ; Bhardwaj, Nina ; Jacobson, Jeffrey M ; AIDS Clin2009 Oct 9Vaccine4327
Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects.Gupta, Samir K ; Komarow, Lauren ; Gulick, Roy M ; Pollard, Richard B ; Robbins, Gregory K ; Franceschini, Nora ; Szczech, Lynda A ; Koletar, Susan L ; Kalayjian, Robert C2009 Aug 15J Infect Dis4200
Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.Robbins, Gregory K ; Spritzler, John G ; Chan, Ellen S ; Asmuth, David M ; Gandhi, Rajesh T ; Rodriguez, Benigno A ; Skowron, Gail ; Skolnik, Paul R ; Shafer, Robert W ; Pollard, Richard B ; AIDS Clinical Trials Group 384 Team2009 Feb 1Clin Infect Dis348
The design and implementation of A5146, a prospective trial assessing the utility of therapeutic drug monitoring using an inhibitory quotient in antiretroviral-experienced HIV-infected patients.Demeter, Lisa M ; Mukherjee, A Lisa ; DiFrancesco, Robin ; Jiang, Hongyu ; DiCenzo, Robert ; Bastow, Barbara ; Rinehart, Alex R ; Morse, Gene D ; Albrecht, Mary2008 Jan-FebHIV Clin Trials19
Class-sparing regimens for initial treatment of HIV-1 infection.Riddler, Sharon A ; Haubrich, Richard ; DiRienzo, A Gregory ; Peeples, Lynne ; Powderly, William G ; Klingman, Karin L ; Garren, Kevin W ; George, Tania ; Rooney, James F ; Brizz, Barbara ; Lalloo, Umesh G ; Murphy, Robert L ; Swindells, Susan ; Havlir, Diane ; Mellors, John W ; AIDS Clinical Trials Group Study A5142 Team2008 May 15N Engl J Med20358
Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers.Ma, Qing ; Forrest, Alan ; Rosenkranz, Susan L ; Para, Michael F ; Yarasheski, Kevin E ; Reichman, Richard C ; Morse, Gene D ; ACTG A5043 Protocol Team, DAIDS, NIH2008 MarBiopharm Drug Dispos229
In vivo emergence of vicriviroc resistance in a human immunodeficiency virus type 1 subtype C-infected subject.Tsibris, Athe M N ; Sagar, Manish ; Gulick, Roy M ; Su, Zhaohui ; Hughes, Michael ; Greaves, Wayne ; Subramanian, Mani ; Flexner, Charles ; Giguel, Francoise ; Leopold, Kay E ; Coakley, Eoin ; Kuritzkes, Daniel R2008 AugJ Virol1682
Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV.Paul, Robert H ; Ernst, Thomas ; Brickman, Adam M ; Yiannoutsos, Constantin T ; Tate, David F ; Cohen, Ronald A ; Navia, Bradford A ; ACTG 301 team ; ACTG 700 team ; HIV MRS Consortium2008 SepJ Int Neuropsychol Soc514
Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis.De Luca, Andrea ; Ammassari, Adriana ; Pezzotti, Patrizio ; Cinque, Paola ; Gasnault, Jacques ; Berenguer, Juan ; Di Giambenedetto, Simona ; Cingolani, Antonella ; Taoufik, Yassine ; Miralles, Pilar ; Marra, Christina M ; Antinori, Andrea ; Gesida 9/99, IRINA, ACTG 363 Study Groups2008 Sep 12AIDS1422
Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial.Reynolds, Nancy R ; Testa, Marcia A ; Su, Max ; Chesney, Margaret A ; Neidig, Judith L ; Frank, Ian ; Smith, Scott ; Ickovics, Jeannette ; Robbins, Gregory K ; AIDS Clinical Trials Group 731 and 384 Teams2008 Jan 1J Acquir Immune Defic Syndr147
A statistical framework for quantile equivalence clinical trials with application to pharmacokinetic studies that bridge from HIV-infected adults to children.Pei, Lixia ; Hughes, Michael D2008 DecBiometrics464
Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk.Tebas, Pablo ; Henry, William Keith ; Matining, Roy ; Weng-Cherng, Deborah ; Schmitz, John ; Valdez, Hernan ; Jahed, Nasreen ; Myers, Laurie ; Powderly, William G ; Katzenstein, David2008PLoS One43
Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy.Stein, James H ; Komarow, Lauren ; Cotter, Bruno R ; Currier, Judith S ; Dubé, Michael P ; Fichtenbaum, Carl J ; Gerschenson, Mariana ; Mitchell, Carol K C ; Murphy, Robert L ; Squires, Kathleen ; Parker, Robert A ; Torriani, Francesca J ; ACTG 5152s Study Team2008 DecJ Clin Lipidol62
Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy.Hulgan, Todd ; Tebas, Pablo ; Canter, Jeffrey A ; Mulligan, Kathleen ; Haas, David W ; Dubé, Michael ; Grinspoon, Steven ; Robbins, Gregory K ; Motsinger, Alison A ; Kallianpur, Asha R ; AIDS Clinical Trials Group 384 and A5005s Study Teams2008 Mar 15J Infect Dis6197
Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084.Cohn, Susan E ; Umbleja, Triin ; Mrus, Joseph ; Bardeguez, Arlene D ; Andersen, Janet W ; Chesney, Margaret A2008 JanAIDS Patient Care STDS122
Evaluation of high-protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial.Sattler, Fred R ; Rajicic, Natasa ; Mulligan, Kathleen ; Yarasheski, Kevin E ; Koletar, Susan L ; Zolopa, Andrew ; Alston Smith, Beverly ; Zackin, Robert ; Bistrian, Bruce ; ACTG 392 Study Team2008 NovAm J Clin Nutr588
Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects.Twigg Iii, Homer L ; Weiden, Michael ; Valentine, Fred ; Schnizlein-Bick, Carol T ; Bassett, Roland ; Zheng, Lu ; Wheat, Joseph ; Day, Richard B ; Rominger, Helen ; Collman, Ronald G ; Fox, Lawrence ; Brizz, Barbara ; Dragavon, Joan ; Coombs, Robert W ; Bucy, R Pat ; AIDS Clinical Trials Group Protocol 723 Team2008 Jan 1J Infect Dis1197
The lymph node in HIV pathogenesis.Lederman, Michael M ; Margolis, Leonid2008 JunSemin Immunol320
Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part I: Panel design by an empiric approach.McLaughlin, Bridget E ; Baumgarth, Nicole ; Bigos, Martin ; Roederer, Mario ; De Rosa, Stephen C ; Altman, John D ; Nixon, Douglas F ; Ottinger, Janet ; Oxford, Carol ; Evans, Thomas G ; Asmuth, David M2008 MayCytometry A573
Improved measures of quality of life, lipid profile, and lipoatrophy after treatment interruption in HIV-infected patients with immune preservation: results of ACTG 5170.Skiest, Daniel J ; Krambrink, Amy ; Su, Zhaohui ; Robertson, Kevin R ; Margolis, David M ; A5170 Study Team2008 Dec 1J Acquir Immune Defic Syndr449
Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy.Davey, Richard T ; Pertel, Peter E ; Benson, Alice ; Cassell, Delanie J ; Gazzard, Brian G ; Holodniy, Mark ; Lalezari, Jacob P ; Levy, Yves ; Mitsuyasu, Ronald T ; Palella, Frank J ; Pollard, Richard B ; Rajagopalan, Prabhu ; Saag, Michael S ; Salata, Robert A ; Sha, Beverly E ; Choudhri, Shurjeel2008 FebJ Interferon Cytokine Res228
AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics.Smurzynski, Marlene ; Collier, Ann C ; Koletar, Susan L ; Bosch, Ronald J ; Wu, Kunling ; Bastow, Barbara ; Benson, Constance A2008 Jul-AugHIV Clin Trials49
Maturation of dendritic cells for enhanced activation of anti-HIV-1 CD8(+) T cell immunity.Huang, Xiao-Li ; Fan, Zheng ; Borowski, Luann ; Rinaldo, Charles R2008 JunJ Leukoc Biol683
Cord blood lipids in infants born to HIV-1-infected women treated with combination antiretroviral therapy.Melvin, Ann J ; Kang, Minhee ; Hitti, Jane ; Livingston, Elizabeth ; Cohn, Susan E ; Stocker, Vicki ; Ross, Allison C ; Watts, Heather ; McComsey, Grace A2008Antivir Ther313
Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapy.McComsey, Grace A ; Kang, Minhee ; Ross, Allison C ; Lebrecht, Dirk ; Livingston, Elizabeth ; Melvin, Ann ; Hitti, Jane ; Cohn, Susan E ; Walker, Ulrich A ; AIDS Clinical Trials Group A50842008 Mar-AprHIV Clin Trials29
Genetic analysis implicates resistin in HIV lipodystrophy.Ranade, Koustubh ; Geese, William J ; Noor, Mustafa ; Flint, Oliver ; Tebas, Pablo ; Mulligan, Kathleen ; Powderly, William ; Grinspoon, Steven K ; Dubé, Michael P2008 Aug 20AIDS1322
The influence of psychosocial characteristics and race/ethnicity on the use, duration, and success of antiretroviral therapy.Pence, Brian Wells ; Ostermann, Jan ; Kumar, Virender ; Whetten, Kathryn ; Thielman, Nathan ; Mugavero, Michael J2008 Feb 1J Acquir Immune Defic Syndr247
Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093.Watts, D Heather ; Park, Jeong-Gun ; Cohn, Susan E ; Yu, Song ; Hitti, Jane ; Stek, Alice ; Clax, Pamela A ; Muderspach, Laila ; Lertora, Juan J L2008 FebContraception277
Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience.Demeter, Lisa M ; Degruttola, Victor ; Lustgarten, Stephanie ; Bettendorf, Daniel ; Fischl, Margaret ; Eshleman, Susan ; Spreen, William ; Nguyen, Bach-Yen ; Koval, Christine E ; Eron, Joseph J ; Hammer, Scott ; Squires, Kathleen2008 Jan-FebHIV Clin Trials19
Simplification of the research diagnosis of HIV-associated sensory neuropathy.Evans, Scott R ; Clifford, David B ; Kitch, Douglas W ; Goodkin, Karl ; Schifitto, Giovanni ; McArthur, Justin C ; Simpson, David M2008 Nov-DecHIV Clin Trials69
S-phase entry leads to cell death in circulating T cells from HIV-infected persons.Sieg, Scott F ; Bazdar, Douglas A ; Lederman, Michael M2008 JunJ Leukoc Biol683
The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis.Gupta, Samir K ; Rosenkranz, Susan L ; Cramer, Yoninah S ; Koletar, Susan L ; Szczech, Lynda A ; Amorosa, Valerianna ; Hall, Stephen D2008 Oct 1AIDS1522
Second assessment of NeuroAIDS in Africa.Robertson, Kevin ; Kopnisky, Kathy ; Hakim, James ; Merry, Concepta ; Nakasujja, Noeline ; Hall, Colin ; Traore, Moussa ; Sacktor, Ned ; Clifford, David ; Newton, Charles ; Van Rie, Annelies ; Holding, Penny ; Clements, Janice ; Zink, Christine ; Mielk, Jens ; Hosseinipour, Mina ; Lalloo, Umesh ; Amod, Farida ; Marra, Christina ; Evans, Sc2008 AprJ Neurovirol214
CD4+ T-cell decline after the interruption of antiretroviral therapy in ACTG A5170 is predicted by differential expression of genes in the ras signaling pathway.Vahey, Maryanne T ; Wang, Zhining ; Su, Zhaohui ; Nau, Martin E ; Krambrink, Amy ; Skiest, Daniel J ; Margolis, David M2008 AugAIDS Res Hum Retroviruses824
Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis.Funderburg, Nicholas ; Luciano, Angel A ; Jiang, Wei ; Rodriguez, Benigno ; Sieg, Scott F ; Lederman, Michael M2008PLoS One43
Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s.Torriani, Francesca J ; Komarow, Lauren ; Parker, Robert A ; Cotter, Bruno R ; Currier, Judith S ; Dubé, Michael P ; Fichtenbaum, Carl J ; Gerschenson, Mariana ; Mitchell, Carol K C ; Murphy, Robert L ; Squires, Kathleen ; Stein, James H ; ACTG 5152s Study Team2008 Aug 12J Am Coll Cardiol752
Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects.Kuritzkes, Daniel R ; Lalama, Christina M ; Ribaudo, Heather J ; Marcial, Michelle ; Meyer, William A ; Shikuma, Cecilia ; Johnson, Victoria A ; Fiscus, Susan A ; D'Aquila, Richard T ; Schackman, Bruce R ; Acosta, Edward P ; Gulick, Roy M2008 Mar 15J Infect Dis6197
Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186.Gerber, John G ; Kitch, Douglas W ; Fichtenbaum, Carl J ; Zackin, Robert A ; Charles, Stéphannie ; Hogg, Evelyn ; Acosta, Edward P ; Connick, Elizabeth ; Wohl, David ; Kojic, E Milu ; Benson, Constance A ; Aberg, Judith A2008 Apr 1J Acquir Immune Defic Syndr447
Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro.Koelsch, Kersten K ; Liu, Lin ; Haubrich, Richard ; May, Susanne ; Havlir, Diane ; Günthard, Huldrych F ; Ignacio, Caroline C ; Campos-Soto, Paula ; Little, Susan J ; Shafer, Robert ; Robbins, Gregory K ; D'Aquila, Richard T ; Kawano, Yuji ; Young, Karen ; Dao, Phillip ; Spina, Celsa A ; Richman, Douglas D ; Wong, Joseph K2008 Feb 1J Infect Dis3197
Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy.Hare, C Bradley ; Mellors, John ; Krambrink, Amy ; Su, Zhaohui ; Skiest, Daniel ; Margolis, David M ; Patel, Sheran S ; Barnas, Douglas ; Frenkel, Lisa ; Coombs, Robert W ; Aweeka, Francesca ; Morse, Gene D ; Haas, David W ; Boltz, Valerie ; Palmer, Sarah ; Coffin, John ; Havlir, Diane V2008 Aug 1Clin Infect Dis347
Effect of low-dose ritonavir on the pharmacokinetics of the CXCR4 antagonist AMD070 in healthy volunteers.Cao, Ying Jun ; Flexner, Charles W ; Dunaway, Shelia ; Park, Jeong-Gun ; Klingman, Karin ; Wiggins, Ilene ; Conley, Jeanne ; Radebaugh, Christine ; Kashuba, Angela D ; MacFarland, Ron ; Becker, Stephen ; Hendrix, Craig W2008 MayAntimicrob Agents Chemother552
Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part II: Panel performance across different instrument platforms.McLaughlin, Bridget E ; Baumgarth, Nicole ; Bigos, Martin ; Roederer, Mario ; De Rosa, Stephen C ; Altman, John D ; Nixon, Douglas F ; Ottinger, Janet ; Li, Judy ; Beckett, Laurel ; Shacklett, Barbara L ; Evans, Thomas G ; Asmuth, David M2008 MayCytometry A573
Effect of low-dose IL-2 immunotherapy on frequency and phenotype of regulatory T cells and NK cells in HIV/HCV-coinfected patients.Velilla, P A ; Shata, M T ; Lages, C S ; Ying, J ; Fichtenbaum, C J ; Chougnet, C2008 JanAIDS Res Hum Retroviruses124
Efavirenz-based regimens in treatment-naive patients with a range of pretreatment HIV-1 RNA levels and CD4 cell counts.Ribaudo, Heather J ; Kuritzkes, Daniel R ; Lalama, Christina M ; Schouten, Jeffrey T ; Schackman, Bruce R ; Acosta, Edward P ; Gulick, Roy M2008 Apr 1J Infect Dis7197
Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease.Kalayjian, Robert C ; Franceschini, Nora ; Gupta, Samir K ; Szczech, Lynda A ; Mupere, Ezekiel ; Bosch, Ronald J ; Smurzynski, Marlene ; Albert, Jeffrey M2008 Feb 19AIDS422
The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathy.Canter, J A ; Haas, D W ; Kallianpur, A R ; Ritchie, M D ; Robbins, G K ; Shafer, R W ; Clifford, D B ; Murdock, D G ; Hulgan, T2008 FebPharmacogenomics J18
Genotypic susceptibility scores and HIV type 1 RNA responses in treatment-experienced subjects with HIV type 1 infection.Anderson, Jeffrey A ; Jiang, Hongyu ; Ding, Xiao ; Petch, Leslie ; Journigan, Terri ; Fiscus, Susan A ; Haubrich, Richard ; Katzenstein, David ; Swanstrom, Ronald ; Gulick, Roy M ; AIDS Clinical Trials Group Study 359 Protocol Team2008 MayAIDS Res Hum Retroviruses524
Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV.Collier, Ann C ; Tierney, Camlin ; Downey, Gerald F ; Eshleman, Susan H ; Kashuba, Angela ; Klingman, Karin ; Vergis, Emanuel N ; Pakes, Gary E ; Rooney, James F ; Rinehart, Alex ; Mellors, John W ; AIDS Clinical Trials Group Protocol A5143 Team2008 Mar-AprHIV Clin Trials29
Assessing multiple-group diagnostic problems with multi-dimensional receiver operating characteristic surfaces: application to proton MR Spectroscopy (MRS) in HIV-related neurological injury.Yiannoutsos, Constantin T ; Nakas, Christos T ; Navia, Bradford A ; proton MRS Consortium2008 Mar 1Neuroimage140
A randomized trial evaluating Prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain.Evans, Scott R ; Simpson, David M ; Kitch, Douglas W ; King, Agnes ; Clifford, David B ; Cohen, Bruce A ; McArthur, Justin C ; Neurologic AIDS Research Consortium ; AIDS Clinical Trials Group2007PLoS One62
Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial.Schackman, Bruce R ; Scott, Callie A ; Sax, Paul E ; Losina, Elena ; Wilkin, Timothy J ; McKinnon, John E ; Swindells, Susan ; Weinstein, Milton C ; Freedberg, Kenneth A2007 Oct 15Clin Infect Dis845
Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily.Acosta, Edward P ; Kendall, Michelle A ; Gerber, John G ; Alston-Smith, Beverly ; Koletar, Susan L ; Zolopa, Andrew R ; Agarwala, Sangeeta ; Child, Michael ; Bertz, Richard ; Hosey, Lara ; Haas, David W2007 SepAntimicrob Agents Chemother951
The role of early viral decline in the treatment of hepatitis C in HIV-1-coinfected persons.Kang, Minhee ; Chung, Raymond T2007 Nov 1J Acquir Immune Defic Syndr346
Non-nucleoside phenotypic hypersusceptibility cut-point determination from ACTG 359.Haubrich, Richard H ; Jiang, Hongyu ; Swanstrom, Ronald ; Bates, Michael ; Katzenstein, David ; Petch, Leslie ; Fletcher, Courtney V ; Fiscus, Susan A ; Gulick, Roy M ; AIDS Clinical Trials Group Protocol 359 Team2007 Mar-AprHIV Clin Trials28
Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090.Evans, Scott R ; Yeh, Tzu-min ; Sacktor, Ned ; Clifford, David B ; Simpson, David ; Miller, Eric N ; Ellis, Ronald J ; Valcour, Victor ; Marra, Christina M ; Millar, Linda ; Schifitto, Giovanni ; AIDS Clinical Trials Group and the Neurologic AIDS Research Consortium2007 Nov-DecHIV Clin Trials68
Comparative efficacy of nucleoside/nucleotide reverse transcriptase inhibitors in combination with efavirenz: results of a systematic overview.Bartlett, John A ; Chen, Shan-Shan ; Quinn, Joseph B2007 Jul-AugHIV Clin Trials48
Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks.Okusanya, Olanrewaju ; Forrest, Alan ; DiFrancesco, Robin ; Bilic, Sanela ; Rosenkranz, Susan ; Para, Michael F ; Adams, Elizabeth ; Yarasheski, Kevin E ; Reichman, Richard C ; Morse, Gene D ; ACTG 5043 Protocol Team2007 MayAntimicrob Agents Chemother551
Monitoring clinical trials of therapeutic vaccines in HIV infection: role of treatment interruption.Lederman, Michael M ; Penn-Nicholson, Adam ; Stone, Shelley F ; Sieg, Scott F ; Rodriguez, Benigno2007 JanCurr Opin HIV AIDS12
Nonparametric tests for two-group comparisons of dependent observations obtained at varying time points.May, Susanne ; Degruttola, Victor2007 MarBiometrics163
Protease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS Clinical Trials Group A5084.Hitti, Jane ; Andersen, Janet ; McComsey, Grace ; Liu, Tun ; Melvin, Ann ; Smith, Laura ; Stek, Alice ; Aberg, Judith ; Hull, Andrew ; Alston-Smith, Beverly ; Watts, D Heather ; Livingston, Elizabeth ; AIDS Clinical Trials Group 5084 Study Team2007 AprAm J Obstet Gynecol4196
Pretreatment factors associated with 3-year (144-week) virologic and immunologic responses to potent antiretroviral therapy.Bosch, Ronald J ; Bennett, Kara ; Collier, Ann C ; Zackin, Robert ; Benson, Constance A2007 Mar 1J Acquir Immune Defic Syndr344
Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.Skiest, Daniel J ; Su, Zhaohui ; Havlir, Diane V ; Robertson, Kevin R ; Coombs, Robert W ; Cain, Pat ; Peterson, Tianna ; Krambrink, Amy ; Jahed, Nasreen ; McMahon, Deborah ; Margolis, David M ; AIDS Clinical Trials Group 5170 Study Team2007 May 15J Infect Dis10195
Combining cross-sectional and prospective data methods to improve transition parameter estimation for characterizing the accumulation of HIV-1 drug resistance mutations.Healy, Brian ; De Gruttola, Victor ; Pagano, Marcello2007 SepBiometrics363
Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions.Cohn, S E ; Park, J-G ; Watts, D H ; Stek, A ; Hitti, J ; Clax, P A ; Yu, S ; Lertora, J J L ; ACTG A5093 Protocol Team2007 FebClin Pharmacol Ther281
Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095).Shikuma, Cecilia M ; Yang, Yang ; Glesby, Marshall J ; Meyer, William A ; Tashima, Karen T ; Ribaudo, Heather J ; Webb, Nancy ; Bastow, Barbara ; Kuritzkes, Daniel R ; Gulick, Roy M2007 Apr 15J Acquir Immune Defic Syndr544
Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.Mulligan, Kathleen ; Zackin, Robert ; Von Roenn, Jamie H ; Chesney, Margaret A ; Egorin, Merrill J ; Sattler, Fred R ; Benson, Constance A ; Liu, Tun ; Umbleja, Triin ; Shriver, Sharon ; Auchus, Richard J ; Schambelan, Morris ; ACTG 313 Study Team2007 FebJ Clin Endocrinol Metab292
Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity.Paul, Robert H ; Yiannoutsos, Constantin T ; Miller, Eric N ; Chang, Linda ; Marra, Christina M ; Schifitto, Giovanni ; Ernst, Thomas ; Singer, Elyse ; Richards, Todd ; Jarvik, G Jeffrey ; Price, Richard ; Meyerhoff, Dieter J ; Kolson, Dennis ; Ellis, Ronald J ; Gonzalez, Gilberto ; Lenkinski, Robert E ; Cohen, Ronald A ; Navia, Bradford A2007 SummerJ Neuropsychiatry Clin Neurosci319
Childhood abuse and initial presentation for HIV care: an opportunity for early intervention.Mugavero, M J ; Pence, B W ; Whetten, K ; Leserman, J ; Swartz, M ; Stangl, D ; Thielman, N M2007 OctAIDS Care919
Nonparametric estimation of the mean function of a stochastic process with missing observations.Hu, X Joan ; Lagakos, Stephen W2007 MarLifetime Data Anal113
Antiretroviral Drug Levels and Interactions Affect Lipid, Lipoprotein, and Glucose Metabolism in HIV-1 Seronegative Subjects: A Pharmacokinetic-Pharmacodynamic Analysis.Rosenkranz, Susan L ; Yarasheski, Kevin E ; Para, Michael F ; Reichman, Richard C ; Morse, Gene D2007 JunMetab Syndr Relat Disord25
Effect of antiretroviral therapy and hepatitis c co-infection on changes in lipid levels in HIV-Infected patients 48 weeks after initiation of therapy.Stapleton, J T ; Bennett, K ; Bosch, R J ; Polgreen, P M ; Swindells, S2007 Nov-DecHIV Clin Trials68
TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection.Yonkers, Nicole L ; Rodriguez, Benigno ; Milkovich, Kimberly A ; Asaad, Robert ; Lederman, Michael M ; Heeger, Peter S ; Anthony, Donald D2007 Apr 1J Immunol7178
Minorities, the poor, and survivors of abuse: HIV-infected patients in the US deep South.Pence, Brian Wells ; Reif, Susan ; Whetten, Kathryn ; Leserman, Jane ; Stangl, Dalene ; Swartz, Marvin ; Thielman, Nathan ; Mugavero, Michael J2007 NovSouth Med J11100
Physicians' attitudes toward homosexuality and HIV: survey of a California Medical Society- revisited (PATHH-II).Smith, Davey M ; Mathews, Wm Christopher2007J Homosex3-452
Discrete stochastic models for compliance analysis based on an AIDS Clinical Trial Group (ACTG) study.Sun, Junfeng ; Nagaraj, H N ; Reynolds, Nancy R2007 AugBiom J549
Virologic characterization of HIV type 1 with a codon 70 deletion in reverse transcriptase.Hu, Zixin ; Hatano, Hiroyu ; Hammond, Sarah P ; Smith, Danielle ; Wild, Mary ; Gupta, Soumi ; Whitcomb, Jeannette ; Kalayjian, Robert C ; Gripshover, Barbara ; Kuritzkes, Daniel R2007 Aug 15J Acquir Immune Defic Syndr545
Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s).Tebas, Pablo ; Zhang, Jiameng ; Yarasheski, Kevin ; Evans, Scott ; Fischl, Margaret A ; Shevitz, Abby ; Feinberg, Judith ; Collier, Ann C ; Shikuma, Cecilia ; Brizz, Barbara ; Sattler, Fred ; AIDS Clinical Trials Group (ACTG)2007 Jun 1J Acquir Immune Defic Syndr245
HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients.McCutchan, J Allen ; Wu, Julia W ; Robertson, Kevin ; Koletar, Susan L ; Ellis, Ronald J ; Cohn, Susan ; Taylor, Michael ; Woods, Steven ; Heaton, Robert ; Currier, Judith ; Williams, Paige L2007 May 31AIDS921
Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of Adult Clinical Trials Group 384.Dubé, Michael P ; Komarow, Lauren ; Mulligan, Kathleen ; Grinspoon, Steven K ; Parker, Robert A ; Robbins, Gregory K ; Roubenoff, Ronenn ; Tebas, Pablo ; Adult Clinical Trials Group 3842007 Aug 15J Acquir Immune Defic Syndr545
Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen.Fischl, Margaret A ; Collier, Ann C ; Mukherjee, A Lisa ; Feinberg, Judith E ; Demeter, Lisa M ; Tebas, Pablo ; Giuliano, Marina ; Dehlinger, Marjorie ; Garren, Kevin ; Brizz, Barbara ; Bassett, Roland2007 Jan 30AIDS321
Improving data reliability using a non-compliance detection method versus using pharmacokinetic criteria.Kshirsagar, Smita A ; Blaschke, Terrence F ; Sheiner, Lewis B ; Krygowski, M ; Acosta, Edward P ; Verotta, Davide2007 FebJ Pharmacokinet Pharmacodyn134
Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study.Schifitto, Giovanni ; Navia, Bradford A ; Yiannoutsos, Constantin T ; Marra, Christina M ; Chang, Linda ; Ernst, Thomas ; Jarvik, Jeffrey G ; Miller, Eric N ; Singer, Elyse J ; Ellis, Ronald J ; Kolson, Dennis L ; Simpson, David ; Nath, Avindra ; Berger, Joseph ; Shriver, Sharon L ; Millar, Linda L ; Colquhoun, Dodi ; Lenkinski, Robert ; G2007 Sep 12AIDS1421
Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application.Keil, Kim ; Hochreitter, Jill ; DiFrancesco, Robin ; Zingman, Barry S ; Reichman, Richard C ; Fischl, Margaret A ; Gripshover, Barbara ; Morse, Gene D2007 FebTher Drug Monit129
Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384.Dubé, Michael P ; Parker, Robert A ; Mulligan, Kathleen ; Tebas, Pablo ; Robbins, Gregory K ; Roubenoff, Ronenn ; Grinspoon, Steven K2007 Jul 1Clin Infect Dis145
Hidden Markov models for settings with interval-censored transition times and uncertain time origin: application to HIV genetic analyses.Healy, Brian ; Degruttola, Victor2007 AprBiostatistics28
A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment.Schifitto, G ; Zhang, J ; Evans, S R ; Sacktor, N ; Simpson, D ; Millar, L L ; Hung, V L ; Miller, E N ; Smith, E ; Ellis, R J ; Valcour, V ; Singer, E ; Marra, C M ; Kolson, D ; Weihe, J ; Remmel, R ; Katzenstein, D ; Clifford, D B ; ACTG A5090 Team2007 Sep 25Neurology1369
Plasma HIV-1 RNA dynamics in antiretroviral-naive subjects receiving either triple-nucleoside or efavirenz-containing regimens: ACTG A5166s.Kuritzkes, Daniel R ; Ribaudo, Heather J ; Squires, Kathleen E ; Koletar, Susan L ; Santana, Jorge ; Riddler, Sharon A ; Reichman, Richard ; Shikuma, Cecilia ; Meyer, William A ; Klingman, Karin L ; Gulick, Roy M ; ACTG A5166s Protocol Team2007 Apr 15J Infect Dis8195
Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.Bhasin, Shalender ; Parker, Robert A ; Sattler, Fred ; Haubrich, Richard ; Alston, Beverly ; Umbleja, Triin ; Shikuma, Cecilia M ; AIDS Clinical Trials Group Protocol A5079 Study Team2007 MarJ Clin Endocrinol Metab392
Factors associated with early study discontinuation in AACTG studies, DACS 200.Andersen, Janet W ; Fass, Robert ; van der Horst, Charles2007 SepContemp Clin Trials528
Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team.Aweeka, F T ; Kang, M ; Yu, J-Y ; Lizak, P ; Alston, B ; Chung, R T ; AIDS Clinical Trials Group 5092s Study Team2007 JulHIV Med58
Comparison of direct and indirect measurement of LDL-C in HIV-infected individuals: ACTG 5087.Evans, Scott R ; Fichtenbaum, Carl J ; Aberg, Judith A ; A5087 Study Team2007 Jan-FebHIV Clin Trials18
Racial differences in virologic failure associated with adherence and quality of life on efavirenz-containing regimens for initial HIV therapy: results of ACTG A5095.Schackman, Bruce R ; Ribaudo, Heather J ; Krambrink, Amy ; Hughes, Valery ; Kuritzkes, Daniel R ; Gulick, Roy M2007 Dec 15J Acquir Immune Defic Syndr546
Challenges in using observational studies to evaluate adverse effects of treatment.Hughes, Michael D ; Williams, Paige L2007 Apr 26N Engl J Med17356
Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects.Behler, Caroline M ; Vittinghoff, Eric ; Lin, Feng ; Chung, Raymond T ; Peters, Marion G ; Robbins, Gregory K ; Volberding, Paul A2007 May 15Clin Infect Dis1044
A truvada hypersensitivity reaction simulating abacavir hypersensitivity.de Perio, Marie A ; Gomez, Francisco J ; Frame, Peter T ; Fichtenbaum, Carl J2007 Oct 18AIDS1621
More on the treatment-tropism relationship: the impact of prior antiretroviral treatment on HIV coreceptor tropism among subjects entering AIDS clinical trials group 175.Shulman, Nancy S ; Kassaye, Seble G ; Winters, Mark A ; Johnston, Elizabeth ; Katzenstein, David A2007 Jul 15J Infect Dis2196
A comparison of three initial antiretroviral AIDS regimens.Ribaudo, Heather J ; Kuritzkes, Daniel R ; Gulick, Roy M2007 Sep 6N Engl J Med10357
Educational attainment and response to HAART during initial therapy for HIV-1 infection.Marc, Linda G ; Testa, Marcia A ; Walker, Alexander M ; Robbins, Gregroy K ; Shafer, Robert W ; Anderson, Norman B ; Berkman, Lisa F ; ACTG Data Analysis Concept Sheet Study Team2007 AugJ Psychosom Res263
Serosorting can potentially increase HIV transmissions.Butler, David M ; Smith, Davey M2007 May 31AIDS921
Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211.Gulick, Roy M ; Su, Zhaohui ; Flexner, Charles ; Hughes, Michael D ; Skolnik, Paul R ; Wilkin, Timothy J ; Gross, Robert ; Krambrink, Amy ; Coakley, Eoin ; Greaves, Wayne L ; Zolopa, Andrew ; Reichman, Richard ; Godfrey, Catherine ; Hirsch, Martin ; Kuritzkes, Daniel R ; AIDS Clinical Trials Group 5211 Team2007 Jul 15J Infect Dis2196
The use of beta-D-2,6-diaminopurine dioxolane with or without mycophenolate mofetil in drug-resistant HIV infection.Margolis, David M ; Mukherjee, A Lisa ; Fletcher, Courtney V ; Hogg, Evelyn ; Ogata-Arakaki, Debra ; Petersen, Tianna ; Rusin, David ; Martinez, Ana ; Mellors, John W2007 Oct 1AIDS1521
HIV drug development: the next 25 years.Flexner, Charles2007 DecNat Rev Drug Discov126
The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.Mitsuyasu, Ronald ; Gelman, Rebecca ; Cherng, Deborah Weng ; Landay, Alan ; Fahey, John ; Reichman, Richard ; Erice, Alejo ; Bucy, R Pat ; Kilby, J Michael ; Lederman, Michael M ; Hamilton, Carol D ; Lertora, Juan ; White, Becky L ; Tebas, Pablo ; Duliege, Anne-Marie ; Pollard, Richard B ; AIDS Clinical Trials Group 328 Study Team2007 Mar 26Arch Intern Med6167
Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects.Stone, Nimalie D ; Dunaway, Shelia B ; Flexner, Charles ; Tierney, Camlin ; Calandra, Gary B ; Becker, Stephen ; Cao, Ying-Jun ; Wiggins, Ilene P ; Conley, Jeanne ; MacFarland, Ron T ; Park, Jeong-Gun ; Lalama, Christina ; Snyder, Sally ; Kallungal, Beatrice ; Klingman, Karin L ; Hendrix, Craig W2007 JulAntimicrob Agents Chemother751
A resampling-based approach to multiple testing with uncertainty in phase.Foulkes, Andrea S ; DeGruttola, Victor G2007Int J Biostat13
Optimizing measurement of self-reported adherence with the ACTG Adherence Questionnaire: a cross-protocol analysis.Reynolds, Nancy R ; Sun, Junfeng ; Nagaraja, Haikady N ; Gifford, Allen L ; Wu, Albert W ; Chesney, Margaret A2007 Dec 1J Acquir Immune Defic Syndr446
Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio.Mulligan, Kathleen ; Yang, Yang ; Wininger, David A ; Koletar, Susan L ; Parker, Robert A ; Alston-Smith, Beverly L ; Schouten, Jeffrey T ; Fielding, Roger A ; Basar, Michael T ; Grinspoon, Steven2007 Jan 2AIDS121
Viral factors associated with cytokine expression during HCV/HIV co-infection.Blackard, Jason T ; Kang, Minhee ; St Clair, J Benjamin ; Lin, Wenyu ; Kamegaya, Yoshitaka ; Sherman, Kenneth E ; Koziel, Margaret James ; Peters, Marion G ; Andersen, Janet ; Chung, Raymond T ; Aids Clinical Trials Group A5071 Study Team2007 AprJ Interferon Cytokine Res427
The effect of lamivudine therapy and M184V on the antiretroviral activity of didanosine.Eron, Joseph J ; Bosch, Ronald J ; Bettendorf, Daniel ; Petch, Leslie ; Fiscus, Susan ; Frank, Ian ; Adult Clinical Trials Group 307 Protocol Team2007 Jun 1J Acquir Immune Defic Syndr245
The prevalence and incidence of neurocognitive impairment in the HAART era.Robertson, Kevin R ; Smurzynski, Marlene ; Parsons, Thomas D ; Wu, Kunling ; Bosch, Ronald J ; Wu, Julia ; McArthur, Justin C ; Collier, Ann C ; Evans, Scott R ; Ellis, Ron J2007 Sep 12AIDS1421
Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy.Moore, Jeff D ; Acosta, Edward P ; Johnson, Victoria A ; Bassett, Roland ; Eron, Joseph J ; Fischl, Margaret A ; Long, Mary C ; Kuritzkes, Daniel R ; Sommadossi, Jean-Pierre2007Antivir Ther612
Clinical utility of HIV standard genotyping among antiretroviral-naive individuals with unknown duration of infection.Smith, Davey ; Moini, Niousha ; Pesano, Rick ; Cachay, Edward ; Aiem, Heidi ; Lie, Yolanda ; Richman, Douglas ; Little, Susan2007 Feb 1Clin Infect Dis344
Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2.Funderburg, Nicholas ; Lederman, Michael M ; Feng, Zhimin ; Drage, Michael G ; Jadlowsky, Julie ; Harding, Clifford V ; Weinberg, Aaron ; Sieg, Scott F2007 Nov 20Proc Natl Acad Sci U S A47104
Antiretroviral therapy for HIV-1-infected children in Haiti.George, Erik ; Noël, Francine ; Bois, Gyrlande ; Cassagnol, Rachelle ; Estavien, Louise ; Rouzier, Patricia De Matteis ; Verdier, Rose I ; Johnson, Warren D ; Pape, Jean W ; Fitzgerald, Daniel W ; Wright, Peter F2007 May 15J Infect Dis10195
Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).Gange, Stephen J ; Kitahata, Mari M ; Saag, Michael S ; Bangsberg, David R ; Bosch, Ronald J ; Brooks, John T ; Calzavara, Liviana ; Deeks, Steven G ; Eron, Joseph J ; Gebo, Kelly A ; Gill, M John ; Haas, David W ; Hogg, Robert S ; Horberg, Michael A ; Jacobson, Lisa P ; Justice, Amy C ; Kirk, Gregory D ; Klein, Marina B ; Martin, Jeffrey 2007 AprInt J Epidemiol236
Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection.Critchfield, J William ; Lemongello, Donna ; Walker, Digna H ; Garcia, Juan C ; Asmuth, David M ; Pollard, Richard B ; Shacklett, Barbara L2007 JunJ Virol1181
Maintenance of Nef-mediated modulation of major histocompatibility complex class I and CD4 after sexual transmission of human immunodeficiency virus type 1.Noviello, C M ; Pond, S L Kosakovsky ; Lewis, M J ; Richman, D D ; Pillai, S K ; Yang, O O ; Little, S J ; Smith, D M ; Guatelli, J C2007 MayJ Virol981
Herpes simplex virus type 2 infection does not influence viral dynamics during early HIV-1 infection.Cachay, Edward R ; Frost, Simon D W ; Richman, Douglas D ; Smith, Davey M ; Little, Susan J2007 May 1J Infect Dis9195
A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS Clinical Trials Group Study A5115.Riddler, Sharon A ; Jiang, Hongyu ; Tenorio, Allan ; Huang, Hairong ; Kuritzkes, Daniel R ; Acosta, Edward P ; Landay, Alan ; Bastow, Barbara ; Haas, David W ; Tashima, Karen T ; Jain, Mamta K ; Deeks, Steven G ; Bartlett, John A2007Antivir Ther412
Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression.Gulick, Roy M ; Lalama, Christina M ; Ribaudo, Heather J ; Shikuma, Cecilia M ; Schackman, Bruce R ; Schouten, Jeffrey ; Squires, Kathleen E ; Koletar, Susan L ; Pilcher, Christopher D ; Reichman, Richard C ; Klingman, Karin L ; Kuritzkes, Daniel R2007 Apr 23AIDS721
Lipids and lactate in human immunodeficiency virus-1 infected pregnancies with or without protease inhibitor-based therapy.Livingston, Elizabeth G ; Cohn, Susan E ; Yang, Yang ; Watts, Heather D ; Bardeguez, Arlene D ; Jones, Theodore B ; Smith, Laura M ; Umbleja, Triin ; McComsey, Grace A2007 AugObstet Gynecol2 Pt 1110
Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.McComsey, Grace A ; Kendall, Michelle A ; Tebas, Pablo ; Swindells, Susan ; Hogg, Evelyn ; Alston-Smith, Beverly ; Suckow, Carol ; Gopalakrishnan, Geetha ; Benson, Constance ; Wohl, David A2007 Nov 30AIDS1821
Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults.Currier, Judith S ; Kendall, Michelle A ; Henry, W Keith ; Alston-Smith, Beverly ; Torriani, Francesca J ; Tebas, Pablo ; Li, Yanjie ; Hodis, Howard N2007 May 31AIDS921
A new approach for 'deep salvage' trials in advanced HIV infection.Lederman, Michael M ; Miller, Veronica ; Weller, Ian ; Deeks, Steven G2007 Jul 31AIDS1221
Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy.Zhou, L ; Kitch, D W ; Evans, S R ; Hauer, P ; Raman, S ; Ebenezer, G J ; Gerschenson, M ; Marra, C M ; Valcour, V ; Diaz-Arrastia, R ; Goodkin, K ; Millar, L ; Shriver, S ; Asmuth, D M ; Clifford, D B ; Simpson, D M ; McArthur, J C ; NARC and ACTG A5117 Study Group2007 Jun 12Neurology2468
Predictors of AIDS-related morbidity and mortality in a southern U.S. Cohort.Mugavero, Michael J ; Pence, Brian Wells ; Whetten, Kathryn ; Leserman, Jane ; Swartz, Marvin ; Stangl, Dalene ; Thielman, Nathan M2007 SepAIDS Patient Care STDS921
Effect of hydroxyurea and dideoxyinosine on intracellular 3'-deoxyadenosine-5'-triphosphate concentrations in HIV-infected patients.Bakshi, Rahul P ; Hamzeh, Fayez ; Frank, Ian ; Eron, Joseph J ; Bosch, Ronald J ; Rosenkranz, Susan L ; Cramer, Yoninah S ; Ussery, Michael ; Flexner, Charles2007 NovAIDS Res Hum Retroviruses1123
Real-time nucleic acid sequence-based amplification assay to quantify changes in mitochondrial DNA concentrations in cell cultures and blood cells from HIV-infected patients receiving antiviral therapy.Timmermans, Eveline C ; Tebas, Pablo ; Ruiter, Jos P N ; Wanders, Ronald J A ; de Ronde, Anthony ; de Baar, Michel P2006 JunClin Chem652
The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine.Aweeka, Francesca T ; Rosenkranz, Susan L ; Segal, Yoninah ; Coombs, Robert W ; Bardeguez, Arlene ; Thevanayagam, Lourdes ; Lizak, Patricia ; Aberg, Judith ; Watts, D Heather ; NIAID AIDS Clinical Trials Group2006 Sep 11AIDS1420
Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission.Palmer, S ; Boltz, V ; Martinson, N ; Maldarelli, F ; Gray, G ; McIntyre, J ; Mellors, J ; Morris, L ; Coffin, J2006 May 2Proc Natl Acad Sci U S A18103
Safety and efficacy of extended-release niacin for the treatment of dyslipidaemia in patients with HIV infection: AIDS Clinical Trials Group Study A5148.Dubé, Michael P ; Wu, Julia W ; Aberg, Judith A ; Deeg, Mark A ; Alston-Smith, Beverly L ; McGovern, Mark E ; Lee, Daniel ; Shriver, Sharon L ; Martinez, Ana I ; Greenwald, Martha ; Stein, James H ; AIDS Clinical Trials Group A5148 Study Team2006Antivir Ther811
Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency.Halvas, Elias K ; Aldrovandi, Grace M ; Balfe, Peter ; Beck, Ingrid A ; Boltz, Valerie F ; Coffin, John M ; Frenkel, Lisa M ; Hazelwood, J Darren ; Johnson, Victoria A ; Kearney, Mary ; Kovacs, Andrea ; Kuritzkes, Daniel R ; Metzner, Karin J ; Nissley, Dwight V ; Nowicki, Marek ; Palmer, Sarah ; Ziermann, Rainer ; Zhao, Richard Y ; Jenning2006 JulJ Clin Microbiol744
Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS Clinical Trials Group A5138.Lederman, Michael M ; Smeaton, Laura ; Smith, Kim Y ; Rodriguez, Benigno ; Pu, Minya ; Wang, Hongying ; Sevin, Anne ; Tebas, Pablo ; Sieg, Scott F ; Medvik, Kathy ; Margolis, David M ; Pollard, Richard ; Ertl, Hildegund C J ; Valdez, Hernan2006 Dec 15J Infect Dis12194
Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy.Palmer, Sarah ; Boltz, Valerie ; Maldarelli, Frank ; Kearney, Mary ; Halvas, Elias K ; Rock, Diane ; Falloon, Judith ; Davey, Richard T ; Dewar, Robin L ; Metcalf, Julia A ; Mellors, John W ; Coffin, John M2006 Mar 21AIDS520
HIV coinfection impairs CD28-mediated costimulation of hepatitis C virus-specific CD8 cells.Yonkers, Nicole L ; Rodriguez, Benigno ; Post, Anthony B ; Asaad, R ; Jones, Linda ; Lederman, Michael M ; Lehmann, Paul V ; Anthony, Donald D2006 Aug 1J Infect Dis3194
Statistical determination of threshold for cellular division in the CFSE-labeling assay.Liu, Dacheng ; Yu, Jie ; Chen, Huiyuan ; Reichman, Richard ; Wu, Hulin ; Jin, Xia2006 May 30J Immunol Methods1-2312
Changes in the slope of the CD4 cell count increase after initiation of potent antiretroviral treatment.Bosch, Ronald J ; Wang, Rui ; Vaida, Florin ; Lederman, Michael M ; Albrecht, Mary A2006 Dec 1J Acquir Immune Defic Syndr443
A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024).Kilby, J Michael ; Bucy, R Pat ; Mildvan, Donna ; Fischl, Margaret ; Santana-Bagur, Jorge ; Lennox, Jeff ; Pilcher, Chris ; Zolopa, Andrew ; Lawrence, Jody ; Pollard, Richard B ; Habib, Raphaelle El ; Sahner, David ; Fox, Lawrence ; Aga, Evgenia ; Bosch, Ronald J ; Mitsuyasu, Ronald ; Adult AIDS Clinical Trials Group A5024 Protocol Team2006 Dec 15J Infect Dis12194
Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy.Siddique, M Atif ; Hartman, Kelly E ; Dragileva, Ella ; Dondero, Marla ; Gebretsadik, Tebeb ; Shintani, Ayumi ; Peiperl, Laurence ; Valentine, Fred ; Kalams, Spyros A2006 Sep 1J Infect Dis5194
HIV and aging.Shah, Sanjiv ; Mildvan, Donna2006 MayCurr Infect Dis Rep38
Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection.Graham, Camilla S ; Wells, Annalee ; Liu, Tun ; Sherman, Kenneth E ; Peters, Marion ; Chung, Raymond T ; Bhan, Atul K ; Andersen, Janet ; Koziel, Margaret James ; ACTG 5071 Study Team2006 Feb 14AIDS320
Robust analysis of biomarker data with informative missingness using a two-stage hypothesis test in an HIV treatment interruption trial: AIEDRP AIN503/ACTG A5217.Messer, Karen ; Vaida, Florin ; Hogan, Christine2006 DecContemp Clin Trials627
Hierarchical Bayesian methods for estimation of parameters in a longitudinal HIV dynamic system.Huang, Yangxin ; Liu, Dacheng ; Wu, Hulin2006 JunBiometrics262
A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy.Schifitto, Giovanni ; Yiannoutsos, Constantin T ; Simpson, David M ; Marra, Christina M ; Singer, Elyse J ; Kolson, Dennis L ; Nath, Avindra ; Berger, Joseph R ; Navia, Bradford ; Adult AIDS Clinical Trials Group (ACTG) 301 tEAM2006 AugJ Neurovirol412
Pharmacokinetic interaction between nelfinavir and pravastatin in HIV-seronegative volunteers: ACTG Study A5108.Aberg, Judith A ; Rosenkranz, Susan L ; Fichtenbaum, Carl J ; Alston, Beverly L ; Brobst, Susan W ; Segal, Yoninah ; Gerber, John G ; ACTG A5108 team2006 Mar 21AIDS520
Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole.Wheat, L Joseph ; Connolly, Patricia ; Smedema, Melinda ; Durkin, Michelle ; Brizendine, Edward ; Mann, Paul ; Patel, Reena ; McNicholas, Paul M ; Goldman, Mitchell2006 JunJ Antimicrob Chemother657
Pharmacodynamics of antiretroviral agents in HIV-1 infected patients: using viral dynamic models that incorporate drug susceptibility and adherence.Wu, Hulin ; Huang, Yangxin ; Acosta, Edward P ; Park, Jeong-Gun ; Yu, Song ; Rosenkranz, Susan L ; Kuritzkes, Daniel R ; Eron, Joseph J ; Perelson, Alan S ; Gerber, John G2006 AugJ Pharmacokinet Pharmacodyn433
Neuropsychiatric complications of antiretroviral therapy.Cespedes, Michelle S ; Aberg, Judith A2006Drug Saf1029
N88D facilitates the co-occurrence of D30N and L90M and the development of multidrug resistance in HIV type 1 protease following nelfinavir treatment failure.Mitsuya, Yumi ; Winters, Mark A ; Fessel, W Jeffrey ; Rhee, Soo-Yon ; Hurley, Leo ; Horberg, Michael ; Schiffer, Celia A ; Zolopa, Andrew R ; Shafer, Robert W2006 DecAIDS Res Hum Retroviruses1222
Genetic attributes of cerebrospinal fluid-derived HIV-1 env.Pillai, Satish K ; Pond, Sergei L Kosakovsky ; Liu, Yang ; Good, Benjamin M ; Strain, Matthew C ; Ellis, Ronald J ; Letendre, Scott ; Smith, Davey M ; Günthard, Huldrych F ; Grant, Igor ; Marcotte, Thomas D ; McCutchan, J Allen ; Richman, Douglas D ; Wong, Joseph K2006 JulBrainPt 7129
Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection.Parsons, Thomas D ; Tucker, Karen A ; Hall, Colin D ; Robertson, Wendy T ; Eron, Joseph J ; Fried, Michael W ; Robertson, Kevin R2006 Aug 1AIDS1220
Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy after sustained virologic suppression.Swindells, Susan ; DiRienzo, A Gregory ; Wilkin, Timothy ; Fletcher, Courtney V ; Margolis, David M ; Thal, Gary D ; Godfrey, Catherine ; Bastow, Barbara ; Ray, M Graham ; Wang, Hongying ; Coombs, Robert W ; McKinnon, John ; Mellors, John W ; AIDS Clinical Trials Group 5201 Study Team2006 Aug 16JAMA7296
Adaptation to different human populations by HIV-1 revealed by codon-based analyses.Pond, Sergei L Kosakovsky ; Frost, Simon D W ; Grossman, Zehava ; Gravenor, Michael B ; Richman, Douglas D ; Brown, Andrew J Leigh2006 Jun 23PLoS Comput Biol62
Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.Gulick, Roy M ; Ribaudo, Heather J ; Shikuma, Cecilia M ; Lalama, Christina ; Schackman, Bruce R ; Meyer, William A ; Acosta, Edward P ; Schouten, Jeffrey ; Squires, Kathleen E ; Pilcher, Christopher D ; Murphy, Robert L ; Koletar, Susan L ; Carlson, Margrit ; Reichman, Richard C ; Bastow, Barbara ; Klingman, Karin L ; Kuritzkes, Daniel R 2006 Aug 16JAMA7296
Association between paired plasma and cervicovaginal lavage fluid HIV-1 RNA levels during 36 months.Cu-Uvin, Susan ; Snyder, Brad ; Harwell, Joseph I ; Hogan, Joseph ; Chibwesha, Carla ; Hanley, Dawn ; Ingersoll, Jessica ; Kurpewski, Jaclynn ; Mayer, Kenneth H ; Caliendo, Angela M2006 Aug 15J Acquir Immune Defic Syndr542
Rationale and uses of a public HIV drug-resistance database.Shafer, Robert W2006 Sep 15J Infect Dis194 Suppl 1
Characteristics of recently HIV-infected men who use the Internet to find male sex partners and sexual practices with those partners.Smith, Davey M ; Drumright, Lydia N ; Frost, Simon D W ; Cheng, W Susan ; Espitia, Stephen ; Daar, Eric S ; Little, Susan J ; Gorbach, Pamina M2006 Dec 15J Acquir Immune Defic Syndr543
Predictors of antiretroviral-related hepatotoxicity in the adult AIDS Clinical Trial Group (1989-1999).Servoss, Julie C ; Kitch, Douglas W ; Andersen, Janet W ; Reisler, Ronald B ; Chung, Raymond T ; Robbins, Gregory K2006 Nov 1J Acquir Immune Defic Syndr343
Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent.Snoeck, Joke ; Kantor, Rami ; Shafer, Robert W ; Van Laethem, Kristel ; Deforche, Koen ; Carvalho, Ana Patricia ; Wynhoven, Brian ; Soares, Marcelo A ; Cane, Patricia ; Clarke, John ; Pillay, Candice ; Sirivichayakul, Sunee ; Ariyoshi, Koya ; Holguin, Africa ; Rudich, Hagit ; Rodrigues, Rosangela ; Bouzas, Maria Belen ; Brun-Vézinet, Franç2006 FebAntimicrob Agents Chemother250
Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasma.Yuste, Eloisa ; Sanford, Hannah B ; Carmody, Jill ; Bixby, Jacqueline ; Little, Susan ; Zwick, Michael B ; Greenough, Tom ; Burton, Dennis R ; Richman, Douglas D ; Desrosiers, Ronald C ; Johnson, Welkin E2006 MarJ Virol680
A computer-based, image-analysis method to quantify HIV-1 infection in a single-cycle infectious center assay.Day, John R ; Martínez, Laura E ; Sásik, Roman ; Hitchin, Douglas L ; Dueck, Megan E ; Richman, Douglas D ; Guatelli, John C2006 OctJ Virol Methods1137
GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype.Schwarze-Zander, Carolynne ; Blackard, Jason T ; Zheng, Hui ; Addo, Marylyn M ; Lin, Wenyu ; Robbins, Gregory K ; Sherman, Kenneth E ; Zdunek, Dietmar ; Hess, Georg ; Chung, Raymond T ; AIDS Clinical Trial Group A5071 Study Team2006 Aug 15J Infect Dis4194
Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.Goicoechea, Miguel ; Smith, Davey M ; Liu, Lin ; May, Susanne ; Tenorio, Allan R ; Ignacio, Caroline C ; Landay, Alan ; Haubrich, Richard2006 Jul 1J Infect Dis1194
Reverse transcriptase mutations 118I, 208Y, and 215Y cause HIV-1 hypersusceptibility to non-nucleoside reverse transcriptase inhibitors.Clark, Shauna A ; Shulman, Nancy S ; Bosch, Ronald J ; Mellors, John W2006 Apr 24AIDS720
Osteopenia and osteoporosis in patients with HIV: a review of current concepts.Brown, Todd T ; McComsey, Grace A2006 MarCurr Infect Dis Rep28
Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group study.Haas, David W ; Geraghty, Daniel E ; Andersen, Janet ; Mar, Jessica ; Motsinger, Alison A ; D'Aquila, Richard T ; Unutmaz, Derya ; Benson, Constance A ; Ritchie, Marylyn D ; Landay, Alan ; AIDS Clinical Trials Group2006 Oct 15J Infect Dis8194
Human genetic variability and HIV treatment response.Haas, David W2006 JulCurr HIV/AIDS Rep23
HIV neuropathy natural history cohort study: assessment measures and risk factors.Simpson, D M ; Kitch, D ; Evans, S R ; McArthur, J C ; Asmuth, D M ; Cohen, B ; Goodkin, K ; Gerschenson, M ; So, Y ; Marra, C M ; Diaz-Arrastia, R ; Shriver, S ; Millar, L ; Clifford, D B ; ACTG A5117 Study Group2006 Jun 13Neurology1166
Oxidant stress and peripheral neuropathy during antiretroviral therapy: an AIDS clinical trials group study.Hulgan, Todd ; Hughes, Michael ; Sun, Xin ; Smeaton, Laura M ; Terry, Erin ; Robbins, Gregory K ; Shafer, Robert W ; Clifford, David B ; McComsey, Grace A ; Canter, Jeffery A ; Morrow, Jason D ; Haas, David W2006 Aug 1J Acquir Immune Defic Syndr442
Potential impact of antiretroviral therapy on HIV-1 transmission and AIDS mortality in resource-limited settings.Abbas, Ume L ; Anderson, Roy M ; Mellors, John W2006 Apr 15J Acquir Immune Defic Syndr541
Interferon-alpha differentially rescues CD4 and CD8 T cells from apoptosis in HIV infection.Rodriguez, Benigno ; Lederman, Michael M ; Jiang, Wei ; Bazdar, Douglas A ; Gàrate, Kristen ; Harding, Clifford V ; Sieg, Scott F2006 Jun 26AIDS1020
A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086.Benson, Constance A ; Vaida, Florin ; Havlir, Diane V ; Downey, Gerald F ; Lederman, Michael M ; Gulick, Roy M ; Glesby, Marshall J ; Wantman, Michael ; Bixby, Christian J ; Rinehart, Alex R ; Snyder, Sally ; Wang, Rui ; Patel, Sheran ; Mellors, John W ; ACTG A5086 Study Team2006 Nov 1J Infect Dis9194
Balancing disfigurement and fear of disease progression: Patient perceptions of HIV body fat redistribution.Reynolds, N R ; Neidig, J L ; Wu, A W ; Gifford, A L ; Holmes, W C2006 OctAIDS Care718
Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384.Gandhi, Rajesh T ; Spritzler, John ; Chan, Ellen ; Asmuth, David M ; Rodriguez, Benigno ; Merigan, Thomas C ; Hirsch, Martin S ; Shafer, Robert W ; Robbins, Gregory K ; Pollard, Richard B ; ACTG 384 Team2006 Aug 1J Acquir Immune Defic Syndr442
The K65R mutation in human immunodeficiency virus type 1 reverse transcriptase exhibits bidirectional phenotypic antagonism with thymidine analog mutations.Parikh, Urvi M ; Bacheler, Lee ; Koontz, Dianna ; Mellors, John W2006 MayJ Virol1080
Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068.Jacobson, Jeffrey M ; Pat Bucy, R ; Spritzler, John ; Saag, Michael S ; Eron, Joseph J ; Coombs, Robert W ; Wang, Rui ; Fox, Lawrence ; Johnson, Victoria A ; Cu-Uvin, Susan ; Cohn, Susan E ; Mildvan, Donna ; O'Neill, Dorothy ; Janik, Jennifer ; Purdue, Lynette ; O'Connor, Deborah K ; Vita, Christine Di ; Frank, Ian ; National Institute of 2006 Sep 1J Infect Dis5194
HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes.Rhee, Soo-Yon ; Kantor, Rami ; Katzenstein, David A ; Camacho, Ricardo ; Morris, Lynn ; Sirivichayakul, Sunee ; Jorgensen, Louise ; Brigido, Luis F ; Schapiro, Jonathan M ; Shafer, Robert W ; International Non Subtype B HIV-1 Working Group2006 Mar 21AIDS520
Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial.Mulligan, Kathleen ; Parker, Robert A ; Komarow, Lauren ; Grinspoon, Steven K ; Tebas, Pablo ; Robbins, Gregory K ; Roubenoff, Ronenn ; Dubé, Michael P2006 Apr 15J Acquir Immune Defic Syndr541
Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy.Foulkes, Andrea S ; Wohl, David A ; Frank, Ian ; Puleo, Elaine ; Restine, Stephanie ; Wolfe, Megan L ; Dubé, Michael P ; Tebas, Pablo ; Reilly, Muredach P2006 MarPLoS Med33
A reduced frequency visit schedule underreports adverse events that resulted in dose modifications or treatment discontinuations in HIV/AIDS clinical trials: ACTG DACS 207.Kendall, Michelle A ; Andersen, Janet W ; van der Horst, Charles2006 JunContemp Clin Trials327
Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy.Kallianpur, Asha R ; Hulgan, Todd ; Canter, Jeffrey A ; Ritchie, Marylyn D ; Haines, Jonathan L ; Robbins, Gregory K ; Shafer, Robert W ; Clifford, David B ; Haas, David W2006 Jul 13AIDS1120
Microbial translocation is a cause of systemic immune activation in chronic HIV infection.Brenchley, Jason M ; Price, David A ; Schacker, Timothy W ; Asher, Tedi E ; Silvestri, Guido ; Rao, Srinivas ; Kazzaz, Zachary ; Bornstein, Ethan ; Lambotte, Olivier ; Altmann, Daniel ; Blazar, Bruce R ; Rodriguez, Benigno ; Teixeira-Johnson, Leia ; Landay, Alan ; Martin, Jeffrey N ; Hecht, Frederick M ; Picker, Louis J ; Lederman, Michael2006 DecNat Med1212
Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapy.Weinberg, Adriana ; Tierney, Camlin ; Kendall, Michelle A ; Bosch, Ronald J ; Patterson-Bartlett, Julie ; Erice, Alejo ; Hirsch, Martin S ; Polsky, Bruce ; AIDS Clinical Trials Group 360 Team2006 Feb 15J Infect Dis4193
Sensitive assay for determining plasma tenofovir concentrations by LC/MS/MS.Delahunty, Tom ; Bushman, Lane ; Fletcher, Courtney V2006 Jan 2J Chromatogr B Analyt Technol Biomed Life Sci1830
Amdoxovir versus placebo with enfuvirtide plus optimized background therapy for HIV-1-infected subjects failing current therapy (AACTG A5118).Gripshover, Barbara M ; Ribaudo, Heather ; Santana, Jorge ; Gerber, John G ; Campbell, Thomas B ; Hogg, Evelyn ; Jarocki, Bernadette ; Hammer, Scott M ; Kuritzkes, Daniel R ; A5118 Team2006Antivir Ther511
Immune surveillance in multiple sclerosis patients treated with natalizumab.Stüve, Olaf ; Marra, Christina M ; Jerome, Keith R ; Cook, Linda ; Cravens, Petra D ; Cepok, Sabine ; Frohman, Elliot M ; Phillips, J Theodore ; Arendt, Gabriele ; Hemmer, Bernhard ; Monson, Nancy L ; Racke, Michael K2006 MayAnn Neurol559
Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.Stüve, Olaf ; Marra, Christina M ; Bar-Or, Amit ; Niino, Masaaki ; Cravens, Petra D ; Cepok, Sabine ; Frohman, Elliot M ; Phillips, J Theodore ; Arendt, Gabriele ; Jerome, Keith R ; Cook, Linda ; Grand'Maison, Francois ; Hemmer, Bernhard ; Monson, Nancy L ; Racke, Michael K2006 OctArch Neurol1063
Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study.Ribaudo, Heather J ; Haas, David W ; Tierney, Camlin ; Kim, Richard B ; Wilkinson, Grant R ; Gulick, Roy M ; Clifford, David B ; Marzolini, Catia ; Fletcher, Courtney V ; Tashima, Karen T ; Kuritzkes, Daniel R ; Acosta, Edward P ; Adult AIDS Clinical Trials Group Study2006 Feb 1Clin Infect Dis342
Lack of neutralizing antibody response to HIV-1 predisposes to superinfection.Smith, Davey M ; Strain, Matthew C ; Frost, Simon D W ; Pillai, Satish K ; Wong, Joseph K ; Wrin, Terri ; Liu, Yang ; Petropolous, Christos J ; Daar, Eric S ; Little, Susan J ; Richman, Douglas D2006 Nov 10Virology1355
HIV-1 drug resistance genotype results in patients with plasma samples with HIV-1 RNA levels less than 75 copies/mL.Mitsuya, Yumi ; Winters, Mark A ; Fessel, W Jeffrey ; Rhee, Soo-Yon ; Slome, Sally ; Flamm, Jason ; Horberg, Michael ; Hurley, Leo ; Klein, Daniel ; Shafer, Robert W2006 SepJ Acquir Immune Defic Syndr143
A pilot study evaluating time to CD4 T-cell count <350 cells/mm(3) after treatment interruption following antiretroviral therapy +/- interleukin 2: results of ACTG A5102.Henry, Keith ; Katzenstein, David ; Cherng, Deborah Weng ; Valdez, Hernan ; Powderly, William ; Vargas, Michelle Blanchard ; Jahed, Nasreen C ; Jacobson, Jeffrey M ; Myers, Laurie S ; Schmitz, John L ; Winters, Mark ; Tebas, Pablo ; A5102 Study Team of the AIDS Clinical Trials Group2006 JunJ Acquir Immune Defic Syndr242
Design issues in initial HIV-treatment trials: focus on ACTG A5095.Ribaudo, Heather J ; Kuritzkes, Daniel R ; Schackman, Bruce R ; Acosta, Edward P ; Shikuma, Cecilia M ; Gulick, Roy M2006Antivir Ther611
Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaboration.Haas, David W ; Bartlett, John A ; Andersen, Janet W ; Sanne, Ian ; Wilkinson, Grant R ; Hinkle, John ; Rousseau, Franck ; Ingram, Christiana D ; Shaw, Audrey ; Lederman, Michael M ; Kim, Richard B ; Adult AIDS Clinical Trials Group2006 Sep 15Clin Infect Dis643
Biology of CCR5 and its role in HIV infection and treatment.Lederman, Michael M ; Penn-Nicholson, Adam ; Cho, Michael ; Mosier, Donald2006 Aug 16JAMA7296
Effects of HCV treatment on cytokine expression during HCV/HIV coinfection.Blackard, Jason T ; Kang, Minhee ; Sherman, Kenneth E ; Koziel, Margaret James ; Peters, Marion G ; Chung, Raymond T2006 NovJ Interferon Cytokine Res1126
Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127.Peters, Marion G ; Andersen, Janet ; Lynch, Patrick ; Liu, Tun ; Alston-Smith, Beverly ; Brosgart, Carol L ; Jacobson, Jeffrey M ; Johnson, Victoria A ; Pollard, Richard B ; Rooney, James F ; Sherman, Kenneth E ; Swindells, Susan ; Polsky, Bruce ; ACTG Protocol A5127 Team2006 NovHepatology544
Antiviral drug resistance.Richman, Douglas D2006 SepAntiviral Res2-371
Variations in self-rated health among patients with HIV infection.Mrus, Joseph M ; Schackman, Bruce R ; Wu, Albert W ; Freedberg, Kenneth A ; Tsevat, Joel ; Yi, Michael S ; Zackin, Robert2006 AprQual Life Res315
Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study.Motsinger, Alison A ; Ritchie, Marylyn D ; Shafer, Robert W ; Robbins, Gregory K ; Morse, Gene D ; Labbe, Line ; Wilkinson, Grant R ; Clifford, David B ; D'Aquila, Richard T ; Johnson, Victoria A ; Pollard, Richard B ; Merigan, Thomas C ; Hirsch, Martin S ; Donahue, John P ; Kim, Richard B ; Haas, David W2006 NovPharmacogenet Genomics1116
What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials.Gilbert, Peter B ; DeGruttola, Victor G ; Hudgens, Michael G ; Self, Steven G ; Hammer, Scott M ; Corey, Lawrence2003 Jul 15J Infect Dis2188
Impact of pre-adapted HIV transmission.